Îñòàâüòå ññûëêó íà ýòó ñòðàíèöó â ñîöñåòÿõ:

Ïîèñê ïî áàçå äîêóìåíòîâ:

 

ÌÈÍÈÑÒÅÐÑÒÂÎ ÇÄÐÀÂÎÎÕÐÀÍÅÍÈß È ÌÅÄÈÖÈÍÑÊÎÉ ÏÐÎÌÛØËÅÍÍÎÑÒÈ

ÐÎÑÑÈÉÑÊÎÉ ÔÅÄÅÐÀÖÈÈ

 

ÁÞÐÎ ÏÎ ÐÅÃÈÑÒÐÀÖÈÈ ËÅÊÀÐÑÒÂÅÍÍÛÕ ÑÐÅÄÑÒÂ,

ÌÅÄÈÖÈÍÑÊÎÉ ÒÅÕÍÈÊÈ È ÈÇÄÅËÈÉ ÌÅÄÈÖÈÍÑÊÎÃÎ ÍÀÇÍÀ×ÅÍÈß

 

ÃÎÑÓÄÀÐÑÒÂÅÍÍÛÉ ÐÅÅÑÒÐ ËÅÊÀÐÑÒÂÅÍÍÛÕ ÑÐÅÄÑÒÂ

(Ïðîäîëæåíèå)

 

Ðàçäåë 2. ËÅÊÀÐÑÒÂÅÍÍÛÅ ÑÐÅÄÑÒÂÀ. (Îêîí÷àíèå)

 


 

┌──────────────────────────────────────────────────┬────────────────────────────────────────┬──────────────────────────────┬──────────────────────────────┬───────────────┐

│ Òîðãîâîå íàçâàíèå [ìåæä.íàçâàíèå] (Ñîñòàâ)          Ôàðì. ãðóïïà [Êîä ÀÒÑ]                    Ôîðìà âûïóñêà                   Ôèðìà (Ñòðàíà)         │ Íîìåð, Äàòà  

├──────────────────────────────────────────────────┼────────────────────────────────────────┼──────────────────────────────┼──────────────────────────────┼───────────────┤

│Öåïðîâà [Öèïðîôëîêñàöèí]                          │ïðîòèâîìèêðîáíîå ñðåäñòâî, ôòîðõèíîëîí  │òàáëåòêè 250, 500 ìã          │Lupin International (Èíäèÿ)   │003011,       

                                                  │[J01MA02]                                                                                           │28.05.93      

                                                                                                                                                                    

│Öåðâèïðîñò [Äèíîïðîñòîí]                          │ðîäîâîé äåÿòåëüíîñòè ñòèìóëÿòîð         │ïîðîøîê äëÿ ïðèãîòîâëåíèÿ     │Organon International         │002749,       

                                                  │[G02AD02]                               │èíòðàöåðâèêàëüíîãî ãåëÿ       │(Íèäåðëàíäû)                  │11.12.92      

                                                                                          │(øïðèö äâóõêàìåðíûé) - 0.5 ìã │                                            

                                                                                          │/â êîìïëåêòå ñ ðàñòâîðèòåëåì/ │                                             

                                                                                                                                                                    

│Öåðåáîë [Ïèðèòèíîë]                               │íîîòðîïíîå ñðåäñòâî [N06BX02]           │òàáëåòêè 100 ìã; ñóñïåíçèÿ    │Themis Chemicals Ltd (Èíäèÿ)  │003406,       

                                                                                          │îðàëüíàÿ 100 ìã|5 ìë                                        │12.10.93      

                                                                                                                                                                    

│Öåðåáðèë [Ïèðàöåòàì]                              │íîîòðîïíîå ñðåäñòâî [N06BX03]           │òàáëåòêè ïîêðûòûå îáîëî÷êîé   │F.Joh.Quisda GmbH (Àâñòðèÿ)   │005940,       

                                                                                          │800 ìã                                                      │10.04.95      

                                                                                                                                                                    

│Öåðåáðèë [Ïèðàöåòàì]                              │íîîòðîïíîå ñðåäñòâî [N06BX03]           │òàáëåòêè ïîêðûòûå îáîëî÷êîé   │F.Joh.Quisda GmbH (Àâñòðèÿ)   │006383,       

                                                                                          │1200 ìã; ñèðîï (ôëàêîíû) 200                                │09.08.95      

                                                                                          │ìã/ìë; ðàñòâîð äëÿ èíôóçèé                                                

                                                                                          │(ôëàêîíû) 12 ã/250 ìë                                                     

                                                                                                                                                                    

│Öåðåáðîëèçèí                                      │íîîòðîïíîå ñðåäñòâî [N06BX]             │ðàñòâîð äëÿ èíúåêöèé (àìïóëû) │Ebewe (Àâñòðèÿ)               │00736,        

                                                                                          │1 ìë                                                        │19.02.80,     

                                                                                                                                                      │24.01.91      

                                                                                                                                                                    

│Öåðåáðîëèçèí                                      │íîîòðîïíîå ñðåäñòâî [N06BX]             │ðàñòâîð äëÿ èíúåêöèé (àìïóëû) │Ebewe (Àâñòðèÿ)               │01970, 01.10.90│

                                                                                          │5 ìë                                                                      

                                                                                                                                                                    

│Öåðåáðîëèçèí                                      │íîîòðîïíîå ñðåäñòâî [N06BX]             │ðàñòâîð äëÿ èíúåêöèé (àìïóëû) │Ebewe (Àâñòðèÿ)               │002067,       

                                                                                          │10 ìë                                                       │13.03.91      

                                                                                                                                                                    

│Öåðóáèäèí [Äàóíîðóáèöèí]                          │öèòîñòàòè÷åñêîå ñðåäñòâî [L01DB02]      │ëèîôèëèç.ïîðîøîê äëÿ          │Rhone-Poulenc Rorer (Ôðàíöèÿ) │005083,       

                                                                                          │ïðèãîòîâëåíèÿ èíúåêöèîííîãî                                 │05.07.94      

                                                                                          │ðàñòâîðà (ôëàêîíû) 20 ìã                                                  

                                                                                                                                                                    

│Öåðóêàë [Ìåòîêëîïðàìèä]                           │äîôàìèí-áëîêàòîð öåíòðàëüíûé [A03FA01]  │òàáëåòêè 10 ìã; ðàñòâîð äëÿ   │Arzneimittelwerk Dresden GmbH │00407,        

                                                                                          │èíúåêöèé (àìïóëû) 10 ìã - 2 ìë│(Ãåðìàíèÿ)                    │03.02.95,     

                                                                                                                                                      │10.05.89,     

                                                                                                                                                      │19.10.76      

                                                                                                                                                                    

│Öåðóëàí [Ìåòîêëîïðàìèä]                           │äîôàìèí-áëîêàòîð öåíòðàëüíûé [A03FA01]  │òàáëåòêè 10 ìã; ðàñòâîð äëÿ   │Rusan Pharma (Èíäèÿ)          │005648,       

                                                                                          │èíúåêöèé (àìïóëû) 10 ìã/2 ìë                                │16.01.95      

                                                                                                                                                                    

│Öåðóòèë [Ìåêëîôåíîêñàò]                           │íîîòðîïíîå ñðåäñòâî [N06BX01]           │äðàæå 250 ìã                  │Isis Pharma GmbH (Ãåðìàíèÿ)   │00946,        

                                                                                                                                                      │09.06.94,     

                                                                                                                                                      │15.11.82       

                                                                                                                                                                    

│Öåñîë [Ïðàçèêâàíòåë]                              │ïðîòèâîãåëüìèíòíîå ñðåäñòâî [P02BA01]   │òàáëåòêè 150 ìã               │Merck (india) Ltd (Èíäèÿ)     │002871,       

                                                                                                                                                      │25.02.93       

                                                                                                                                                                    

│Öåòåáå [Àñêîðáèíîâàÿ êèñëîòà]                     │âèòàìèí [A11GA01]                       │êàïñóëû 500 ìã                │Otto A.H.Wolfer GmbH          │005851,       

                                                                                                                        │(Ãåðìàíèÿ)                    │13.03.95      

                                                                                                                                                                    

│Öåòðèí [Öåòèðèçèí]                                │H1-ãèñòàìèíîâûõ ðåöåïòîðîâ áëîêàòîð     │òàáëåòêè ïîêðûòûå îáîëî÷êîé   │Dr.Reddy's Laboratories Ltd   │006937,       

                                                  │[R06AE07]                               │10 ìã                         │(Èíäèÿ)                       │21.12.95      

                                                                                                                                                                    

│Öåôàáåíå [Öåôàëåêñèí]                             │àíòèáèîòèê, öåôàëîñïîðèí [J01DA01]      │òàáëåòêè ïîêðûòûå ïëåíî÷íîé   │Ludwig Merckle GmbH (Àâñòðèÿ) │002987,       

                                                                                          │îáîëî÷êîé 500, 1000 ìã;                                     │27.04.93      

                                                                                          │ïîðîøîê äëÿ ïðèãîòîâëåíèÿ                                                 

                                                                                          │ñèðîïà 250 ìã|5 ìë                                                        

                                                                                                                                                                    

│Öåôàäàð [Öåôàëåêñèí]                              │àíòèáèîòèê, öåôàëîñïîðèí [J01DA01]      │êàïñóëû 250 ìã; êàïñóëû ôîðòå │Dar Al Dava (Èîðäàíèÿ)        │003146,       

                                                                                          │500 ìã; ãðàíóëû äëÿ                                         │07.07.93      

                                                                                          │ïðèãîòîâëåíèÿ îðàëüíîé                                                    

                                                                                          │ñóñïåíçèè (ôëàêîíû) 125 ìã|5                                              

                                                                                          │ìë, 250 ìã|5 ìë                                                           

                                                                                                                                                                    

│Öåôàäæåò [Öåôîòàêñèì]                             │àíòèáèîòèê, öåôàëîñïîðèí [J01DA10]      │ïîðîøîê äëÿ ïðèãîòîâëåíèÿ     │Armour Chemicals Ltd (Èíäèÿ)  │002502,       

                                                                                          │èíúåêöèîííîãî ðàñòâîðà                                      │08.06.92      

                                                                                          │(ôëàêîíû) 250, 500, 1000 ìã                                               

                                                                                                                                                                    

│Öåôàçîëèí [Öåôàçîëèí]                             │àíòèáèîòèê, öåôàëîñïîðèí [J01DA04]      │ïîðîøîê äëÿ ïðèãîòîâëåíèÿ     │Astrapin (Ãåðìàíèÿ)           │003636,       

                                                                                          │èíúåêöèîííîãî ðàñòâîðà                                      │20.01.94      

                                                                                          │(ôëàêîíû) 1 ã                                                             

                                                                                                                                                                    

│Öåôàçîëèí [Öåôàçîëèí]                             │àíòèáèîòèê, öåôàëîñïîðèí [J01DA04]      │ïîðîøîê äëÿ ïðèãîòîâëåíèÿ     │Biochemie GmbH (Àâñòðèÿ)      │003526,       

                                                                                          │èíúåêöèîííîãî ðàñòâîðà                                      │25.11.93      

                                                                                          │(ôëàêîíû) 1 ã                                                             

                                                                                                                                                                    

│Öåôàçîëèí [Öåôàçîëèí]                             │àíòèáèîòèê, öåôàëîñïîðèí [J01DA04]      │ïîðîøîê äëÿ ïðèãîòîâëåíèÿ     │Biochemie GmbH (Àâñòðèÿ)      │005152,       

                                                                                          │èíúåêöèîííîãî ðàñòâîðà                                      │20.07.94      

                                                                                          │(ôëàêîíû) 500 ìã                                                          

                                                                                                                                                                    

│Öåôàçîëèí [Öåôàçîëèí]                             │àíòèáèîòèê, öåôàëîñïîðèí [J01DA04]      │ïîðîøîê äëÿ ïðèãîòîâëåíèÿ     │Dee-Pharma Ltd (Èíäèÿ)        │003585,       

                                                                                          │èíúåêöèîííîãî ðàñòâîðà                                      │14.12.93      

                                                                                          │(ôëàêîíû) 250, 500, 1000 ìã                                               

                                                                                                                                                                    

│Öåôàçîëèí [Öåôàçîëèí]                             │àíòèáèîòèê, öåôàëîñïîðèí [J01DA04]      │ïîðîøîê äëÿ ïðèãîòîâëåíèÿ     │Mir Pharmaceutical Inc/Lemmon │007670,       

                                                                                          │èíúåêöèîííîãî ðàñòâîðà        │(ÑØÀ)                         │23.07.96      

                                                                                          │(ôëàêîíû) 0.25, 0.5, 1 ã - 10 │                                            

                                                                                          │ìë; ðàñòâîð äëÿ ïðèãîòîâëåíèÿ │                                            

                                                                                          │èíôóçèîííîãî ðàñòâîðà                                                     

                                                                                          │(ôëàêîíû) 0.5, 1 ã - 100 ìë                                               

                                                                                                                                                                    

│Öåôàçîëèí [Öåôàçîëèí]                             │àíòèáèîòèê, öåôàëîñïîðèí [J01DA04]      │ïîðîøîê äëÿ ïðèãîòîâëåíèÿ     │Pan Pharma (Ôðàíöèÿ)          │005363,       

                                                                                          │èíúåêöèîííîãî ðàñòâîðà                                      │26.09.94      

                                                                                          │(ôëàêîíû) 0.5, 1 ã                                                        

                                                                                                                                                                    

│Öåôàçîëèí [Öåôàçîëèí]                             │àíòèáèîòèê, öåôàëîñïîðèí [J01DA04]      │ïîðîøîê äëÿ ïðèãîòîâëåíèÿ     │Pharmachim (ÍÐÁ)              │3005, 28.12.90 │

                                                                                          │èíúåêöèîííîãî ðàñòâîðà                                                    

                                                                                          │(ôëàêîíû) 250, 500 ìã                                                     

                                                                                                                                                                    

│Öåôàçîëèí [Öåôàçîëèí]                             │àíòèáèîòèê, öåôàëîñïîðèí [J01DA04]      │ïîðîøîê äëÿ ïðèãîòîâëåíèÿ     │Pharmachim (ÍÐÁ)              │3013, 22.03.91 │

                                                                                          │èíúåêöèîííîãî ðàñòâîðà                                                     

                                                                                          │(ôëàêîíû) 1 ã, 2 ã                                                        

                                                                                                                                                                    

│Öåôàçîëèí íàòðèåâûé [Öåôàçîëèí]                   │àíòèáèîòèê, öåôàëîñïîðèí [J01DA04]      │ïîðîøîê äëÿ ïðèãîòîâëåíèÿ     │Pan Pharma (Ôðàíöèÿ)          │003022,        

                                                                                          │èíúåêöèîííîãî ðàñòâîðà                                      │01.06.93      

                                                                                          │(ôëàêîíû) 1 ã                                                             

                                                                                                                                                                     

│Öåôàçîëèí íàòðèÿ [Öåôàçîëèí]                      │àíòèáèîòèê, öåôàëîñïîðèí [J01DA04]      │ïîðîøîê äëÿ ïðèãîòîâëåíèÿ     │Rotexmedica Osoo (Ãåðìàíèÿ)   │005436,       

                                                                                          │èíúåêöèîííîãî ðàñòâîðà                                      │28.10.94      

                                                                                          │(ôëàêîíû) 500 ìã                                                           

                                                                                                                                                                    

│Öåôàçîëèí-Òåâà [Öåôàçîëèí]                        │àíòèáèîòèê, öåôàëîñïîðèí [J01DA04]      │ïîðîøîê äëÿ ïðèãîòîâëåíèÿ     │Teva Pharmaceutical           │003755,       

                                                                                          │èíúåêöèîííîãî ðàñòâîðà        │Industries Ltd (Èçðàèëü)      │15.03.94      

                                                                                          │(ôëàêîíû) 1 ã                                                             

                                                                                                                                                                    

│Öåôàçîëèíà íàòðèåâàÿ ñîëü [Öåôàçîëèí]             │àíòèáèîòèê, öåôàëîñïîðèí [J01DA04]      │ïîðîøîê äëÿ ïðèãîòîâëåíèÿ     │Cheil Foods & Chemicals Inc   │005831,       

                                                                                          │èíúåêöèîííîãî ðàñòâîðà        │(Êîðåÿ Þæíàÿ)                 │16.03.95      

                                                                                          │(ôëàêîíû) 0.5, 1 ã                                                        

                                                                                                                                                                    

│Öåôàçîëèíà íàòðèåâàÿ ñîëü [Öåôàçîëèí]             │àíòèáèîòèê, öåôàëîñïîðèí [J01DA04]      │ïîðîøîê äëÿ ïðèãîòîâëåíèÿ     │Hindustan Antibiotics Ltd     │006023,       

                                                                                          │èíúåêöèîííîãî ðàñòâîðà        │(Èíäèÿ)                       │04.05.95      

                                                                                          │(ôëàêîíû) 0.5, 1 ã                                                        

                                                                                                                                                                    

│Öåôàêëåí [Öåôàëåêñèí]                             │àíòèáèîòèê, öåôàëîñïîðèí [J01DA01]      │òàáëåòêè 250, 500 ìã          │Slovakofarma SA (Ñëîâàêèÿ)    │005157,       

                                                                                                                                                      │20.07.94      

                                                                                                                                                                    

│Öåôàêñîí [Öåôòðèàêñîí]                            │àíòèáèîòèê, öåôàëîñïîðèí [J01DA13]      │ïîðîøîê äëÿ ïðèãîòîâëåíèÿ     │Lupin International (Èíäèÿ)   │002835,       

                                                                                          │èíúåêöèîííîãî ðàñòâîðà                                      │10.02.93      

                                                                                          │(ôëàêîíû) 250, 500, 1000 ìã                                               

                                                                                                                                                                    

│Öåôàëåêñ [Öåôàëåêñèí]                             │àíòèáèîòèê, öåôàëîñïîðèí [J01DA01]      │òàáëåòêè ïîêðûòûå îáîëî÷êîé   │CT-Arzneimittel Chemishe      │002892,       

                                                                                          │500, 1000 ìã                  │Tempelchof GmbH (ÔÐÃ)         │03.03.93      

                                                                                                                                                                    

│Öåôàëåêñèí [Öåôàëåêñèí]                           │àíòèáèîòèê, öåôàëîñïîðèí [J01DA01]      │êàïñóëû 250, 500 ìã           │Sanavita Gesundcheitsmittel & │005862,       

                                                                                                                        │Co Kg (Ãåðìàíèÿ)              │23.03.95      

                                                                                                                                                                    

│Öåôàëåêñèí [Öåôàëåêñèí]                           │àíòèáèîòèê, öåôàëîñïîðèí [J01DA01]      │êàïñóëû 250, 500 ìã; ïîðîøîê  │Dee-Pharma Ltd (Èíäèÿ)        │003580,       

                                                                                          │äëÿ ïðèãîòîâëåíèÿ îðàëüíîé                                  │14.12.93      

                                                                                          │ñóñïåíçèè 125 ìã|5 ìë                                                     

                                                                                                                                                                    

│Öåôàëåêñèí [Öåôàëåêñèí]                           │àíòèáèîòèê, öåôàëîñïîðèí [J01DA01]      │êàïñóëû 250, 500 ìã; ñèðîï    │Hemofarm D.D. (Þãîñëàâèÿ)     │003796,       

                                                                                                                                                      │29.03.94      

                                                                                                                                                                    

│Öåôàëåêñèí [Öåôàëåêñèí]                           │àíòèáèîòèê, öåôàëîñïîðèí [J01DA01]      │êàïñóëû 250 ìã                │Pharmachim (ÍÐÁ)              │2996, 30.10.90 │

                                                                                                                                                                    

│Öåôàëåêñèí-ðàòèîôàðì [Öåôàëåêñèí]                 │àíòèáèîòèê, öåôàëîñïîðèí [J01DA01]      │òàáëåòêè ïîêðûòûå îáîëî÷êîé   │Ratiopharm GmbH & Co          │005647,       

                                                                                          │500 ìã; ãðàíóëû äëÿ           │(Ãåðìàíèÿ)                    │13.01.95      

                                                                                          │ïðèãîòîâëåíèÿ îðàëüíîé                                                    

                                                                                          │ñóñïåíçèè 250 ìã|5 ìë                                                     

                                                                                                                                                                    

│Öåôàëåêñèí-Òåâà [Öåôàëåêñèí]                      │àíòèáèîòèê, öåôàëîñïîðèí [J01DA01]      │êàïñóëû 250, 500 ìã;          │Teva Pharmaceutical           │003176,       

                                                                                          │ñóñïåíçèÿ îðàëüíàÿ 125 ìã|5   │Industries Ltd (Èçðàèëü)      │02.08.93      

                                                                                          │ìë, 250 ìã|5 ìë                                                           

                                                                                                                                                                    

│Öåôàëîòèí [Öåôàëîòèí]                             │àíòèáèîòèê, öåôàëîñïîðèí [J01DA03]      │ïîðîøîê äëÿ ïðèãîòîâëåíèÿ     │Pharmachim (ÍÐÁ)              │3014, 25.03.91 │

                                                                                          │èíúåêöèîííîãî ðàñòâîðà                                                    

                                                                                          │(ôëàêîíû) 1 ã                                                             

                                                                                                                                                                    

│Öåôàìàíäîë [Öåôàìàíäîë]                           │àíòèáèîòèê, öåôàëîñïîðèí [J01DA07]      │ïîðîøîê äëÿ ïðèãîòîâëåíèÿ     │Pharmachim (Áîëãàðèÿ)         │003874,        

                                                                                          │èíúåêöèîííîãî ðàñòâîðà                                      │26.04.94      

                                                                                          │(ôëàêîíû) 0.5, 1, 2 ã                                                     

                                                                                                                                                                     

│Öåôàìåçèí [Öåôàçîëèí]                             │àíòèáèîòèê, öåôàëîñïîðèí [J01DA04]      │ïîðîøîê äëÿ ïðèãîòîâëåíèÿ     │Al-Hikma Pharmaceuticals      │002103,       

                                                                                          │èíúåêöèîííîãî ðàñòâîðà        │(Èîðäàíèÿ)                    │12.04.91      

                                                                                          │(ôëàêîíû) 1 ã                                                              

                                                                                                                                                                    

│Öåôàìåçèí [Öåôàçîëèí]                             │àíòèáèîòèê, öåôàëîñïîðèí [J01DA04]      │ïîðîøîê äëÿ ïðèãîòîâëåíèÿ     │Al-Hikma Pharmaceuticals      │002590,       

                                                                                          │èíúåêöèîííîãî ðàñòâîðà        │(Èîðäàíèÿ)                    │05.08.92      

                                                                                          │(ôëàêîíû) 0.25, 0.5, 10 ã                                                 

                                                                                                                                                                    

│Öåôàìåçèí [Öåôàçîëèí]                             │àíòèáèîòèê, öåôàëîñïîðèí [J01DA04]      │ïîðîøîê äëÿ ïðèãîòîâëåíèÿ     │Dong-A Pharmaceuticals Co Ltd │002145,       

                                                                                          │èíúåêöèîííîãî ðàñòâîðà        │(Êîðåÿ Þæíàÿ)                 │28.05.91      

                                                                                          │(ôëàêîíû) 0.5, 1 ã                                                        

                                                                                                                                                                    

│Öåôàìåçèí [Öåôàçîëèí]                             │àíòèáèîòèê, öåôàëîñïîðèí [J01DA04]      │ïîðîøîê äëÿ ïðèãîòîâëåíèÿ     │Eczacibasi (Òóðöèÿ)           │01473, 30.08.88│

                                                                                          │èíúåêöèîííîãî ðàñòâîðà                                                    

                                                                                          │(ôëàêîíû) 0.5, 1 ã                                                        

                                                                                                                                                                    

│Öåôàìåçèí [Öåôàçîëèí]                             │àíòèáèîòèê, öåôàëîñïîðèí [J01DA04]      │ïîðîøîê äëÿ ïðèãîòîâëåíèÿ     │Fujisawa Pharmaceutical Co    │00399,        

                                                                                          │èíúåêöèîííîãî ðàñòâîðà        │Ltd (ßïîíèÿ)                  │14.09.76,     

                                                                                          │(ôëàêîíû) 250, 500, 1000 ìã                                 │20.02.87      

                                                                                                                                                                    

│Öåôàìåçèí [Öåôàçîëèí]                             │àíòèáèîòèê, öåôàëîñïîðèí [J01DA04]      │ïîðîøîê äëÿ ïðèãîòîâëåíèÿ     │Fujisawa Pharmaceutical Co    │002352,       

                                                                                          │èíúåêöèîííîãî ðàñòâîðà        │Ltd (Òàéâàíü)                 │16.01.92      

                                                                                          │(ôëàêîíû) 0.5, 1 ã                                                        

                                                                                                                                                                    

│Öåôàìåçèí [Öåôàçîëèí]                             │àíòèáèîòèê, öåôàëîñïîðèí [J01DA04]      │ïîðîøîê äëÿ ïðèãîòîâëåíèÿ     │Fujisawa Pharmaceutical Co    │003955,       

                                                                                          │èíúåêöèîííîãî ðàñòâîðà        │Ltd (Êîðåÿ Þæíàÿ)             │30.05.94      

                                                                                          │(ôëàêîíû) 0.5, 1 ã                                                        

                                                                                                                                                                    

│Öåôàìåçèí [Öåôàçîëèí]                             │àíòèáèîòèê, öåôàëîñïîðèí [J01DA04]      │ïîðîøîê äëÿ ïðèãîòîâëåíèÿ     │Krka (Þãîñëàâèÿ)              │00418,        

                                                                                          │èíúåêöèîííîãî ðàñòâîðà                                      │04.11.87,     

                                                                                          │(ôëàêîíû) 1 ã                                               │27.10.76      

                                                                                                                                                                    

│Öåôàíòðàë [Öåôîòàêñèì]                            │àíòèáèîòèê, öåôàëîñïîðèí [J01DA10]      │ëèîôèëèç.ïîðîøîê äëÿ          │Lupin Laboratories Ltd (Èíäèÿ)│003816,       

                                                                                          │ïðèãîòîâëåíèÿ èíúåêöèîííîãî                                 │31.03.94      

                                                                                          │ðàñòâîðà (ôëàêîíû) 250, 500,                                              

                                                                                          │1000 ìã                                                                   

                                                                                                                                                                    

│Öåôàïèçîí [Öåôîïåðàçîí]                           │àíòèáèîòèê, öåôàëîñïîðèí [J01DA32]      │ïîðîøîê äëÿ ïðèãîòîâëåíèÿ     │Shin Poong Ltd (Êîðåÿ Þæíàÿ)  │002735,       

                                                                                          │èíúåêöèîííîãî ðàñòâîðà                                      │09.12.92      

                                                                                          │(ôëàêîíû) 1 ã                                                             

                                                                                                                                                                    

│Öåôàòðåêñèë [Öåôàïèðèí]                           │àíòèáèîòèê, öåôàëîñïîðèí [J01DA30]      │ïîðîøîê äëÿ ïðèãîòîâëåíèÿ     │Bristol Italiana (Èòàëèÿ)     │00761, 19.05.80│

                                                                                          │èíúåêöèîííîãî ðàñòâîðà                                                    

                                                                                          │(ôëàêîíû) 1 ã                                                             

                                                                                                                                                                    

│Öåôìåòàçîí [Öåôìåòàçîë]                           │àíòèáèîòèê, öåôàëîñïîðèí [J01DA40]      │ïîðîøîê äëÿ ïðèãîòîâëåíèÿ     │Sankyo Co Ltd (ßïîíèÿ)        │002869,       

                                                                                          │âíóòðèâåííîãî ðàñòâîðà                                      │22.02.93      

                                                                                          │(ôëàêîíû) 0.5 ã, 1 ã, 2 ã;                                                

                                                                                          │ïîðîøîê äëÿ ïðèãîòîâëåíèÿ                                                 

                                                                                          │âíóòðèìûøå÷íîãî ðàñòâîðà                                                  

                                                                                          │(ôëàêîíû) 0.5 ã                                                           

                                                                                                                                                                    

│Öåôîáàê [Öèïðîôëîêñàöèí]                          │ïðîòèâîìèêðîáíîå ñðåäñòâî, ôòîðõèíîëîí  │òàáëåòêè ïîêðûòûå îáîëî÷êîé   │Rusan Pharma (Èíäèÿ)          │007609,       

                                                  │[J01MA02]                               │250, 500 ìã; ðàñòâîð äëÿ                                    │25.06.96      

                                                                                          │èíôóçèé (ôëàêîíû) 200 ìã|100                                               

                                                                                          │ìë - 100 ìë                                                               

                                                                                                                                                                    

│Öåôîáèä [Öåôîïåðàçîí]                             │àíòèáèîòèê, öåôàëîñïîðèí [J01DA32]      │ïîðîøîê äëÿ ïðèãîòîâëåíèÿ     │Biogal (Âåíãðèÿ)              │002523,        

                                                                                          │èíúåêöèîííîãî ðàñòâîðà                                      │22.06.92      

                                                                                          │(àìïóëû) 1 ã, 2 ã                                                         

                                                                                                                                                                     

│Öåôîáèä [Öåôîïåðàçîí]                             │àíòèáèîòèê, öåôàëîñïîðèí [J01DA32]      │ïîðîøîê äëÿ ïðèãîòîâëåíèÿ     │Pfizer (ÑØÀ)                  │01483, 14.09.88│

                                                                                          │èíúåêöèîííîãî ðàñòâîðà                                                    

                                                                                          │(ôëàêîíû) 0.5, 1, 2 ã                                                      

                                                                                                                                                                    

│Öåôîáèä [Öåôîïåðàçîí]                             │àíòèáèîòèê, öåôàëîñïîðèí [J01DA32]      │ëèîôèëèç.ïîðîøîê äëÿ          │Pfizer (Èíäîíåçèÿ)            │003213,       

                                                                                          │ïðèãîòîâëåíèÿ èíúåêöèîííîãî                                 │10.08.93      

                                                                                          │ðàñòâîðà (ôëàêîíû) 1 ã                                                    

                                                                                                                                                                    

│Öåôîáèä [Öåôîïåðàçîí]                             │àíòèáèîòèê, öåôàëîñïîðèí [J01DA32]      │ïîðîøîê äëÿ ïðèãîòîâëåíèÿ     │Pfizer (Èòàëèÿ)               │003300,       

                                                                                          │èíúåêöèîííîãî ðàñòâîðà                                      │03.09.93      

                                                                                          │(ôëàêîíû) 0.5, 1, 2 ã                                                     

                                                                                                                                                                    

│Öåôîáèä [Öåôîïåðàçîí]                             │àíòèáèîòèê, öåôàëîñïîðèí [J01DA32]      │ïîðîøîê äëÿ ïðèãîòîâëåíèÿ     │Pfizer Ilaclari AS (Òóðöèÿ)   │01673, 01.09.89│

                                                                                          │èíúåêöèîííîãî ðàñòâîðà                                                    

                                                                                          │(ôëàêîíû) 1 ã                                                             

                                                                                                                                                                    

│Öåôîáèä [Öåôîïåðàçîí]                             │àíòèáèîòèê, öåôàëîñïîðèí [J01DA32]      │ïîðîøîê äëÿ ïðèãîòîâëåíèÿ     │Pfizer SA (Èñïàíèÿ)           │002295,       

                                                                                          │èíúåêöèîííîãî ðàñòâîðà                                      │26.11.91      

                                                                                          │(ôëàêîíû) 0.5 ã, 1 ã, 2 ã                                                 

                                                                                                                                                                    

│Öåôîãåí [Öåôóðîêñèì]                              │àíòèáèîòèê, öåôàëîñïîðèí [J01DA06]      │ïîðîøîê äëÿ ïðèãîòîâëåíèÿ     │Cadila Laboratories Ltd       │003595,       

                                                                                          │èíúåêöèîííîãî ðàñòâîðà        │(Èíäèÿ)                       │16.12.93      

                                                                                          │(ôëàêîíû) 250, 750 ìã                                                     

                                                                                                                                                                    

│Öåôîïðèä [Öåôàçîëèí]                              │àíòèáèîòèê, öåôàëîñïîðèí [J01DA04]      │ïîðîøîê äëÿ ïðèãîòîâëåíèÿ     │Sun Pharmaceutical Industries │007100,       

                                                                                          │èíúåêöèîííîãî ðàñòâîðà        │Ltd (Èíäèÿ)                   │22.02.96      

                                                                                          │(ôëàêîíû) 0.25, 0.5, 1 ã                                                  

                                                                                                                                                                    

│Öåôîòàêñèì [Öåôîòàêñèì]                           │àíòèáèîòèê, öåôàëîñïîðèí [J01DA10]      │ïîðîøîê äëÿ ïðèãîòîâëåíèÿ     │Han Mi Pharmaceutical Co Ltd  │002488,       

                                                                                          │èíúåêöèîííîãî ðàñòâîðà        │(Êîðåÿ Þæíàÿ)                 │29.05.92      

                                                                                          │(ôëàêîíû) 1 ã                                                             

                                                                                                                                                                    

│Öåôîòàêñèì [Öåôîòàêñèì]                           │àíòèáèîòèê, öåôàëîñïîðèí [J01DA10]      │ïîðîøîê äëÿ ïðèãîòîâëåíèÿ     │Lek (Ñëîâåíèÿ)                │002326,       

                                                                                          │èíúåêöèîííîãî ðàñòâîðà                                      │14.01.92      

                                                                                          │(ôëàêîíû) 1 ã, 2 ã                                                        

                                                                                                                                                                    

│Öåôîòàêñèì [Öåôîòàêñèì]                           │àíòèáèîòèê, öåôàëîñïîðèí [J01DA10]      │ëèîôèëèç.ïîðîøîê äëÿ          │Wave International (Èíäèÿ)    │003517,       

                                                                                          │ïðèãîòîâëåíèÿ èíúåêöèîííîãî                                 │24.10.93      

                                                                                          │ðàñòâîðà (ôëàêîíû) 250, 500,                                              

                                                                                          │1000 ìã                                                                   

                                                                                                                                                                    

│Öåôîòàêñèì íàòðèÿ [Öåôîòàêñèì]                    │àíòèáèîòèê, öåôàëîñïîðèí [J01DA10]      │ëèîôèëèç.ïîðîøîê äëÿ          │Cheil Foods & Chemicals Inc   │005517,       

                                                                                          │ïðèãîòîâëåíèÿ èíúåêöèîííîãî   │(Êîðåÿ Þæíàÿ)                 │22.11.94      

                                                                                          │ðàñòâîðà (ôëàêîíû) 0.5 ã, 1                                               

                                                                                          │ã, 2 ã                                                                    

                                                                                                                                                                    

│Öåôîòàì [Öåôîòàêñèì]                              │àíòèáèîòèê, öåôàëîñïîðèí [J01DA10]      │ëèîôèëèç.ïîðîøîê äëÿ          │Dee-Pharma Ltd (Èíäèÿ)        │006122,       

                                                                                          │ïðèãîòîâëåíèÿ èíúåêöèîííîãî                                 │30.05.95      

                                                                                          │ðàñòâîðà (ôëàêîíû) 250, 500,                                              

                                                                                          │1000 ìã                                                                   

                                                                                                                                                                    

│Öåôîòåòàí [Öåôîòåòàí]                             │àíòèáèîòèê, öåôàëîñïîðèí [J01DA14]      │ïîðîøîê äëÿ ïðèãîòîâëåíèÿ     │Biochemie GmbH (Àâñòðèÿ)      │002354,        

                                                                                          │èíúåêöèîííîãî ðàñòâîðà                                      │16.01.92      

                                                                                          │(ôëàêîíû) 1 ã                                                             

                                                                                                                                                                     

│Öåôðàäèí [Öåôðàäèí]                               │àíòèáèîòèê, öåôàëîñïîðèí [J01DA31]      │êàïñóëû 250, 500 ìã           │Mir Pharmaceutical            │007668,       

                                                                                                                        │Inc/biocraft Laboratories Inc │23.07.96      

                                                                                                                        │(ÑØÀ)                                        

                                                                                                                                                                    

Öåôðàäóð [Öåôàäðîêñèë]                            àíòèáèîòèê, öåôàëîñïîðèí [J01DA09]      êàïñóëû 500 ìã; ñóñïåíçèÿ     │Eczacibasi (Òóðöèÿ)           │003383,       

                                                                                          îðàëüíàÿ 250 ìã|5 ìë                                        │06.10.93      

                                                                                                                                                                    

Öåôñïàí [Öåôèêñèì]                                àíòèáèîòèê, öåôàëîñïîðèí [J01DA23]      êàïñóëû 200, 400 ìã;          │Al-Hikma Pharmaceuticals      │002278,       

                                                                                          │ñóñïåíçèÿ îðàëüíàÿ 100 ìã|5 ìë│(Èîðäàíèÿ)                    │12.11.91      

                                                                                                                                                                    

│Öåôñïàí [Öåôèêñèì]                                │àíòèáèîòèê, öåôàëîñïîðèí [J01DA23]      │êàïñóëû 100 ìã; ìèêðîãðàíóëû  │Fujisawa Pharmaceutical Co    │02009, 20.11.90│

                                                                                          │5%                            │Ltd (ßïîíèÿ)                                

                                                                                                                                                                    

│Öåôòîð [Öåôàêëîð]                                 │àíòèáèîòèê, öåôàëîñïîðèí [J01DA08]      │êàïñóëû 250 ìã                │Torrent Exports Ltd (Èíäèÿ)   │005010,       

                                                                                                                                                      │16.06.94      

                                                                                                                                                                    

│Öåôòðèàêñîíà íàòðèåâàÿ ñîëü [Öåôòðèàêñîí]         │àíòèáèîòèê, öåôàëîñïîðèí [J01DA13]      │ëèîôèëèç.ïîðîøîê äëÿ          │Cheil Foods & Chemicals Inc   │006155,       

                                                                                          │ïðèãîòîâëåíèÿ èíúåêöèîííîãî   │(Êîðåÿ Þæíàÿ)                 │06.06.95      

                                                                                          │ðàñòâîðà (ôëàêîíû) 0.25, 0.5, │                                            

                                                                                          │1 ã                                                                       

                                                                                                                                                                    

│Öåôô [Öåôàëåêñèí]                                 │àíòèáèîòèê, öåôàëîñïîðèí [J01DA01]      │êàïñóëû 250 ìã                │Lupin Laboratories Ltd (Èíäèÿ)│002621,       

                                                                                                                                                      │10.09.92      

                                                                                                                                                                    

│Öèãàìåò [Öèìåòèäèí]                               │H2-ãèñòàìèíîâûõ ðåöåïòîðîâ áëîêàòîð     │òàáëåòêè 200 ìã               │General Drug House (Òàéëàíä)  │003818,       

                                                  │[A02BA01]                                                                                           │04.04.94      

                                                                                                                                                                    

│Öèãíîäåðì {äèòðàíîë 0.1%, 0.5%, 1%, 2%;           │ïðîòèâîïñîðèàòè÷åñêîå ñðåäñòâî [D05AC]  │ìàçü 0.1%, 0.5%, 1%, 2%;      │Komindex Ltd, Biocom Zaklady  │003861,       

│ñàëèöèëîâàÿ êèñëîòà 0.5%}                                                                 │ïîìàäà 2%                     │Farmaceutyczne (Ïîëüøà)       │21.04.94      

                                                                                                                                                                    

│Öèêëî-ïðîãèíîâà {ýñòðàäèîë âàëåðàò 2 ìã - äðàæå   │ïðîòèâîêëèìàêòåðè÷åñêîå ñðåäñòâî        │äðàæå                         │Schering AG (ÔÐÃ)             │003061,       

│N10; ýñòðàäèîë âàëåðàò 2 ìã, íîðãåñòðåë 0.5 ìã -  │[G03FB01]                                                                                           │16.06.93      

│äðàæå N11}                                                                                                                                                          

                                                                                                                                                                    

│Öèêëîâàêñ [Àöèêëîâèð]                             │ïðîòèâîâèðóñíîå ñðåäñòâî [J05AB01]      │òàáëåòêè 200 ìã               │Remedica Ltd - Minnex (Êèïð)  │006902,       

                                                                                                                                                      │18.12.95      

                                                                                                                                                                    

│Öèêëîâåí ôîðòå [Ýñöèí]                            │àíãèîïðîòåêòîðíîå ñðåäñòâî [C05CX]      │äðàæå                         │CT-Arzneimittel Chemishe      │006518,       

                                                                                                                        │Tempelchof GmbH (Ãåðìàíèÿ)    │20.09.95      

                                                                                                                                                                    

│Öèêëîâèð [Àöèêëîâèð]                              │ïðîòèâîâèðóñíîå ñðåäñòâî                │òàáëåòêè 200 ìã; êðåì äëÿ êîæè│Cadila Laboratories Ltd       │003398,       

                                                  │[D06BB03][J05AB01]                                                    │(Èíäèÿ)                       │08.10.93      

                                                                                                                                                                    

│Öèêëîêàïðîí [Òðàíåêñàìîâàÿ êèñëîòà]               │ãåìîñòàòè÷åñêîå ñðåäñòâî [B02AA02]      │òàáëåòêè ïîêðûòûå ïëåíî÷íîé   │Pharmacia Ab (Øâåöèÿ)         │006665,       

                                                                                          │îáîëî÷êîé 500 ìã; ðàñòâîð äëÿ │                              │20.03.96      

                                                                                          │âíóòðèâåííîãî ââåäåíèÿ                                                    

                                                                                          │(àìïóëû) 100 ìã/ìë - 5 ìë                                                 

                                                                                                                                                                    

│Öèêëîìåä [Öèïðîôëîêñàöèí]                         │ïðîòèâîìèêðîáíîå ñðåäñòâî, ôòîðõèíîëîí  │êàïëè ãëàçíûå (ôëàêîíû) 1%    │Promed Exports Pvt Ltd (Èíäèÿ)│006952,       

                                                  │[S01AX13]                                                                                           │29.12.95      

                                                                                                                                                                    

│Öèêëîïëàòèí [Êàðáîïëàòèí]                         │öèòîñòàòè÷åñêîå ñðåäñòâî [L01XA02]      │ëèîôèëèç.ïîðîøîê äëÿ          │Lachema (×ÑÔÐ)                │3011, 25.02.91 │

                                                                                          │ïðèãîòîâëåíèÿ èíúåêöèîííîãî                                               

                                                                                          │ðàñòâîðà (ôëàêîíû) 50, 200 ìã │                                            

                                                                                                                                                                     

│Öèêëîòàë [Ìåäðîêñèïðîãåñòåðîí]                    │ïðîãåñòàãåí [G03DA02]                   │òàáëåòêè (ôëàêîíû) 100, 500   │Lemery (Ìåêñèêà)              │006391,       

                                                                                          │ìã; àýðîçîëü äîçèðîâàííûé                                   │10.08.95      

                                                                                          │(ôëàêîíû)                                                                  

                                                                                                                                                                    

│Öèêëîôîñôàìèä-Òåâà [Öèêëîôîñôàìèä]                │öèòîñòàòè÷åñêîå ñðåäñòâî [L01AA01]      │òàáëåòêè ïîêðûòûå îáîëî÷êîé   │Taro International Ltd        │006823,       

                                                                                          │50 ìã; ïîðîøîê äëÿ            │(Èçðàèëü)                     │13.11.95      

                                                                                          │ïðèãîòîâëåíèÿ èíúåêöèîííîãî                                               

                                                                                          │ðàñòâîðà (ôëàêîíû) 200, 500,                                              

                                                                                          │1000 ìã                                                                    

                                                                                                                                                                    

│Öèìàëîí {íàòðèÿ öèòðàò äèãèäðàò 2.819 ã, ëèìîííàÿ │ñðåäñòâî äëÿ ëå÷åíèÿ íåôðîëèòèàçà       │ãðàíóëû øèïó÷èå (ïàêåòèêè)    │Sterling Health               │005139,       

│êèñëîòà 1.063 ã, íàòðèÿ ãèäðîêàðáîíàò 1.2 ã,      │[G04BC]                                                               │(Âåëèêîáðèòàíèÿ)              │18.07.94      

│íàòðèÿ êàðáîíàò 0.13 ã}                                                                                                                                             

                                                                                                                                                                    

│Öèìåâåí [Ãàíöèêëîâèð]                             │ïðîòèâîâèðóñíîå ñðåäñòâî [J05AB06]      │ïîðîøîê äëÿ ïðèãîòîâëåíèÿ     │Syntex (Øâåéöàðèÿ)            │002285,       

                                                                                          │èíúåêöèîííîãî ðàñòâîðà                                      │13.11.91      

                                                                                          │(ôëàêîíû) 500 ìã - 10 ìë                                                  

                                                                                                                                                                    

│Öèìåãåêñàëü [Öèìåòèäèí]                           │H2-ãèñòàìèíîâûõ ðåöåïòîðîâ áëîêàòîð     │òàáëåòêè ïîêðûòûå ïëåíî÷íîé   │Hexal Pharma GmbH (ÔÐÃ)       │002773,       

                                                  │[A02BA01]                               │îáîëî÷êîé 200, 400, 800 ìã                                  │21.12.92      

                                                                                                                                                                    

│Öèìåäèí [Öèìåòèäèí]                               │H2-ãèñòàìèíîâûõ ðåöåïòîðîâ áëîêàòîð     │òàáëåòêè ïîêðûòûå îáîëî÷êîé   │Dar Al Dava (Èîðäàíèÿ)        │003147,       

                                                  │[A02BA01]                               │200, 400 ìã                                                 │07.07.93      

                                                                                                                                                                    

│Öèìåò [Öèìåòèäèí]                                 │H2-ãèñòàìèíîâûõ ðåöåïòîðîâ áëîêàòîð     │òàáëåòêè ïîêðûòûå îáîëî÷êîé   │Thiemann GmbH (Ãåðìàíèÿ)      │007073,       

                                                  │[A02BA01]                               │400, 800 ìã; ðàñòâîð äëÿ                                    │13.02.96      

                                                                                          │èíúåêöèé (àìïóëû) 200 ìã - 2                                              

                                                                                          │ìë                                                                        

                                                                                                                                                                    

│Öèìåòèäèí [Öèìåòèäèí]                             │H2-ãèñòàìèíîâûõ ðåöåïòîðîâ áëîêàòîð     │òàáëåòêè 200 ìã               │Cadila Laboratories Ltd       │003116,       

                                                  │[A02BA01]                                                             │(Èíäèÿ)                       │30.06.93      

                                                                                                                                                                    

│Öèìåòèäèí [Öèìåòèäèí]                             │H2-ãèñòàìèíîâûõ ðåöåïòîðîâ áëîêàòîð     │òàáëåòêè 200, 400, 800 ìã     │Cox Pharmaceuticals           │005301,       

                                                  │[A02BA01]                                                             │(Âåëèêîáðèòàíèÿ)              │06.09.94      

                                                                                                                                                                    

│Öèìåòèäèí [Öèìåòèäèí]                             │H2-ãèñòàìèíîâûõ ðåöåïòîðîâ áëîêàòîð     │òàáëåòêè 200, 400, 800 ìã     │Heumann Pharma (Ãåðìàíèÿ)     │003926,       

                                                  │[A02BA01]                                                                                           │19.05.94      

                                                                                                                                                                    

│Öèìåòèäèí [Öèìåòèäèí]                             │H2-ãèñòàìèíîâûõ ðåöåïòîðîâ áëîêàòîð     │òàáëåòêè 200 ìã               │Indopharma (Èíäîíåçèÿ)        │005066,       

                                                  │[A02BA01]                                                                                           │30.06.94      

                                                                                                                                                                    

│Öèìåòèäèí [Öèìåòèäèí]                             │H2-ãèñòàìèíîâûõ ðåöåïòîðîâ áëîêàòîð     │òàáëåòêè 200 ìã               │Krka (Ñëîâåíèÿ)               │00892,        

                                                  │[A02BA01]                                                                                           │15.01.82,     

                                                                                                                                                      │15.04.94      

                                                                                                                                                                    

│Öèìåòèäèí [Öèìåòèäèí]                             │H2-ãèñòàìèíîâûõ ðåöåïòîðîâ áëîêàòîð     │òàáëåòêè 200, 400, 800 ìã     │Norton Healthcare Ltd         │003248,       

                                                  │[A02BA01]                                                             │(Âåëèêîáðèòàíèÿ)              │18.08.93      

                                                                                                                                                                    

│Öèìåòèäèí [Öèìåòèäèí]                             │H2-ãèñòàìèíîâûõ ðåöåïòîðîâ áëîêàòîð     │òàáëåòêè ïîêðûòûå îáîëî÷êîé   │Pharmachim (Áîëãàðèÿ)         │2779, 29.06.84 │

                                                  │[A02BA01]                               │200 ìã                                                                    

                                                                                                                                                                    

│Öèìåòèäèí [Öèìåòèäèí]                             │H2-ãèñòàìèíîâûõ ðåöåïòîðîâ áëîêàòîð     │ðàñòâîð äëÿ èíúåêöèé (àìïóëû) │Pharmachim (Áîëãàðèÿ)         │003959,       

                                                  │[A02BA01]                               │200 ìã - 2 ìë                                               │31.05.94      

                                                                                                                                                                    

│Öèìåòèäèí [Öèìåòèäèí]                             │H2-ãèñòàìèíîâûõ ðåöåïòîðîâ áëîêàòîð     │òàáëåòêè 200, 400 ìã          │Pharmaline Ltd (Ëèâàí)        │007117,       

                                                  │[A02BA01]                                                                                           │01.03.96      

                                                                                                                                                                    

│Öèìåòèäèí-Ðèâîôàðì [Öèìåòèäèí]                    │H2-ãèñòàìèíîâûõ ðåöåïòîðîâ áëîêàòîð     │òàáëåòêè 200 ìã               │Rivopharm SA (Øâåéöàðèÿ)      │006947,        

                                                  │[A02BA01]                                                                                           │26.12.95      

                                                                                                                                                                    

│Öèíàçèí [Öèííàðèçèí]                              │ÁÌÊÊ [N07CA02]                          │òàáëåòêè 25 ìã                │Rusan Pharma (Èíäèÿ)          │005143,        

                                                                                                                                                      │19.07.94      

                                                                                                                                                                    

│Öèíåäèë [Öèííàðèçèí]                              │ÁÌÊÊ [N07CA02]                          │òàáëåòêè 75 ìã                │Alkaloid (Ìàêåäîíèÿ)          │003419,       

                                                                                                                                                      │14.10.93      

                                                                                                                                                                    

│Öèíêòåðàë [Öèíêà ñóëüôàò]                         │ïðåïàðàò öèíêà [A12CB01]                │òàáëåòêè ïîêðûòûå îáîëî÷êîé   │Polfa, Kutnowskie Zaklady     │005827,       

                                                                                          │200 ìã                        │Farmaceutyczne SA (Ïîëüøà)    │16.03.95      

                                                                                                                                                                    

│Öèííàðèçèí [Öèííàðèçèí]                           │ÁÌÊÊ [N07CA02]                          │òàáëåòêè 25 ìã                │Gardis (Ãðóçèÿ)               │006764,       

                                                                                                                                                      │31.10.95      

                                                                                                                                                                    

│Öèííàðèçèí [Öèííàðèçèí]                           │ÁÌÊÊ [N07CA02]                          │òàáëåòêè 25 ìã                │Indopharma (Èíäîíåçèÿ)        │003859,       

                                                                                                                                                      │18.04.94      

                                                                                                                                                                    

│Öèííàðèçèí [Öèííàðèçèí]                           │ÁÌÊÊ [N07CA02]                          │òàáëåòêè 25 ìã                │Pharmachim (ÍÐÁ)              │2529, 22.08.77 │

                                                                                                                                                                    

│Öèííàðèçèí [Öèííàðèçèí]                           │ÁÌÊÊ [N07CA02]                          │êàïñóëû æåëàòèíîâûå 75 ìã     │Pharmachim (Áîëãàðèÿ)         │003960,       

                                                                                                                                                      │31.05.94      

                                                                                                                                                                    

│Öèííàðèçèí [Öèííàðèçèí]                           │ÁÌÊÊ [N07CA02]                          │òàáëåòêè 25 ìã                │Polfa, Warszawskie Zaklady    │005284,       

                                                                                                                        │Farmaceutyczne SA (Ïîëüøà)    │31.08.94      

                                                                                                                                                                    

│Öèííàðèçèí [Öèííàðèçèí]                           │ÁÌÊÊ [N07CA02]                          │òàáëåòêè 25 ìã                │Wave International (Èíäèÿ)    │002990,       

                                                                                                                                                      │28.04.93      

                                                                                                                                                                    

│Öèííàðèçèí Èíáèîòåõ [Öèííàðèçèí]                  │ÁÌÊÊ [N07CA02]                          │òàáëåòêè 25 ìã                │Inbiotech (Áîëãàðèÿ)          │006337,       

                                                                                                                                                      │02.08.95      

                                                                                                                                                                    

│Öèííàðèçèí ôîðòå [Öèííàðèçèí]                     │ÁÌÊÊ [N07CA02]                          │òàáëåòêè 75 ìã                │CT-Arzneimittel Chemishe      │005774,       

                                                                                                                        │Tempelchof GmbH (Ãåðìàíèÿ)    │24.02.95      

                                                                                                                                                                    

│Öèííàðèçèí ôîðòå-Ðàòèîôàðì [Öèííàðèçèí]           │ÁÌÊÊ [N07CA02]                          │êàïñóëû ôîðòå 75 ìã           │Ratiopharm GmbH & Co          │005814,       

                                                                                                                        │(Ãåðìàíèÿ)                    │10.03.95      

                                                                                                                                                                    

│Öèííàðîí [Öèííàðèçèí]                             │ÁÌÊÊ [N07CA02]                          │òàáëåòêè 75 ìã                │Remedica Ltd - Minnex (Êèïð)  │006800,       

                                                                                                                                                      │09.11.95      

                                                                                                                                                                    

│Öèíîáàê [Öèíîêñàöèí]                              │ïðîòèâîìèêðîáíîå ñðåäñòâî, õèíîëîí      │êàïñóëû 500 ìã                │Eli Lilly (ÑØÀ)               │006219,       

                                                  │[G04AB05]                                                                                           │26.06.95      

                                                                                                                                                                    

│Öèíò [Ìîêñîíèäèí]                                 │àëüôà-àäðåíîáëîêàòîð [C02AC05]          │òàáëåòêè ïîêðûòûå îáîëî÷êîé   │Eli Lilly (Ãåðìàíèÿ)          │006359,       

                                                                                          │0.2, 0.4 ìã                                                 │07.08.95      

                                                                                                                                                                    

│Öèïëèí [Êî-òðèìîêñàçîë] {ñóëüôàìåòîêñàçîë 400 ìã, │ïðîòèâîìèêðîáíîå êîìáèíèðîâàííîå        │òàáëåòêè 400 ìã/80 ìã, 800    │Cipla Ltd (Èíäèÿ)             │003218,       

│òðèìåòîïðèì 80 ìã; ñóëüôàìåòîêñàçîë 800 ìã,       │ñðåäñòâî [J01EE01]                      │ìã/160 ìã; ñóñïåíçèÿ îðàëüíàÿ │                              │10.08.93      

│òðèìåòîïðèì 160 ìã}                                                                       │(ôëàêîíû) 200 ìã/40 ìã|5 ìë                                               

                                                                                                                                                                    

│Öèïëîêñ [Öèïðîôëîêñàöèí]                          │ïðîòèâîìèêðîáíîå ñðåäñòâî, ôòîðõèíîëîí  │òàáëåòêè ïîêðûòûå îáîëî÷êîé   │Cipla Ltd (Èíäèÿ)             │003002,       

                                                  │[J01MA02]                               │250, 500 ìã; ðàñòâîð äëÿ                                    │26.05.93      

                                                                                          │èíôóçèé (ôëàêîíû) 100 ìã/50                                               

                                                                                          │ìë, 200 ìã/100 ìë                                                         

                                                                                                                                                                    

│Öèïëîêñ [Öèïðîôëîêñàöèí]                          │ïðîòèâîìèêðîáíîå ñðåäñòâî, ôòîðõèíîëîí  │ìàçü ãëàçíàÿ (òóáû) 0.3%;     │Cipla Ltd (Èíäèÿ)             │005826,       

                                                  │[S01AX13][S02AA]                        │êàïëè ãëàçíûå (ôëàêîíû) 0.3%; │                              │15.03.95      

                                                                                          │êàïëè óøíûå (ôëàêîíû) 0.3%                                                 

                                                                                                                                                                    

│Öèïðèíîë [Öèïðîôëîêñàöèí]                         │ïðîòèâîìèêðîáíîå ñðåäñòâî, ôòîðõèíîëîí  │òàáëåòêè 250, 500 ìã; ðàñòâîð │Krka (ÑÔÐÞ)                   │002287,       

                                                  │[J01MA02]                               │äëÿ âíóòðèâåííîãî ââåäåíèÿ                                  │14.11.91       

                                                                                          │(àìïóëû) 100 ìã - 10 ìë                                                   

                                                                                                                                                                    

│Öèïðîáàé [Öèïðîôëîêñàöèí]                         │ïðîòèâîìèêðîáíîå ñðåäñòâî, ôòîðõèíîëîí  │òàáëåòêè ëàêèðîâàííûå 100,    │Bayer AG (ÔÐÃ)                │01674, 12.09.89│

                                                  │[J01MA02]                               │250, 500 ìã; ðàñòâîð äëÿ                                                  

                                                                                          │èíúåêöèé (àìïóëû) 1% - 10 ìë; │                                            

                                                                                          │ðàñòâîð äëÿ èíôóçèé (ôëàêîíû) │                                             

                                                                                          │0.2% - 50, 100 ìë                                                         

                                                                                                                                                                    

│Öèïðîáèä [Öèïðîôëîêñàöèí]                         │ïðîòèâîìèêðîáíîå ñðåäñòâî, ôòîðõèíîëîí  │òàáëåòêè 250, 500 ìã          │Cadila Laboratories Ltd       │002999,       

                                                  │[J01MA02]                                                             │(Èíäèÿ)                       │26.05.93      

                                                                                                                                                                    

│Öèïðîáèä [Öèïðîôëîêñàöèí]                         │ïðîòèâîìèêðîáíîå ñðåäñòâî, ôòîðõèíîëîí  │ðàñòâîð äëÿ èíôóçèé (ôëàêîíû) │Cadila Laboratories Ltd       │005692,       

                                                  │[J01MA02][S01AX13]                      │200 ìã/100 ìë; ðàñòâîð        │(Èíäèÿ)                       │26.01.95      

                                                                                          │îôòàëüìîëîãè÷åñêèé (ôëàêîíû)                                              

                                                                                          │0.3%                                                                      

                                                                                                                                                                    

│Öèïðîâà [Öèïðîôëîêñàöèí]                          │ïðîòèâîìèêðîáíîå ñðåäñòâî, ôòîðõèíîëîí  │ðàñòâîð äëÿ èíôóçèé (ôëàêîíû) │Lupin Laboratories Ltd (Èíäèÿ)│006189,       

                                                  │[J01MA02]                               │200 ìã - 100 ìë                                             │15.06.95      

                                                                                                                                                                    

│Öèïðîäàð [Öèïðîôëîêñàöèí]                         │ïðîòèâîìèêðîáíîå ñðåäñòâî, ôòîðõèíîëîí  │òàáëåòêè 250, 500 ìã          │Dar Al Dava (Èîðäàíèÿ)        │003507,       

                                                  │[J01MA02]                                                                                           │16.11.93      

                                                                                                                                                                    

│Öèïðîêâèí [Öèïðîôëîêñàöèí]                        │ïðîòèâîìèêðîáíîå ñðåäñòâî, ôòîðõèíîëîí  │òàáëåòêè 250, 500 ìã          │Kopran Ltd (Èíäèÿ)            │005209,       

                                                  │[J01MA02]                                                                                           │03.08.94      

                                                                                                                                                                    

│Öèïðîëåò [Öèïðîôëîêñàöèí]                         │ïðîòèâîìèêðîáíîå ñðåäñòâî, ôòîðõèíîëîí  │òàáëåòêè 250, 500 ìã; ðàñòâîð │Dr.Reddy's Laboratories Ltd   │002470,       

                                                  │[J01MA02]                               │äëÿ èíôóçèé (ôëàêîíû) 200 ìã  │(Èíäèÿ)                       │13.05.92      

                                                                                          │- 100 ìë                                                                  

                                                                                                                                                                    

│Öèïðîëåò [Öèïðîôëîêñàöèí]                         │ïðîòèâîìèêðîáíîå ñðåäñòâî, ôòîðõèíîëîí  │êàïëè ãëàçíûå (ôëàêîíû) 3     │Dr.Reddy's Laboratories Ltd   │005977,       

                                                  │[S01AX13]                               │ìã/ìë                         │(Èíäèÿ)                       │19.04.95      

                                                                                                                                                                    

│Öèïðîìåä [Öèïðîôëîêñàöèí]                         │ïðîòèâîìèêðîáíîå ñðåäñòâî, ôòîðõèíîëîí  │êàïëè ãëàçíûå (ôëàêîíû) 0.3%  │Promed Exports Pvt Ltd (Èíäèÿ)│005878,       

                                                  │[S01AX13]                                                                                           │30.03.95      

                                                                                                                                                                    

│Öèïðîíàò [Öèïðîôëîêñàöèí]                         │ïðîòèâîìèêðîáíîå ñðåäñòâî, ôòîðõèíîëîí  │òàáëåòêè 250, 500 ìã; ðàñòâîð │Natco Pharma Ltd (Èíäèÿ)      │003239,       

                                                  │[J01MA02]                               │äëÿ èíôóçèé (ôëàêîíû) 200 ìã                                │18.08.93      

                                                                                          │- 100 ìë                                                                  

                                                                                                                                                                    

│Öèïðîïàí [Öèïðîôëîêñàöèí]                         │ïðîòèâîìèêðîáíîå ñðåäñòâî, ôòîðõèíîëîí  │òàáëåòêè ïîêðûòûå îáîëî÷êîé   │Panacea Biotec Ltd (Èíäèÿ)    │005937,       

                                                  │[J01MA02]                               │250, 500 ìã                                                 │07.04.95      

                                                                                                                                                                    

│Öèïðîñàí [Öèïðîôëîêñàöèí]                         │ïðîòèâîìèêðîáíîå ñðåäñòâî, ôòîðõèíîëîí  │òàáëåòêè 250, 500 ìã          │Sun Pharmaceutical Industries │003581,       

                                                  │[J01MA02]                                                             │Ltd (Èíäèÿ)                   │13.12.93      

                                                                                                                                                                    

│Öèïðîñîë [Öèïðîôëîêñàöèí]                         │ïðîòèâîìèêðîáíîå ñðåäñòâî, ôòîðõèíîëîí  │òàáëåòêè 250, 500 ìã          │Sol Pharmaceuticals Ltd       │003602,       

                                                  │[J01MA02]                                                             │(Èíäèÿ)                       │17.12.93      

                                                                                                                                                                    

│Öèïðîôëîêñàöèí [Öèïðîôëîêñàöèí]                   │ïðîòèâîìèêðîáíîå ñðåäñòâî, ôòîðõèíîëîí  │òàáëåòêè 250, 500 ìã          │Mesco Laboratories Ltd (Èíäèÿ)│003697,       

                                                  │[J01MA02]                                                                                           │15.02.94      

                                                                                                                                                                    

│Öèïðîôëîêñàöèí [Öèïðîôëîêñàöèí]                   │ïðîòèâîìèêðîáíîå ñðåäñòâî, ôòîðõèíîëîí  │ðàñòâîð äëÿ èíúåêöèé          │Promed Exports Pvt Ltd (Èíäèÿ)│003224,       

                                                  │[J01MA02]                               │(êîíòåéíåðû îäíîðàçîâûå) 200                                │11.08.93      

                                                                                          │ìã - 100 ìë                                                               

                                                                                                                                                                     

│Öèïðîôëîêñàöèí [Öèïðîôëîêñàöèí]                   │ïðîòèâîìèêðîáíîå ñðåäñòâî, ôòîðõèíîëîí  │òàáëåòêè 250, 500 ìã          │Promed Exports Pvt Ltd (Èíäèÿ)│003289,       

                                                  │[J01MA02]                                                                                           │31.08.93      

                                                                                                                                                                     

│Öèïðîôëîêñàöèí [Öèïðîôëîêñàöèí]                   │ïðîòèâîìèêðîáíîå ñðåäñòâî, ôòîðõèíîëîí  │òàáëåòêè 250, 500 ìã          │Wave International (Èíäèÿ)    │003548,       

                                                  │[J01MA02]                                                                                           │06.12.93      

                                                                                                                                                                     

│Öèïðîöèíàë [Öèïðîôëîêñàöèí]                       │ïðîòèâîìèêðîáíîå ñðåäñòâî, ôòîðõèíîëîí  │òàáëåòêè 250 ìã               │Zdravle (ÑÔÐÞ)                │002503,       

                                                  │[J01MA02]                                                                                           │08.06.92      

                                                                                                                                                                     

│Öèðèçèí [Öèííàðèçèí]                              │ÁÌÊÊ [N07CA02]                          │òàáëåòêè 25 ìã                │Panacea Biotec Ltd (Èíäèÿ)    │005080,       

                                                                                                                                                      │04.07.94      

                                                                                                                                                                    

│Öèñàïèä [Öèçàïðèä]                                │äîôàìèí-áëîêàòîð öåíòðàëüíûé [A03FA02]  │òàáëåòêè 10 ìã; ñóñïåíçèÿ     │Kopran Ltd (Èíäèÿ)            │005821,       

                                                                                          │îðàëüíàÿ (ôëàêîíû) 1 ìã/ìë                                  │15.03.95      

                                                                                                                                                                    

│Öèñïëàòèë [Öèñïëàòèí]                             │öèòîñòàòè÷åñêîå ñðåäñòâî [L01XA01]      │ëèîôèëèç.ïîðîøîê äëÿ          │Rhone-Poulenc Rorer (Ôðàíöèÿ) │003093,       

                                                                                          │ïðèãîòîâëåíèÿ èíúåêöèîííîãî                                 │23.06.93      

                                                                                          │ðàñòâîðà (ôëàêîíû) 10, 25, 50 │                                            

                                                                                          │ìã                                                                        

                                                                                                                                                                    

│Öèñïëàòèí [Öèñïëàòèí]                             │öèòîñòàòè÷åñêîå ñðåäñòâî [L01XA01]      │ðàñòâîð äëÿ èíúåêöèé          │Delta West (Àâñòðàëèÿ)        │006825,       

                                                                                          │(ôëàêîíû) 1 ìã/ìë                                           │14.11.95      

                                                                                                                                                                    

│Öèñïëàòèí [Öèñïëàòèí]                             │öèòîñòàòè÷åñêîå ñðåäñòâî [L01XA01]      │êîíöåíòðàò äëÿ ïðèãîòîâëåíèÿ  │Ebewe (Àâñòðèÿ)               │002659,       

                                                                                          │èíôóçèîííîãî ðàñòâîðà                                       │27.10.92      

                                                                                          │(ôëàêîíû) 10 ìã/20 ìë, 25                                                 

                                                                                          │ìã/50 ìë, 50 ìã/100 ìë                                                    

                                                                                                                                                                    

│Öèñïëàòèí [Öèñïëàòèí]                             │öèòîñòàòè÷åñêîå ñðåäñòâî [L01XA01]      │ðàñòâîð äëÿ èíúåêöèé          │Nippon Kayaku Co Ltd (ßïîíèÿ) │003841,       

                                                                                          │(ôëàêîíû) 10 ìã/20 ìë, 25                                   │08.04.94      

                                                                                          │ìã/50 ìë, 50 ìã/100 ìë                                                    

                                                                                                                                                                    

│Öèñïëàòèí [Öèñïëàòèí]                             │öèòîñòàòè÷åñêîå ñðåäñòâî [L01XA01]      │ðàñòâîð äëÿ èíúåêöèé          │Tissen Laboratories (Áåëüãèÿ) │003932,       

                                                                                          │(ôëàêîíû) 10 ìã/20 ìë, 25                                   │23.05.94      

                                                                                          │ìã/50 ìë, 50 ìã/100 ìë                                                    

                                                                                                                                                                    

│Öèñïëàòèí-Òåâà [Öèñïëàòèí]                        │öèòîñòàòè÷åñêîå ñðåäñòâî [L01XA01]      │ëèîôèëèç.ïîðîøîê äëÿ          │Teva Pharmaceutical           │005652,       

                                                                                          │ïðèãîòîâëåíèÿ èíúåêöèîííîãî   │Industries Ltd (Èçðàèëü)      │16.01.95      

                                                                                          │ðàñòâîðà (ôëàêîíû) 10, 20, 50 │                                            

                                                                                          │ìã; ðàñòâîð äëÿ èíúåêöèé                                                  

                                                                                          │(ôëàêîíû) 10 ìã/20 ìë, 25                                                 

                                                                                          │ìã/50 ìë, 50 ìã/100 ìë;                                                   

                                                                                          │ðàñòâîð äëÿ èíôóçèé (ôëàêîíû) │                                            

                                                                                          │50 ìã/100 ìë, 100 ìã/200 ìë                                               

                                                                                                                                                                    

│Öèñòèöèä [Ïðàçèêâàíòåë]                           │ïðîòèâîãåëüìèíòíîå ñðåäñòâî [P02BA01]   │òàáëåòêè 500 ìã               │Merck (india) Ltd (Èíäèÿ)     │002872,       

                                                                                                                                                      │25.02.93      

                                                                                                                                                                    

│Öèòåàë {õëîðãåêñèäèí 0.5 ìë, ãåêñàìèäèí 0.1 ã,    │àíòèñåïòè÷åñêîå ñðåäñòâî [D08AC52]      │ðàñòâîð äëÿ íàðóæíîãî         │Pierre Fabre Medicament       │003465,       

│õëîðîêðåçîë 0.3 ã - 100 ìë}                                                               │ïðèìåíåíèÿ (ôëàêîíû) 250,     │(Ôðàíöèÿ)                     │28.10.93      

                                                                                          │500, 1000 ìë                                                              

                                                                                                                                                                    

│Öèòåðàë [Öèïðîôëîêñàöèí]                          │ïðîòèâîìèêðîáíîå ñðåäñòâî, ôòîðõèíîëîí  │òàáëåòêè 250, 500 ìã          │Alkaloid (Ìàêåäîíèÿ)          │005786,       

                                                  │[J01MA02]                                                                                           │24.02.95      

                                                                                                                                                                    

│Öèòèâèð [Àöèêëîâèð]                               │ïðîòèâîâèðóñíîå ñðåäñòâî                │òàáëåòêè 200, 400, 800 ìã;    │Laboratorio Pharmacheutica    │006997,       

                                                  │[D06BB03][J05AB01]                      │ñóñïåíçèÿ îðàëüíàÿ (ôëàêîíû)  │S.T. (Èòàëèÿ)                 │19.01.96      

                                                                                          │8 ã - 100 ìë; êðåì (òóáû) 5%                                               

                                                                                                                                                                    

│Öèòî-Ìàê [Öèòîõðîì Ñ]                             │ðåãåíåðàöèè ñòèìóëÿòîð [C01CX]          │ëèîôèëèç.ïîðîøîê äëÿ          │Heinrich Mack Nachf.          │005963,       

                                                                                          │ïðèãîòîâëåíèÿ èíúåêöèîííîãî   │(Ãåðìàíèÿ)                    │13.04.95       

                                                                                          │ðàñòâîðà (àìïóëû) 15 ìã /â                                                

                                                                                          │êîìïëåêòå ñ ðàñòâîðèòåëåì/                                                

                                                                                                                                                                     

│Öèòîáëàñòèí âîäíûé [Âèíáëàñòèí] {áàðâèíêà         │öèòîñòàòè÷åñêîå ñðåäñòâî [L01CA01]      │ðàñòâîð äëÿ èíúåêöèé          │Cipla Ltd (Èíäèÿ)             │005822,       

│ðîçîâîãî àëêàëîèä}                                                                        │(ôëàêîíû) 10 ìã/10 ìë                                       │17.03.95      

                                                                                                                                                                     

│Öèòîçàð [Öèòàðàáèí]                               │öèòîñòàòè÷åñêîå ñðåäñòâî [L01BC01]      │ïîðîøîê äëÿ ïðèãîòîâëåíèÿ     │Upjohn (Áåëüãèÿ)              │002065,       

                                                                                          │èíúåêöèîííîãî ðàñòâîðà                                      │13.03.91      

                                                                                          │(ôëàêîíû) 0.5, 1 ã                                                        

                                                                                                                                                                    

│Öèòîçàð [Öèòàðàáèí]                               │öèòîñòàòè÷åñêîå ñðåäñòâî [L01BC01]      │ëèîôèëèç.ïîðîøîê äëÿ          │Upjohn (Áåëüãèÿ)              │006641,       

                                                                                          │ïðèãîòîâëåíèÿ èíúåêöèîííîãî                                 │13.02.96      

                                                                                          │ðàñòâîðà (ôëàêîíû) 100 ìã /â                                              

                                                                                          │êîìïëåêòå ñ ðàñòâîðèòåëåì/                                                

                                                                                                                                                                    

│Öèòîêðèñòèí [Âèíêðèñòèí] {áàðâèíêà ðîçîâîãî       │öèòîñòàòè÷åñêîå ñðåäñòâî [L01CA02]      │ëèîôèëèç.ïîðîøîê äëÿ          │Cipla Ltd (Èíäèÿ)             │003006,       

│àëêàëîèä}                                                                                 │ïðèãîòîâëåíèÿ èíúåêöèîííîãî                                 │26.05.93      

                                                                                          │ðàñòâîðà (ôëàêîíû) 1 ìã;                                                  

                                                                                          │ðàñòâîð äëÿ èíúåêöèé (àìïóëû) │                                            

                                                                                          │1 ìã/ìë                                                                   

                                                                                                                                                                    

│Öèòîêñàí [Öèêëîôîñôàìèä]                          │öèòîñòàòè÷åñêîå ñðåäñòâî [L01AA01]      │ëèîôèëèç.ïîðîøîê äëÿ          │Bristol-Myers Squibb (ÑØÀ)    │003990,       

                                                                                          │ïðèãîòîâëåíèÿ èíúåêöèîííîãî                                 │08.06.94      

                                                                                          │ðàñòâîðà (ôëàêîíû) 100, 200,                                              

                                                                                          │500, 1000, 2000 ìã; òàáëåòêè                                              

                                                                                          │25, 50 ìã                                                                 

                                                                                                                                                                    

│Öèòîìèä [Âèíêðèñòèí] {áàðâèíêà ðîçîâîãî àëêàëîèä} │öèòîñòàòè÷åñêîå ñðåäñòâî [L01CA02]      │ëèîôèëèç.ïîðîøîê äëÿ          │Lemery (Ìåêñèêà)              │003520,       

                                                                                          │ïðèãîòîâëåíèÿ èíúåêöèîííîãî                                 │25.11.93      

                                                                                          │ðàñòâîðà (ôëàêîíû) 1 ìã                                                   

                                                                                                                                                                    

│Öèòîíàë [Öèòàðàáèí]                               │öèòîñòàòè÷åñêîå ñðåäñòâî [L01BC01]      │ðàñòâîð äëÿ èíúåêöèé (àìïóëû) │Cts Chemical Industries Ltd   │005702,       

                                                                                          │20, 50 ìã/ìë                  │(Èçðàèëü)                     │31.01.95      

                                                                                                                                                                    

│Öèòîñòàçàí [Áåíäàìóñòèí]                          │öèòîñòàòè÷åñêîå ñðåäñòâî [L01A]         │ëèîôèëèç.ïîðîøîê äëÿ          │Jenapharm GmbH (ÔÐÃ)          │002410,       

                                                                                          │ïðèãîòîâëåíèÿ èíúåêöèîííîãî                                 │30.01.92      

                                                                                          │ðàñòâîðà (ôëàêîíû) 25 ìã                                                  

                                                                                                                                                                    

│Öèòîòåêò [Èììóíîãëîáóëèí (â/â ââåäåíèå)]          │ïðîòèâîâèðóñíîå ñðåäñòâî [J06BA02]      │ðàñòâîð äëÿ èíúåêöèé (àìïóëû) │Biotest Pharma GmbH (Ãåðìàíèÿ)│007190,       

                                                                                          │10% - 10, 20 ìë; ðàñòâîð äëÿ                                │15.05.96      

                                                                                          │èíúåêöèé (ôëàêîíû) 10% - 50 ìë│                                            

                                                                                                                                                                    

│Öèòðàò áåòàèíà Áîôóð [Áåòàèí]                     │ïèùåâàðèòåëüíîå ôåðìåíòíîå ñðåäñòâî,    │ãðàíóëû                       │Beaufour-Ipsen International  │003024,       

                                                  │ãåïàòîïðîòåêòîð [A09AB02]                                             │(Ôðàíöèÿ)                     │01.06.93      

                                                                                                                                                                    

│Öèòðèïàí {ïàðàöåòàìîë 500 ìã, àñêîðáèíîâàÿ        │àíàëüãåòè÷åñêîå íåíàðêîòè÷åñêîå         │ãðàíóëÿò (ñàøå) 500 ìã/20 ìã  │Krka (Ñëîâåíèÿ)               │006564,       

│êèñëîòà 20 ìã}                                    │ñðåäñòâî [N02BE51]                      │- 5 ã                                                       │28.09.95      

                                                                                                                                                                    

│Öèòðèïàí÷åê-ãðàíóëÿò {ïàðàöåòàìîë 120 ìã,         │àíàëüãåòè÷åñêîå íåíàðêîòè÷åñêîå         │ãðàíóëÿò (ñàøå) 120 ìã/10 ìã  │Krka (Ñëîâåíèÿ)               │006563,       

│àñêîðáèíîâàÿ êèñëîòà 10 ìã}                       │ñðåäñòâî [N02BE51]                      │- 5 ã                                                       │28.09.95      

                                                                                                                                                                    

│Öèôëîçèí [Öèïðîôëîêñàöèí]                         │ïðîòèâîìèêðîáíîå ñðåäñòâî, ôòîðõèíîëîí  │òàáëåòêè 250, 500 ìã          │Deva Holding AS (Òóðöèÿ)      │02027, 13.12.90│

                                                  │[J01MA02]                                                                                                         

                                                                                                                                                                    

│Öèôëîñèí [Öèïðîôëîêñàöèí]                         │ïðîòèâîìèêðîáíîå ñðåäñòâî, ôòîðõèíîëîí  │ðàñòâîð äëÿ èíôóçèé (ôëàêîíû) │Deva Holding AS (Òóðöèÿ)      │002400,        

                                                  │[J01MA02]                               │100 ìã/50 ìë, 200 ìã/100 ìë                                 │30.01.92      

                                                                                                                                                                    

│Öèôðàí [Öèïðîôëîêñàöèí]                           │ïðîòèâîìèêðîáíîå ñðåäñòâî, ôòîðõèíîëîí  │òàáëåòêè 250, 500 ìã; ïîðîøîê │Ranbaxy Laboratories Ltd      │02008, 20.11.90│

                                                  │[J01MA02]                               │äëÿ ïðèãîòîâëåíèÿ             │(Èíäèÿ)                                     

                                                                                          │èíôóçèîííîãî ðàñòâîðà 100                                                 

                                                                                          │ìã/50 ìë, 200 ìã/100 ìë                                                    

                                                                                                                                                                    

│Öþêëè {öèêëàìàò 40 ìã, ñàõàðèí 4 ìã - òàáëåòêà;   │çàìåíèòåëü ñàõàðà [V06A]                │òàáëåòêè; ñèðîï               │Berlin-Chemie AG (Ãåðìàíèÿ)   │006408,       

│öèêëàìàò 12 ìã, ñàõàðèí 1.2 ìã - 100 ìë}                                                                                                              │15.08.95      

                                                                                                                                                                    

│×åððè íàìàãåë {àëãåëäðàò 225 ìã, ìàãíèÿ ãèäðîêñèä │àíòàöèäíîå ñðåäñòâî [A02AX]             │ñóñïåíçèÿ îðàëüíàÿ (ôëàêîíû)  │Myevska Pharmaceuticals Inc   │007460,       

│200 ìã - 5 ìë}                                                                            │355 ìë                        │(ÑØÀ)                         │23.04.96      

                                                                                                                                                                    

│×åððè íàñèãåë {àëãåëäðàò 200 ìã, ìàãíèÿ ãèäðîêñèä │àíòàöèäíîå ñðåäñòâî [A02AF]             │ñóñïåíçèÿ îðàëüíàÿ (ôëàêîíû)  │Myevska Pharmaceuticals Inc   │007459,       

│200 ìã, ñèìåòèêîí 20 ìã - 5 ìë}                                                           │355 ìë                        │(ÑØÀ)                         │23.04.96      

                                                                                                                                                                    

│×èáðîêñèí [Íîðôëîêñàöèí]                          │ïðîòèâîìèêðîáíîå ñðåäñòâî, ôòîðõèíîëîí  │êàïëè ãëàçíûå (ôëàêîíû) 0.3%  │Merck Sharp & Dohme B.V.      │006908,       

                                                  │[S01AX12]                                                             │(Ãîëëàíäèÿ)                   │19.12.95      

                                                                                                                                                                    

│Øàìïóíü ðÍ-áàëàíñ {òðèýòàíîëàìèíëàóðèë ñóëüôàò,   │ðîñòà âîëîñ ñòèìóëÿòîð [A07AC]          │øàìïóíü                       │Schering-Plough (ÑØÀ)         │005016,       

│ìàêðîãîë-8-äèñòåàðàò, ìîíîýòàíîëàìèä êîêàìèä}                                                                                                         │16.06.94      

                                                                                                                                                                    

│Øàìïóíü Òàð {äåãîòü êàìåííîóãîëüíûé,              │ïðîòèâîñåáîðåéíîå ñðåäñòâî [A07AC]      │øàìïóíü                       │Schering-Plough (ÑØÀ)         │005015,       

│òðèýòàíîëàìèíëàóðèë ñóëüôàò,                                                                                                                          │16.06.94      

│ìàêðîãîë-8-äèñòåàðàò, ìîíîýòàíîëàìèä êîêàìèä,                                                                                                                       

│äèýòàíîëàìèä êîêàìèä, íàòðèÿ õëîðèä}                                                                                                                                

                                                                                                                                                                    

│Øàìïóíü Öèíê {ïèðèòèîíà öèíê, òðèýòàíîëàìèíëàóðèë │ïðîòèâîñåáîðåéíîå ñðåäñòâî [A07AC]      │øàìïóíü                       │Schering-Plough (ÑØÀ)         │005014,       

│ñóëüôàò, ìàêðîãîë-8-äèñòåàðàò, ìîíîýòàíîëàìèä                                                                                                         │16.06.94      

│êîêàìèä, äèýòàíîëàìèä êîêàìèä, íàòðèÿ õëîðèä,                                                                                                                       

│àëþìèíèé-ìàãíèé ñèëèêàò, ìåòèëöåëëþëîçà}                                                                                                                            

                                                                                                                                                                    

│Øåðèçîëîí [Ïðåäíèçîëîí]                           │ãëþêîêîðòèêîñòåðîèä [H02AB06]           │òàáëåòêè 5 ìã                 │Schering AG (Ãåðìàíèÿ)        │003560,       

                                                                                                                                                      │07.12.93      

                                                                                                                                                                    

│Øóãàôðè [Àñïàðòàì]                                │çàìåíèòåëü ñàõàðà [V06AA]               │òàáëåòêè                      │Cadila Laboratories Ltd       │003938,       

                                                                                                                        │(Èíäèÿ)                       │25.05.94      

                                                                                                                                                                    

│Ý-ìîêñ [Àìîêñèöèëëèí]                             │àíòèáèîòèê, ïåíèöèëëèí øèðîêîãî ñïåêòðà │ñóñïåíçèÿ 125 ìã|5 ìë, 250    │Eipico (Åãèïåò)               │003536,       

                                                  │[J01CA04]                               │ìã|5 ìë                                                     │03.12.93      

                                                                                                                                                                    

│Ýáðàíòèë [Óðàïèäèë]                               │àëüôà-àäðåíîáëîêàòîð [C02CA06]          │êàïñóëû ðåòàðä 30 ìã; ðàñòâîð │Byk Gulden GmbH (ÔÐÃ)         │002151,       

                                                                                          │äëÿ èíúåêöèé (àìïóëû) 25 ìã/5 │                              │30.05.91      

                                                                                          │ìë, 50 ìã/10 ìë                                                           

                                                                                                                                                                    

│Ýáðàíòèë [Óðàïèäèë]                               │àëüôà-àäðåíîáëîêàòîð [C02CA06]          │êàïñóëû ðåòàðä 60, 90 ìã      │Byk Gulden GmbH (ÔÐÃ)         │002225,       

                                                                                                                                                      │04.09.91      

                                                                                                                                                                    

│Ýáðèìèöèí {ïðèìèäèí 20 ìã, ëèäîêàèí 0.2 ã - 1 ã}  │àíòèñåïòè÷åñêîå ñðåäñòâî [D08]          │ãåëü                          │Chinoin (Âåíãðèÿ)             │002524,       

                                                                                                                                                      │22.06.92      

                                                                                                                                                                    

│Ýâåðèäåí [Âàëüïðîåâàÿ êèñëîòà] {âàëüïðîàò íàòðèÿ} │ïðîòèâîñóäîðîæíîå ñðåäñòâî [N03AG01]    │òàáëåòêè 300 ìã               │Slovakofarma SA (Ñëîâàêèÿ)    │006426,       

                                                                                                                                                      │21.08.95      

                                                                                                                                                                    

│Ýâèîí [Âèòàìèí Å]                                 │âèòàìèí [A11HA03]                       │êàïñóëû 100, 200, 400 ìã      │E.Merck (Èíäèÿ)               │005947,       

                                                                                                                                                      │12.04.95      

                                                                                                                                                                    

│Ýâèòîë [Âèòàìèí Å]                                │âèòàìèí [A11HA03]                       │äðàæå                         │Krka (Ñëîâåíèÿ)               │002486,        

                                                                                                                                                      │27.05.92      

                                                                                                                                                                    

│Ýãèôåðîí [Èíòåðôåðîí àëüôà]                       │èììóíîñòèìóëÿòîð [L03AA04]              │ëèîôèëèç.ïîðîøîê äëÿ          │Egis (Âåíãðèÿ)                │002251,        

                                                                                          │ïðèãîòîâëåíèÿ èíúåêöèîííîãî                                 │14.10.91      

                                                                                          │ðàñòâîðà (ôëàêîíû) 1000000,                                               

                                                                                          │3000000 ÌÅ /â êîìïëåêòå ñ                                                  

                                                                                          │ðàñòâîðèòåëåì/                                                            

                                                                                                                                                                    

│Ýãëîíèë [Ñóëüïèðèä]                               │äîôàìèí-áëîêàòîð [N05AL01]              │òàáëåòêè 200 ìã; êàïñóëû 50   │Laboratoires Delagrange,      │005341,       

                                                                                          │ìã; ðàñòâîð äëÿ èíúåêöèé      │Synthelabo (Ôðàíöèÿ)          │21.09.94      

                                                                                          │(àìïóëû) 100 ìã - 2 ìë;                                                   

                                                                                          │ðàñòâîð îðàëüíûé 0.5%                                                     

                                                                                                                                                                    

│Ýäåêñ [Àëïðîñòàäèë]                               │âàçîäèëàòèðóþùåå ñðåäñòâî [C01EA01]     │ëèîôèëèç.ïîðîøîê (àìïóëû) 20  │Schwarz Pharma AG (Ãåðìàíèÿ)  │005495,       

                                                                                          │ìêã /â êîìïëåêòå ñî øïðèöåì ñ │                              │15.11.94      

                                                                                          │1 ìë ôèçèîëîãè÷åñêîãî                                                     

                                                                                          │ðàñòâîðà, 2 èíúåêöèîííûìè                                                 

                                                                                          │èãëàìè è 2 ñïèðòîâûìè                                                     

                                                                                          │òàìïîíàìè/                                                                

                                                                                                                                                                    

│Ýäíèò [Ýíàëàïðèë]                                 │ÀÊÔ áëîêàòîð [C09AA02]                  │òàáëåòêè 2.5, 5, 10, 20 ìã    │Gedeon Richter (Âåíãðèÿ)      │006257,       

                                                                                                                                                      │10.07.95      

                                                                                                                                                                    

│Ýçàöèíîí [Ôëóîöèíîëîíà àöåòîíèä]                  │ãëþêîêîðòèêîñòåðîèä äëÿ ìåñòíîãî        │êðåì (òóáû) 0.025%            │Lisapharma (Èòàëèÿ)           │006503,       

                                                  │ïðèìåíåíèÿ [D07AC04]                                                                                │15.09.95      

                                                                                                                                                                    

│Ýêçàöèë [Òðàíåêñàìîâàÿ êèñëîòà]                   │ãåìîñòàòè÷åñêîå ñðåäñòâî [B02AA02]      │òàáëåòêè 250, 500 ìã; ðàñòâîð │Sanofi-Winthrop (Ôðàíöèÿ)     │005092,       

                                                                                          │äëÿ èíúåêöèé (àìïóëû) 500                                   │06.07.94      

                                                                                          │ìã/5 ìë                                                                   

                                                                                                                                                                    

│Ýêçàöèë [Òðàíåêñàìîâàÿ êèñëîòà]                   │ãåìîñòàòè÷åñêîå ñðåäñòâî [B02AA02]      │ðàñòâîð îðàëüíûé (àìïóëû) 1 ã │Sanofi-Winthrop (Ôðàíöèÿ)     │005876,       

                                                                                          │- 10 ìë                                                     │30.03.95      

                                                                                                                                                                    

│Ýêçîäåðèë [Íàôòèôèí] {íàôòèôèí 10 ìã, áåíçèëîâûé  │ïðîòèâîãðèáêîâîå ñðåäñòâî [D01AE22]     │êðåì 1%; ðàñòâîð äëÿ          │Biochemie GmbH (Àâñòðèÿ)      │003705,       

│ñïèðò 10 ìã - 1 ã}                                                                        │íàðóæíîãî ïðèìåíåíèÿ 1%                                     │18.02.94      

                                                                                                                                                                    

│Ýêçîäåðèë [Íàôòèôèí]                              │ïðîòèâîãðèáêîâîå ñðåäñòâî [D01AE22]     │êðåì 1%                       │Eczacibasi (Òóðöèÿ)           │003907,       

                                                                                                                                                      │12.05.94      

                                                                                                                                                                    

│Ýêçîìþê [Àöåòèëöèñòåèí]                           │îòõàðêèâàþùåå ñðåäñòâî [R05CB01]        │ãðàíóëû (ïàêåòèêè) 200 ìã     │Laboratoires Du Docteur       │006552,       

                                                                                                                        │E.Bouchara (Ôðàíöèÿ)          │25.09.95      

                                                                                                                                                                    

│Ýêçîñóðô ïåäèàòðè÷åñêèé [Êîëôîñöåðèëà ïàëüìèòàò]  │ñóðôàêòàíò [R07AA01]                    │ïîðîøîê äëÿ ïðèãîòîâëåíèÿ     │Wellcome Foundation Ltd       │003895,       

                                                                                          │ýíäîòðàõåàëüíîãî ðàñòâîðà     │(Âåëèêîáðèòàíèÿ)              │06.05.94      

                                                                                          │(ôëàêîíû) 108 ìã /â êîìïëåêòå │                                            

                                                                                          │ñ ðàñòâîðèòåëåì/                                                          

                                                                                                                                                                    

│Ýêèáàð [Ìåòèëäîïà]                                │àëüôà2-àäðåíîñòèìóëÿòîð öåíòðàëüíûé     │òàáëåòêè ïîêðûòûå îáîëî÷êîé   │Biogalenique (Ôðàíöèÿ)        │003211,       

                                                  │[C02AB02]                               │íåäåëèìûå 250, 500 ìã                                       │09.08.93      

                                                                                                                                                                    

│Ýêîâåíò [Ñàëüáóòàìîë]                             │áåòà2-àäðåíîñòèìóëÿòîð ñåëåêòèâíûé      │àýðîçîëü äîçèðîâàííûé         │Ecosol AG Pharmaceutical      │006090,       

                                                  │[R03AC02]                               │(ôëàêîíû) 0.1 ìã|äîçà         │Production (Øâåéöàðèÿ)        │23.05.95      

                                                                                                                                                                    

│Ýêîäàêñ [Ýêîíàçîë]                                │ïðîòèâîãðèáêîâîå ñðåäñòâî [D01AC03]     │êðåì 1%                       │Unique Pharmaceutical         │005805,       

                                                                                                                        │Laboratories (Èíäèÿ)          │06.03.95      

                                                                                                                                                                    

│Ýêîäèïèí [Íèôåäèïèí]                              │ÁÌÊÊ [C08CA05]                          │òàáëåòêè ïîêðûòûå îáîëî÷êîé   │Ecosol AG (Øâåéöàðèÿ)         │005767,       

                                                                                          │ðåòàðä 20 ìã; êàïñóëû                                       │21.02.95       

                                                                                          │æåëàòèíîâûå 10 ìã                                                         

                                                                                                                                                                    

│Ýêîäóðåêñ {àìèëîðèä 5 ìã, ãèäðîõëîðîòèàçèä 50 ìã} │äèóðåòè÷åñêîå êîìáèíèðîâàííîå ñðåäñòâî  │òàáëåòêè 5 ìã/50 ìã           │Ecosol AG (Øâåéöàðèÿ)         │006538,        

                                                  │[C03EA01]                                                                                           │21.09.95      

                                                                                                                                                                    

│Ýêîôåíàê [Äèêëîôåíàê]                             │ÍÏÂÑ [M01AB05]                          │òàáëåòêè ïîêðûòûå îáîëî÷êîé   │Ecosol AG (Øâåéöàðèÿ)         │005768,       

                                                                                          │25, 50 ìã; òàáëåòêè ïîêðûòûå                                │21.02.95      

                                                                                          │îáîëî÷êîé ðåòàðä 100 ìã                                                   

                                                                                                                                                                     

│Ýêñëþòîí [Ëèíåñòðåíîë]                            │ïðîãåñòàãåí [G03DC03]                   │òàáëåòêè 0.5 ìã               │N.V.Organon (Íèäåðëàíäû)      │006689,       

                                                                                                                                                      │10.10.95      

                                                                                                                                                                    

│Ýêñïîçîë [Êî-òðèìîêñàçîë] {ñóëüôàìåòîêñàçîë,      │ïðîòèâîìèêðîáíîå êîìáèíèðîâàííîå        │ñóñïåíçèÿ îðàëüíàÿ äëÿ äåòåé  │M.J.Pharmaceuticals Ltd       │005270,       

│òðèìåòîïðèì}                                      │ñðåäñòâî [J01EE01]                      │(ôëàêîíû) 200 ìã/40 ìã|5 ìë   │(Èíäèÿ)                       │29.08.94      

                                                                                                                                                                    

│Ýêñòåíöèëëèí [Áåíçàòèí áåíçèëïåíèöèëëèí]          │àíòèáèîòèê, ïåíèöèëëèí [J01CE08]        │ëèîôèëèç.ïîðîøîê äëÿ          │Rhone-Poulenc Rorer (Ôðàíöèÿ) │003833,       

                                                                                          │ïðèãîòîâëåíèÿ èíúåêöèîííîãî                                 │07.04.94      

                                                                                          │ðàñòâîðà (ôëàêîíû) 600000,                                                

                                                                                          │1200000, 2400000 ÅÄ                                                       

                                                                                                                                                                    

│Ýêòîôåð [Æåëåçà ñîðáàò]                           │ãåìîïîýçà ñòèìóëÿòîð, ïðåïàðàò æåëåçà   │ðàñòâîð äëÿ èíúåêöèé (àìïóëû) │Eczacibasi (Òóðöèÿ)           │01539, 06.01.89│

                                                  │[B03AA]                                 │2 ìë                                                                      

                                                                                                                                                                    

│Ýëàñòîòåðàçà èììîáèëèçîâàííàÿ                     │ïðîòåîëèòè÷åñêîå ñðåäñòâî äëÿ ìåñòíîãî  │ñàëôåòêè (ïàêåòû)             │(Óêðàèíà)                     │94/108/3      

                                                  │ïðèìåíåíèÿ [D03BA]                                                                                                

                                                                                                                                                                    

│Ýëäåïðèë [Ñåëåãèëèí]                              │ïðîòèâîïàðêèíñîíè÷åñêîå ñðåäñòâî        │òàáëåòêè 5 ìã                 │Farmos Group (Ôèíëÿíäèÿ)      │002265,       

                                                  │[N04BD01]                                                                                           │22.10.91      

                                                                                                                                                                    

│Ýëäåïðèë [Ñåëåãèëèí]                              │ïðîòèâîïàðêèíñîíè÷åñêîå ñðåäñòâî        │òàáëåòêè 5 ìã                 │Themis Chemicals Ltd (Èíäèÿ)  │006378,       

                                                  │[N04BD01]                                                                                           │08.08.95      

                                                                                                                                                                    

│Ýëåíèóì [Õëîðäèàçåïîêñèä]                         │òðàíêâèëèçàòîð [N05BA02]                │äðàæå 10 ìã                   │Polfa, Tarchominskie Zaklady  │007188,       

                                                                                                                        │Farmaceutyczne SA (Ïîëüøà)    │07.05.96      

                                                                                                                                                                    

│Ýëèâåë [Àìèòðèïòèëèí]                             │àíòèäåïðåññàíò [N06AA09]                │òàáëåòêè 10, 25 ìã            │Sun Pharmaceutical Industries │003159,       

                                                                                                                        │Ltd (Èíäèÿ)                   │19.07.93      

                                                                                                                                                                    

│Ýëîêîì [Ìîìåòàçîí]                                │ãëþêîêîðòèêîñòåðîèä äëÿ ìåñòíîãî        │êðåì (òóáû) 0.1%; ìàçü (òóáû) │Schering-Plough (Áåëüãèÿ)     │007457,       

                                                  │ïðèìåíåíèÿ [D07AC13]                    │0.1%; ëîñüîí äëÿ íàðóæíîãî                                  │22.04.96      

                                                                                          │ïðèìåíåíèÿ (ôëàêîíû) 0.1%                                                 

                                                                                                                                                                    

│Ýëüäåðèí [Ýòîäîëàê]                               │ÍÏÂÑ [M01AB08]                          │ôèëìòàáëåòêè 200 ìã;          │Lek D.D. (Ñëîâåíèÿ)           │006482,       

                                                                                          │ôèëìòàáëåòêè ôîðòå 300 ìã                                   │11.09.95      

                                                                                                                                                                    

│Ýëüìåòàöèí [Èíäîìåòàöèí]                          │ÍÏÂÑ [M01AB01]                          │ðàñòâîð 1%                    │Luitpold-Werk (ÔÐÃ)           │002056,       

                                                                                                                                                      │01.03.91      

                                                                                                                                                                    

│Ýìåñåò [Îíäàíñåòðîí]                              │ñåðîòîíèíîâûõ ðåöåïòîðîâ àíòàãîíèñò     │òàáëåòêè 4 ìã, 8 ìã; ðàñòâîð  │Cipla Ltd (Èíäèÿ)             │006675,       

                                                  │[A04AA01]                               │äëÿ èíúåêöèé (àìïóëû) 2 ìã/ìë │                              │29.09.95      

                                                                                          │- 2 ìë, 4 ìë                                                              

                                                                                                                                                                    

│Ýí âåé äæå ýð èíü                                 │äåðìàòîïðîòåêòîðíîå ñðåäñòâî [D11A]     │ðàñòâîð äëÿ íàðóæíîãî         │Enwei Pharma Company (ÊÍÐ)    │005936,       

                                                                                          │ïðèìåíåíèÿ (ôëàêîíû)                                        │06.04.95      

                                                                                                                                                                    

│Ýíàëàïðèë [Ýíàëàïðèë]                             │ÀÊÔ áëîêàòîð [C09AA02]                  │òàáëåòêè 10, 20 ìã            │Zdravle (Þãîñëàâèÿ)           │005456,       

                                                                                                                                                      │03.11.94      

                                                                                                                                                                     

│Ýíàì [Ýíàëàïðèë]                                  │ÀÊÔ áëîêàòîð [C09AA02]                  │òàáëåòêè 2.5, 5, 10, 20 ìã    │Dr.Reddy's Laboratories Ltd   │002402,       

                                                                                                                        │(Èíäèÿ)                       │30.01.92      

                                                                                                                                                                     

│Ýíàï [Ýíàëàïðèë]                                  │ÀÊÔ áëîêàòîð [C09AA02]                  │òàáëåòêè 10, 20 ìã            │Krka (ÑÔÐÞ)                   │002255,       

                                                                                                                                                      │14.10.91      

                                                                                                                                                                     

│Ýíàï [Ýíàëàïðèë]                                  │ÀÊÔ áëîêàòîð [C09AA02]                  │ðàñòâîð äëÿ èíúåêöèé (àìïóëû) │Krka (Ñëîâåíèÿ)               │003676,       

                                                                                          │1.25 ìã/ìë                                                  │09.02.94      

                                                                                                                                                                     

│Ýíàï-5 [Ýíàëàïðèë]                                │ÀÊÔ áëîêàòîð [C09AA02]                  │òàáëåòêè 5 ìã                 │Krka (Ñëîâåíèÿ)               │006356,       

                                                                                                                                                      │07.08.95      

                                                                                                                                                                    

│Ýíàï-H {ýíàëàïðèë 10 ìã, ãèäðîõëîðîòèàçèä 25 ìã}  │ãèïîòåíçèâíîå êîìáèíèðîâàííîå ñðåäñòâî  │òàáëåòêè 10 ìã/25 ìã          │Krka (Ñëîâåíèÿ)               │005320,       

                                                  │[C09BA02]                                                                                           │14.09.94      

                                                                                                                                                                    

│Ýíàï-HL {ýíàëàïðèë 10 ìã, ãèäðîõëîðîòèàçèä 12.5   │ÀÊÔ áëîêàòîð [C09BA02]                  │òàáëåòêè                      │Krka (Ñëîâåíèÿ)               │006357,       

│ìã}                                                                                                                                                   │07.08.95      

                                                                                                                                                                    

│Ýíàïðèë [Ýíàëàïðèë]                               │ÀÊÔ áëîêàòîð [C09AA02]                  │òàáëåòêè 5, 10 ìã             │Intas (Èíäèÿ)                 │003924,       

                                                                                                                                                      │19.05.94      

                                                                                                                                                                    

│Ýíàïðèí [Ýíàëàïðèë]                               │ÀÊÔ áëîêàòîð [C09AA02]                  │òàáëåòêè 10 ìã                │Chung Kun Dah Corporation     │002736,       

                                                                                                                        │(Êîðåÿ Þæíàÿ)                 │09.12.92      

                                                                                                                                                                    

│Ýíáóòîë [Ýòàìáóòîë]                               │ïðîòèâîòóáåðêóëåçíîå ñðåäñòâî [J04AK02] │òàáëåòêè 200, 400, 800 ìã     │Dee-Pharma Ltd (Èíäèÿ)        │006520,       

                                                                                                                                                      │20.09.95      

                                                                                                                                                                    

│Ýíâàñ [Ýíàëàïðèë]                                 │ÀÊÔ áëîêàòîð [C09AA02]                  │òàáëåòêè 5, 10 ìã             │Cadila Laboratories Ltd       │003699,       

                                                                                                                        │(Èíäèÿ)                       │15.02.94      

                                                                                                                                                                    

│Ýíäîêñàí [Öèêëîôîñôàìèä]                          │öèòîñòàòè÷åñêîå ñðåäñòâî [L01AA01]      │òàáëåòêè â îáîëî÷êå èç ñàõàðà │Asta Pharma AG (ÔÐÃ)          │02016, 27.11.90│

                                                                                                                                                                    

│Ýíäîêñàí-Àñòà [Öèêëîôîñôàìèä]                     │öèòîñòàòè÷åñêîå ñðåäñòâî [L01AA01]      │ïîðîøîê äëÿ ïðèãîòîâëåíèÿ     │Asta Pharma AG (ÔÐÃ)          │002202,       

                                                                                          │èíúåêöèîííîãî ðàñòâîðà                                      │30.07.91      

                                                                                          │(ôëàêîíû) 100, 200, 500, 1000 │                                            

                                                                                          │ìã                                                                        

                                                                                                                                                                    

│Ýíäðþñ àíñâåð {ïàðàöåòàìîë 1 ã, êîôåèí 60 ìã,     │àíàëüãåòè÷åñêîå íåíàðêîòè÷åñêîå         │ïîðîøîê øèïó÷èé (ïàêåòèêè     │Smithkline Beecham Consumer   │007246,       

│íàòðèÿ êàðáîíàò 1.408 ã - 5 ã}                    │ñðåäñòâî [N02BE51]                      │îäíîðàçîâûå)                  │Healthcare (Âåëèêîáðèòàíèÿ)   │16.07.96      

                                                                                                                                                                    

│Ýíäðþñ àíòàöèä {êàëüöèÿ êàðáîíàò 0.6 ã, ìàãíèÿ    │àíòàöèäíîå ñðåäñòâî [A02AX]             │òàáëåòêè 600 ìã/125 ìã        │Sterling Health               │003809,       

│êàðáîíàò 0.124 ìã}                                                                                                      │(Âåëèêîáðèòàíèÿ)              │31.03.94      

                                                                                                                                                                    

│Ýíäðþñ ëèâåð ñîëò {ëàêòîçà 40.5%, íàòðèÿ êàðáîíàò │àíòàöèäíîå ñðåäñòâî [A02AX]             │ïîðîøîê øèïó÷èé (ïàêåòèêè     │Smithkline Beecham Consumer   │007253,       

│22.6%, ëèìîííàÿ êèñëîòà 19.5%, ìàãíèÿ ñóëüôàò                                             │îäíîðàçîâûå) 5 ã; ïîðîøîê     │Healthcare (Âåëèêîáðèòàíèÿ)   │16.07.96      

│17.4%}                                                                                    │øèïó÷èé (áàíêè) 100, 113,                                                 

                                                                                          │200, 227 ã                                                                

                                                                                                                                                                    

│Ýíäóð - Å200 {òîêîôåðîë 200 ÌÅ, êàëüöèÿ ôîñôàò    │âèòàìèí [A11JB]                         │òàáëåòêè 200 ÌÅ               │Innovite Inc (ÑØÀ)            │006977,       

│100 ìã}                                                                                                                                               │12.01.96      

                                                                                                                                                                    

│Ýíäóðàöèí [Íèêîòèíîâàÿ êèñëîòà]                   │ãèïîëèïèäåìè÷åñêîå ñðåäñòâî [B04AE02]   │òàáëåòêè 500 ìã               │Endurance Products (ÑØÀ)      │003168,       

                                                                                                                                                      │20.07.93      

                                                                                                                                                                    

│Ýíåðáîë [Ïèðèòèíîë]                               │íîîòðîïíîå ñðåäñòâî [N06BX02]           │äðàæå                         │Polfa (Ïîëüøà)                │2522,         

                                                                                                                                                      │14.04.77,     

                                                                                                                                                      │17.06.88      

                                                                                                                                                                     

│Ýíçàïðîñò-Ô [Äèíîïðîñò]                           │ðîäîâîé äåÿòåëüíîñòè ñòèìóëÿòîð         │ðàñòâîð äëÿ èíúåêöèé (àìïóëû) │Chinoin (Âåíãðèÿ)             │2546,         

                                                  │[G02AD01]                               │1 ìã/1 ìë, 5 ìã/5 ìë                                        │13.03.78,     

                                                                                                                                                      │28.08.90       

                                                                                                                                                                    

│Ýíçèñòàë {ïàíêðåàòèí 0.192 ã, ãåìèöåëëþëàçà 50    │ïèùåâàðèòåëüíîå ôåðìåíòíîå ñðåäñòâî     │äðàæå                         │Torrent Exports Ltd (Èíäèÿ)   │002135,       

│ìã, æåë÷è êîìïîíåíòû 25 ìã}                       │[A09AA02]                                                                                           │24.05.91      

                                                                                                                                                                    

│Ýíèìàêñ ýíèìà [Íàòðèÿ ôîñôàò]                     │ñëàáèòåëüíîå ñðåäñòâî [A06AG01]         │ðàñòâîð (êëèçìû) 120 ìë       │Amoun Pharmaceutical          │005553,       

                                                                                                                        │Industries Co, Apic (Åãèïåò)  │06.12.94      

                                                                                                                                                                    

│Ýíêîðàò [Âàëüïðîåâàÿ êèñëîòà] {âàëüïðîàò íàòðèÿ}  │ïðîòèâîñóäîðîæíîå ñðåäñòâî [N03AG01]    │òàáëåòêè ïîêðûòûå îáîëî÷êîé   │Sun Pharmaceutical Industries │002578,       

                                                                                          │200, 300 ìã                   │Ltd (Èíäèÿ)                   │28.07.92      

                                                                                                                                                                    

│Ýíïðèë [Ýíàëàïðèë]                                │ÀÊÔ áëîêàòîð [C09AA02]                  │òàáëåòêè 10 ìã                │Inbiotech (Áîëãàðèÿ)          │006338,       

                                                                                                                                                      │02.08.95      

                                                                                                                                                                    

│Ýíòåðîáåíå [Ëîïåðàìèä]                            │ïðîòèâîäèàðåéíîå ñðåäñòâî [A07DA03]     │òàáëåòêè ïîêðûòûå îáîëî÷êîé 2 │Ludwig Merckle GmbH (Àâñòðèÿ) │005018,       

                                                                                          │ìã                                                          │20.06.94      

                                                                                                                                                                    

│Ýíòåðîñãåëü                                       │ýíòåðîñîðáèðóþùåå ñðåäñòâî [A07B]       │æåëå (ïàêåòû) 45, 135, 225,   │(Óêðàèíà)                     │94/158/6      

                                                                                          │450, 650, 900 ã                                                           

                                                                                                                                                                    

│Ýíöåôàáîë [Ïèðèòèíîë]                             │íîîòðîïíîå ñðåäñòâî [N06BX02]           │òàáëåòêè ïîêðûòûå îáîëî÷êîé   │E.Merck (Ãåðìàíèÿ)            │00433,        

                                                                                          │100 ìã; ñóñïåíçèÿ îðàëüíàÿ                                  │10.05.95,     

                                                                                          │100 ìã|5 ìë                                                 │27.12.76      

                                                                                                                                                                    

│Ýíöåôàáîë [Ïèðèòèíîë]                             │íîîòðîïíîå ñðåäñòâî [N06BX02]           │ñóñïåíçèÿ îðàëüíàÿ (ôëàêîíû)  │Merck (india) Ltd (Èíäèÿ)     │00790,        

                                                                                          │100 ìã|5 ìë - 200 ìë;                                       │11.09.80,     

                                                                                          │òàáëåòêè ïîêðûòûå îáîëî÷êîé                                 │22.09.93      

                                                                                          │100 ìã                                                                    

                                                                                                                                                                    

│Ýíöèïàëüìåä {ïàíêðåàòèí 72 ìã, æåë÷è êîìïîíåíòû   │ïèùåâàðèòåëüíîå ôåðìåíòíîå ñðåäñòâî     │äðàæå                         │Trima (Èçðàèëü)               │002597,       

│25 ìã, ãåìèöåëëþëàçà}                             │[A09AA02]                                                                                           │12.08.92      

                                                                                                                                                                    

│Ýîçèí Æèôðåð                                      │àíòèñåïòè÷åñêîå ñðåäñòâî [D08A]         │ðàñòâîð äëÿ íàðóæíîãî         │Gifrer Barbezat (Ôðàíöèÿ)     │007479,       

                                                                                          │ïðèìåíåíèÿ ñòåðèëüíûé                                       │29.04.96      

                                                                                          │(ôëàêîíû) 2% - 2, 5, 45 ìë                                                

                                                                                                                                                                    

│Ýïàñåë {ýéêîçàïåíòàåíîâàÿ êèñëîòà 18%,            │àäàïòîãåííîå ñðåäñòâî [A13A]            │êàïñóëû                       │Biorex (Âåíãðèÿ)              │002651,       

│äåêàçàãåêñàåíîâàÿ êèñëîòà 12%, òîêîôåðîë 0.4 ìã}                                                                                                      │08.10.92      

                                                                                                                                                                    

│Ýïèàë [Êàðáàìàçåïèí]                              │ïðîòèâîñóäîðîæíîå ñðåäñòâî [N03AF01]    │òàáëåòêè 200 ìã               │Alkaloid (Ìàêåäîíèÿ)          │005595,       

                                                                                                                                                      │22.12.94      

                                                                                                                                                                    

│Ýïèêîöèëëèí [Àìïèöèëëèí]                          │àíòèáèîòèê, ïåíèöèëëèí øèðîêîãî ñïåêòðà │ñóñïåíçèÿ äëÿ ïðèãîòîâëåíèÿ   │Eipico (Åãèïåò)               │003537,       

                                                  │[J01CA01]                               │ìèêñòóðû 125 ìã|5 ìë, 250                                   │03.12.93      

                                                                                          │ìã|5 ìë                                                                   

                                                                                                                                                                    

│Ýïîöåëèí [Öåôòèçîêñèì]                            │àíòèáèîòèê, öåôàëîñïîðèí [J01DA22]      │ïîðîøîê äëÿ ïðèãîòîâëåíèÿ     │Al-Hikma Pharmaceuticals      │002277,       

                                                                                          │èíúåêöèîííîãî ðàñòâîðà        │(Èîðäàíèÿ)                    │12.11.91      

                                                                                          │(ôëàêîíû) 1 ã                                                             

                                                                                                                                                                    

│Ýïîöåëèí [Öåôòèçîêñèì]                            │àíòèáèîòèê, öåôàëîñïîðèí [J01DA22]      │ëèîôèëèç.ïîðîøîê äëÿ          │Al-Hikma Pharmaceuticals      │002591,       

                                                                                          │ïðèãîòîâëåíèÿ èíúåêöèîííîãî   │(Èîðäàíèÿ)                    │05.08.92      

                                                                                          │ðàñòâîðà (ôëàêîíû) 0.5, 2 ã                                               

                                                                                                                                                                    

│Ýïîöåëèí [Öåôòèçîêñèì]                            │àíòèáèîòèê, öåôàëîñïîðèí [J01DA22]      │ïîðîøîê äëÿ ïðèãîòîâëåíèÿ     │Eczacibasi (Òóðöèÿ)           │01474, 30.08.88│

                                                                                          │èíúåêöèîííîãî ðàñòâîðà                                                     

                                                                                          │(ôëàêîíû) 0.5, 1 ã                                                        

                                                                                                                                                                    

│Ýïîöåëèí [Öåôòèçîêñèì]                            │àíòèáèîòèê, öåôàëîñïîðèí [J01DA22]      │ïîðîøîê äëÿ ïðèãîòîâëåíèÿ     │Fujisawa Pharmaceutical Co    │01228, 25.12.85│

                                                                                          │èíúåêöèîííîãî ðàñòâîðà        │Ltd (ßïîíèÿ)                                

                                                                                          │(ôëàêîíû) 0.5, 1 ã                                                        

                                                                                                                                                                     

│Ýïðåêñ [Ýïîýòèí áåòà]                             │ãåìîïîýçà ñòèìóëÿòîð [B03XA01]          │ðàñòâîð äëÿ èíúåêöèé (øïðèöû) │Cilag (Øâåéöàðèÿ)             │007462,       

                                                                                          │1000 ÅÄ/0.5 ìë, 2000 ÅÄ/0.5                                 │23.04.96      

                                                                                          │ìë, 3000 ÅÄ/0.3 ìë, 4000                                                   

                                                                                          │ÅÄ/0.4 ìë, 10000 ÅÄ/1 ìë                                                  

                                                                                                                                                                    

│Ýïðåêñ [Ýïîýòèí áåòà]                             │ãåìîïîýçà ñòèìóëÿòîð [B03XA01]          │ðàñòâîð äëÿ èíúåêöèé          │Cilag (Øâåéöàðèÿ)             │007185,       

                                                                                          │(ôëàêîíû) 1000 ÅÄ/0.5 ìë,                                   │24.04.96      

                                                                                          │2000 ÅÄ/1 ìë, 4000 ÅÄ/1 ìë,                                               

                                                                                          │10000 ÅÄ/1 ìë                                                             

                                                                                                                                                                    

│Ýðàçîí [Ïèðîêñèêàì]                               │ÍÏÂÑ [M02AA07]                          │êàïñóëû 10, 20 ìã; ñâå÷è 20 ìã│Krka (ÑÔÐÞ)                   │01687, 05.10.89│

                                                                                                                                                                    

│Ýðàçîí [Ïèðîêñèêàì]                               │ÍÏÂÑ [M02AA07]                          │êðåì 1%                       │Krka (ÑÔÐÞ)                   │002088,       

                                                                                                                                                      │21.03.91      

                                                                                                                                                                    

│Ýðàçîí [Ïèðîêñèêàì]                               │ÍÏÂÑ [M02AA07]                          │ãåëü 1%                       │Krka (ÑÔÐÞ)                   │002217,       

                                                                                                                                                      │20.08.91      

                                                                                                                                                                    

│Ýðàöèí [Ýðèòðîìèöèí]                              │àíòèáèîòèê, ìàêðîëèä [J01FA01]          │òàáëåòêè 200, 400 ìã          │Orion Pharmaceutica           │002228,       

                                                                                                                        │(Ôèíëÿíäèÿ)                   │17.09.91      

                                                                                                                                                                    

│Ýðãîìåòðèí [Ýðãîìåòðèí] {ñïîðûíüè àëêàëîèä}       │àëüôà-àäðåíîñòèìóëÿòîð [G02AB03]        │ðàñòâîð äëÿ èíúåêöèé (àìïóëû) │Sanavita Gesundcheitsmittel & │006849,       

                                                                                          │0.2 ìã - 1 ìë                 │Co Kg (Ãåðìàíèÿ)              │22.11.95      

                                                                                                                                                                    

│Ýðãîòîï [Íèöåðãîëèí]                              │àëüôà-àäðåíîáëîêàòîð [C04AE02]          │òàáëåòêè 10 ìã; òàáëåòêè      │F.Joh.Quisda GmbH (Àâñòðèÿ)   │006423,       

                                                                                          │ïîêðûòûå îáîëî÷êîé 20, 30 ìã                                │21.08.95      

                                                                                                                                                                    

│Ýðåìôàò 600 [Ðèôàìïèöèí]                          │ïðîòèâîòóáåðêóëåçíîå ñðåäñòâî [J04AB02] │òàáëåòêè ïîêðûòûå îáîëî÷êîé   │Fatol Arzneimittel GmbH       │006446,       

                                                                                          │600 ìã                        │(Ãåðìàíèÿ)                    │29.08.95      

                                                                                                                                                                    

│Ýðåñïàë [Ôåíñïèðèä]                               │ïðîòèâîâîñïàëèòåëüíîå ñðåäñòâî [R03DX03]│òàáëåòêè ïîêðûòûå îáîëî÷êîé   │Laboratoires Servier (Ôðàíöèÿ)│005548,       

                                                                                          │80 ìã; ñèðîï (ôëàêîíû) 2 ìã/ìë│                              │06.12.94      

                                                                                                                                                                    

│Ýðèãåêñàë [Ýðèòðîìèöèí]                           │àíòèáèîòèê, ìàêðîëèä [J01FA01]          │êàïñóëû 250 ìã; ôèëìòàáëåòêè  │Hexal Pharma GmbH (Ãåðìàíèÿ)  │005759,       

                                                                                          │500 ìã; ãðàíóëû äëÿ                                         │17.02.95      

                                                                                          │ïðèãîòîâëåíèÿ îðàëüíîé                                                    

                                                                                          │ñóñïåíçèè (ïàêåòû) 500, 1000                                              

                                                                                          │ìã; ãðàíóëÿò äëÿ                                                          

                                                                                          │ïðèãîòîâëåíèÿ îðàëüíîé                                                    

                                                                                          │ñóñïåíçèè (ôëàêîíû) 36.6 ã -                                              

                                                                                          │100 ìë                                                                    

                                                                                                                                                                    

│Ýðèäåðì [Ýðèòðîìèöèí]                             │àíòèáèîòèê, ìàêðîëèä [J01FA01]          │ðàñòâîð 2%                    │Abbott Laboratories (ÑØÀ)     │003339,       

                                                                                                                                                      │21.09.93      

                                                                                                                                                                    

│Ýðèê [Ýðèòðîìèöèí]                                │àíòèáèîòèê, ìàêðîëèä [J01FA01]          │êàïñóëû 250 ìã                │Biogal (Âåíãðèÿ)              │002141,       

                                                                                                                                                      │27.05.91      

                                                                                                                                                                    

│Ýðèòðàí [Ýðèòðîìèöèí]                             │àíòèáèîòèê, ìàêðîëèä [J01FA01]          │ãðàíóëû äëÿ ïðèãîòîâëåíèÿ     │Pharmachim (Áîëãàðèÿ)         │2323,         

                                                                                          │ñèðîïà                                                      │07.05.73,     

                                                                                                                                                      │26.03.87      

                                                                                                                                                                     

│Ýðèòðîìèöèí [Ýðèòðîìèöèí]                         │àíòèáèîòèê, ìàêðîëèä [J01FA01]          │òàáëåòêè ïîêðûòûå îáîëî÷êîé   │Abbott Laboratories (ÑØÀ)     │005069,       

                                                                                          │250 ìã                                                      │01.07.94      

                                                                                                                                                                     

│Ýðèòðîìèöèí [Ýðèòðîìèöèí]                         │àíòèáèîòèê, ìàêðîëèä [J01FA01]          │òàáëåòêè 500 ìã; ãðàíóëû äëÿ  │Sanavita Gesundcheitsmittel & │006847,       

                                                                                          │ïðèãîòîâëåíèÿ îðàëüíîé        │Co Kg (Ãåðìàíèÿ)              │22.11.95      

                                                                                          │ñóñïåíçèè (ôëàêîíû) 125 ìã|5                                               

                                                                                          │ìë, 200 ìã|5 ìë                                                           

                                                                                                                                                                    

│Ýðèòðîìèöèí [Ýðèòðîìèöèí]                         │àíòèáèîòèê, ìàêðîëèä [J01FA01]          │òàáëåòêè 200 ìã               │Polfa (Ïîëüøà)                │2873, 16.10.87 │

                                                                                                                                                                    

│Ýðèòðîìèöèí 250 [Ýðèòðîìèöèí]                     │àíòèáèîòèê, ìàêðîëèä [J01FA01]          │òàáëåòêè ïîêðûòûå îáîëî÷êîé   │Euderma (Èòàëèÿ)              │006999,       

                                                                                          │250 ìã                                                      │22.01.96      

                                                                                                                                                                    

│Ýðèòðîìèöèí ëàêòîáèîíàò [Ýðèòðîìèöèí]             │àíòèáèîòèê, ìàêðîëèä [J01FA01]          │ðàñòâîð äëÿ âíóòðèâåííîãî     │Abbott Laboratories (ÑØÀ)     │003339,       

                                                                                          │ââåäåíèÿ (ôëàêîíû) 0.3, 1 ã                                 │21.09.93      

                                                                                                                                                                    

│Ýðèòðîìèöèí Ïñè Äèñïåðòàá [Ýðèòðîìèöèí]           │àíòèáèîòèê, ìàêðîëèä [J01FA01]          │òàáëåòêè ïîêðûòûå îáîëî÷êîé   │Abbott Laboratories (ÑØÀ)     │003339,       

                                                                                          │333 ìã                                                      │21.09.93      

                                                                                                                                                                    

│Ýðèòðîìèöèí ñòåàðàò [Ýðèòðîìèöèí]                 │àíòèáèîòèê, ìàêðîëèä [J01FA01]          │òàáëåòêè ïîêðûòûå ïëåíî÷íîé   │Tamilnadu Dadha               │005435,       

                                                                                          │îáîëî÷êîé 125, 250 ìã         │Pharmaceuticals Ltd (Èíäèÿ)   │28.10.94      

                                                                                                                                                                    

│Ýðèòðîìèöèí ñòåàðåéò [Ýðèòðîìèöèí]                │àíòèáèîòèê, ìàêðîëèä [J01FA01]          │òàáëåòêè 250, 500 ìã          │Abbott Laboratories (ÑØÀ)     │003339,       

                                                                                                                                                      │21.09.93      

                                                                                                                                                                    

│Ýðèòðîìèöèí-Ðàòèîôàðì [Ýðèòðîìèöèí]               │àíòèáèîòèê, ìàêðîëèä [J01FA01]          │ïîðîøîê äëÿ ïðèãîòîâëåíèÿ     │Ratiopharm GmbH & Co          │003779,       

                                                                                          │îðàëüíîé ñóñïåíçèè 40 ìã/ìë   │(Ãåðìàíèÿ)                    │23.03.94      

                                                                                                                                                                    

│Ýðèòðîìèöèí-Òåâà [Ýðèòðîìèöèí]                    │àíòèáèîòèê, ìàêðîëèä [J01FA01]          │òàáëåòêè 250, 500 ìã; ãðàíóëû │Teva Pharmaceutical           │005756,       

                                                                                          │äëÿ ïðèãîòîâëåíèÿ îðàëüíîé    │Industries Ltd (Èçðàèëü)      │17.02.95      

                                                                                          │ñóñïåíçèè (ôëàêîíû) 125 ìã|5                                              

                                                                                          │ìë, 200 ìã|5 ìë, 400 ìã|5 ìë                                              

                                                                                                                                                                    

│Ýðèòðîïåä [Ýðèòðîìèöèí]                           │àíòèáèîòèê, ìàêðîëèä [J01FA01]          │ãðàíóëû äëÿ ïðèãîòîâëåíèÿ     │Abbott Laboratories (ÑØÀ)     │003339,       

                                                                                          │îðàëüíîé ñóñïåíçèè 250 ìã|5 ìë│                              │21.09.93      

                                                                                                                                                                    

│Ýðñåôóðèë [Íèôóðîêñàçèä]                          │ïðîòèâîìèêðîáíîå ñðåäñòâî, íèòðîôóðàí   │êàïñóëû 200 ìã; ñóñïåíçèÿ     │Laboratoires Synthelabo       │005477,       

                                                  │[A07AX03]                               │îðàëüíàÿ (ôëàêîíû) 4%         │(Ôðàíöèÿ)                     │11.11.94      

                                                                                                                                                                    

│Ýðöåôóðèë [Íèôóðîêñàçèä]                          │ïðîòèâîìèêðîáíîå ñðåäñòâî, íèòðîôóðàí   │êàïñóëû 100 ìã; ñóñïåíçèÿ     │Bosnalijek (ÑÔÐÞ)             │01952, 06.09.90│

                                                  │[A07AX03]                               │îðàëüíàÿ                                                                  

                                                                                                                                                                    

│Ýñêàíäèí [Èáîïàìèí]                               │êàðäèîòîíè÷åñêîå ñðåäñòâî [C01CA16]     │òàáëåòêè ïîêðûòûå îáîëî÷êîé   │Zambon Groupp Spa (Èòàëèÿ)    │005944,       

                                                                                          │100 ìã                                                      │11.04.95      

                                                                                                                                                                    

│Ýñêóçàí {ýñöèí 4 ìã, òèàìèí 2.25 ìã}              │âåíîòîíèçèðóþùåå ñðåäñòâî [C05CX]       │äðàæå                         │Jenapharm GmbH (ÔÐÃ)          │002408,       

                                                                                                                                                      │30.01.92      

                                                                                                                                                                    

│Ýñêóçàí {ýñöèí 4 ìã, òèàìèí 2.25 ìã}              │âåíîòîíèçèðóþùåå ñðåäñòâî [C05CX]       │êàïëè îðàëüíûå (ôëàêîíû) 20 ìë│Pharma Wernigerode GmbH       │007189,       

                                                                                                                        │(Ãåðìàíèÿ)                    │14.05.96      

                                                                                                                                                                    

│Ýñïà-Ëèïîí [Ãèîñöèíà áóòèëáðîìèä]                 │ì-õîëèíîáëîêàòîð [A03BB01]              │òàáëåòêè ïîêðûòûå îáîëî÷êîé   │Esparma Pharmazeutische       │006769,       

                                                                                          │200, 600 ìã; ðàñòâîð äëÿ      │Fabrik GmbH (Ãåðìàíèÿ)        │31.10.95      

                                                                                          │èíúåêöèé (àìïóëû) 150, 300,                                               

                                                                                          │600 ìã                                                                    

                                                                                                                                                                    

│Ýñïåðàëü [Äèñóëüôèðàì]                            │ñðåäñòâî äëÿ ëå÷åíèÿ àëêîãîëèçìà        │òàáëåòêè äëÿ èìïëàíòàöèé      │Laboratoires Solyak (Ôðàíöèÿ) │00845, 03.04.81│

                                                  │[V03AA01]                                                                                                          

                                                                                                                                                                    

│Ýñïåðàëü [Äèñóëüôèðàì]                            │ñðåäñòâî äëÿ ëå÷åíèÿ àëêîãîëèçìà        │òàáëåòêè 500 ìã               │Sanofi-Winthrop (Ôðàíöèÿ)     │005697,       

                                                  │[V03AA01]                                                                                           │30.01.95       

                                                                                                                                                                    

│Ýñïóìèçàí [Ñèìåòèêîí] {ñèìåòèêîí 40 ìã|5 ìë}      │âåòðîãîííîå ñðåäñòâî [A02DA]            │ýìóëüñèÿ îðàëüíàÿ             │Berlin-Chemie AG (Ãåðìàíèÿ)   │006166,       

                                                                                                                                                      │13.06.95      

                                                                                                                                                                    

│Ýññàâåí {ýñöèí 1 ã, ãåïàðèí 10000 ÌÅ, ôîñôîëèïèäû │âåíîòîíèçèðóþùåå ñðåäñòâî [C05CX]       │ãåëü                          │Rhone-Poulenc Rorer (Ôðàíöèÿ) │002978,       

│1 ã - 100 ã}                                                                                                                                          │23.04.93      

                                                                                                                                                                    

│Ýññåë ôîðòå {ôîñôîëèïèäû 300 ìã, ïèðèäîêñèí 6 ìã, │ãåïàòîïðîòåêòîð [A05C]                  │êàïñóëû                       │Nabros Pharma Pvt.Ltd (Èíäèÿ) │007065,       

│öèàíîêîáàëàìèí 6 ìêã, íèêîòèíàìèä 30 ìã, òèàìèí 6 │                                                                                                    │08.02.96      

│ìã, ðèáîôëàâèí 6 ìã, òîêîôåðîë 6 ìã}                                                                                                                                

                                                                                                                                                                    

│Ýññåíöèàëå {ôîñôîëèïèäû 1 ã/250 ìã, ïèðèäîêñèí 5  │ãåïàòîïðîòåêòîð [A05C]                  │ðàñòâîð äëÿ èíúåêöèé (àìïóëû) │Berlin-Chemie AG (ÔÐÃ)        │002902,       

│ìã/2.5 ìã, öèàíîêîáàëàìèí 15 ìã/10 ìêã,                                                   │5 ìë; êàïñóëû ôîðòå                                         │11.03.93      

│ïàíòîòåíàò íàòðèÿ 3 ìã/1.5 ìã, íèêîòèíàìèä 100                                                                                                                      

│ìã/25 ìã - àìïóëû 10 ìë/5 ìë; ôîñôîëèïèäû 0.3 ã,                                                                                                                    

│òèàìèí 6 ìã, ðèáîôëàâèí 6 ìã, ïèðèäîêñèí 6 ìã,                                                                                                                      

│öèàíîêîáàëàìèí 6 ìêã, íèêîòèíàìèä 30 ìã,                                                                                                                            

│òîêîôåðîë 6 ìã - êàïñóëà}                                                                                                                                           

                                                                                                                                                                    

│Ýññåíöèàëå {ôîñôîëèïèäû 1 ã/250 ìã, ïèðèäîêñèí 5  │ãåïàòîïðîòåêòîð [A05C]                  │ðàñòâîð äëÿ èíúåêöèé (àìïóëû) │Bosnalijek (ÑÔÐÞ)             │00531,        

│ìã/2.5 ìã, öèàíîêîáàëàìèí 15 ìã/10 ìêã,                                                   │5, 10 ìë                                                    │06.12.77,     

│ïàíòîòåíàò íàòðèÿ 3 ìã/1.5 ìã, íèêîòèíàìèä 100                                                                                                        │23.05.89      

│ìã/25 ìã - àìïóëû 10 ìë/5 ìë}                                                                                                                                       

                                                                                                                                                                    

│Ýññåíöèàëå {ôîñôîëèïèäû 0.3 ã, òèàìèí 6 ìã,       │ãåïàòîïðîòåêòîð [A05C]                  │êàïñóëû ôîðòå                 │Bosnalijek (ÑÔÐÞ)             │01627, 30.06.89│

│ðèáîôëàâèí 6 ìã, ïèðèäîêñèí 6 ìã, öèàíîêîáàëàìèí                                                                                                                    

│6 ìêã, íèêîòèíàìèä 30 ìã, òîêîôåðîë 6 ìã}                                                                                                                           

                                                                                                                                                                    

│Ýññåíöèàëå {ôîñôîëèïèäû 250 ìã, ïèðèäîêñèí 2.5    │ãåïàòîïðîòåêòîð [A05C]                  │ðàñòâîð äëÿ èíúåêöèé (àìïóëû) │Rhone-Poulenc Rorer (Ãåðìàíèÿ)│006611,       

│ìã, öèàíîêîáàëàìèí 10 ìêã, ïàíòîòåíàò íàòðèÿ 1.5                                          │5 ìë                                                        │21.12.95      

│ìã, íèêîòèíàìèä 25 ìã - 5 ìë}                                                                                                                                       

                                                                                                                                                                    

│Ýññåíöèàëå {ôîñôîëèïèäû 0.3 ã, òèàìèí 6 ìã,       │ãåïàòîïðîòåêòîð [A05C]                  │êàïñóëû ôîðòå                 │Nattermann GmbH (ÔÐÃ)         │01691,        

│ðèáîôëàâèí 6 ìã, ïèðèäîêñèí 6 ìã, öèàíîêîáàëàìèí                                                                                                      │20.07.93,     

│6 ìêã, íèêîòèíàìèä 30 ìã, òîêîôåðîë 6 ìã}                                                                                                             │26.10.89      

                                                                                                                                                                    

│Ýññåíöèàëå {ôîñôîëèïèäû 0.3 ã, òèàìèí 6 ìã,       │ãåïàòîïðîòåêòîð [A05C]                  │êàïñóëû ôîðòå                 │Torrent Exports Ltd (Èíäèÿ)   │002232,       

│ðèáîôëàâèí 6 ìã, ïèðèäîêñèí 6 ìã, öèàíîêîáàëàìèí                                                                                                      │05.09.91      

│6 ìêã, íèêîòèíàìèä 30 ìã, òîêîôåðîë 6 ìã}                                                                                                                           

                                                                                                                                                                    

│Ýñòàçîëàì [Ýñòàçîëàì]                             │òðàíêâèëèçàòîð [N05CD04]                │òàáëåòêè 2 ìã                 │Polfa, Tarchominskie Zaklady  │005304,       

                                                                                                                        │Farmaceutyczne SA (Ïîëüøà)    │07.09.94      

                                                                                                                                                                    

│Ýñòðàäåðì ÒÒÑ 100 [Ýñòðàäèîë]                     │ýñòðîãåí [G03CA03]                      │òðàíñäåðìàëüíàÿ               │Ciba-Geigy (Øâåéöàðèÿ)        │002166,       

                                                                                          │òåðàïåâòè÷åñêàÿ ñèñòåìà                                     │19.06.91      

                                                                                          │(ïëàñòûðü) 8 ìã|20 êâ. ñì                                                 

                                                                                                                                                                    

│Ýñòðàäåðì ÒÒÑ 25 [Ýñòðàäèîë]                      │ýñòðîãåí [G03CA03]                      │òðàíñäåðìàëüíàÿ               │Ciba-Geigy (Øâåéöàðèÿ)        │002166,       

                                                                                          │òåðàïåâòè÷åñêàÿ ñèñòåìà                                     │19.06.91      

                                                                                          │(ïëàñòûðü) - 2 ìã|5 êâ. ñì                                                

                                                                                                                                                                    

│Ýñòðàäåðì ÒÒÑ 50 [Ýñòðàäèîë]                      │ýñòðîãåí [G03CA03]                      │òðàíñäåðìàëüíàÿ               │Ciba-Geigy (Øâåéöàðèÿ)        │002166,       

                                                                                          │òåðàïåâòè÷åñêàÿ ñèñòåìà                                     │19.06.91      

                                                                                          │(ïëàñòûðü) - 4 ìã|10 êâ. ñì                                               

                                                                                                                                                                     

│Ýñòðàäóðèí [Ïîëèýñòðàäèîë ôîñôàò]                 │ýñòðîãåí [L02AA]                        │ëèîôèëèç.ïîðîøîê äëÿ          │Pharmacia (Èòàëèÿ)            │007551,       

                                                                                          │ïðèãîòîâëåíèÿ èíúåêöèîííîãî                                 │30.05.96      

                                                                                          │ðàñòâîðà (ôëàêîíû) 80 ìã - 5                                               

                                                                                          │ìë /â êîìïëåêòå ñ                                                         

                                                                                          │ðàñòâîðèòåëåì - âîäà äëÿ                                                  

                                                                                          │èíúåêöèé (àìïóëû) 2 ìë/                                                    

                                                                                                                                                                    

│Ýñòðàöèò [Ýñòðàìóñòèí]                            │ýñòðîãåí [L01XX11]                      │êàïñóëû 140 ìã                │Pharmacia (Øâåöèÿ)            │007183,       

                                                                                                                                                      │16.04.96      

                                                                                                                                                                    

│Ýñòðàöèò [Ýñòðàìóñòèí]                            │ýñòðîãåí [L01XX11]                      │ëèîôèëèç.ïîðîøîê äëÿ          │Pharmacia (Èòàëèÿ)            │007570,       

                                                                                          │ïðèãîòîâëåíèÿ èíúåêöèîííîãî                                 │05.06.96      

                                                                                          │ðàñòâîðà (ôëàêîíû) 300 ìã /â                                              

                                                                                          │êîìïëåêòå ñ ðàñòâîðèòåëåì -                                               

                                                                                          │âîäà äëÿ èíúåêöèé (àìïóëû)/                                               

                                                                                                                                                                    

│Ýñòðàöèò [Ýñòðàìóñòèí]                            │ýñòðîãåí [L01XX11]                      │àìïóëû 150, 300 ìã            │Leo (Øâåöèÿ)                  │00600, 04.07.78│

                                                                                                                                                                    

│Ýñòóëèê [Ãóàíôàöèí]                               │àëüôà2-àäðåíîñòèìóëÿòîð öåíòðàëüíûé     │òàáëåòêè 1 ìã                 │Egis (Âåíãðèÿ)                │002522,       

                                                  │[C02AC02]                                                                                           │19.06.92      

                                                                                                                                                                    

│Ýòàìáóòîë [Ýòàìáóòîë]                             │ïðîòèâîòóáåðêóëåçíîå ñðåäñòâî [J04AK02] │òàáëåòêè 100, 400 ìã          │Chinoin (Âåíãðèÿ)             │006615,       

                                                                                                                                                      │25.12.95      

                                                                                                                                                                    

│Ýòàìáóòîë [Ýòàìáóòîë]                             │ïðîòèâîòóáåðêóëåçíîå ñðåäñòâî [J04AK02] │òàáëåòêè 200, 400, 600, 800 ìã│Ipca Laboratories Ltd (Èíäèÿ) │006353,       

                                                                                                                                                      │07.08.95      

                                                                                                                                                                    

│Ýòàìáóòîë [Ýòàìáóòîë]                             │ïðîòèâîòóáåðêóëåçíîå ñðåäñòâî [J04AK02] │òàáëåòêè 200, 400 ìã          │Life Pharma (Èòàëèÿ)          │006985,       

                                                                                                                                                      │16.01.96      

                                                                                                                                                                    

│Ýòàìáóòîë [Ýòàìáóòîë]                             │ïðîòèâîòóáåðêóëåçíîå ñðåäñòâî [J04AK02] │êàïñóëû                       │Polfa (Ïîëüøà)                │2488,         

                                                                                                                                                      │14.05.76,     

                                                                                                                                                      │16.06.93      

                                                                                                                                                                    

│Ýòàìáóòîë [Ýòàìáóòîë]                             │ïðîòèâîòóáåðêóëåçíîå ñðåäñòâî [J04AK02] │òàáëåòêè 100, 400 ìã          │Sanavita Gesundcheitsmittel & │007638,       

                                                                                                                        │Co Kg (Ãåðìàíèÿ)              │10.07.96      

                                                                                                                                                                    

│Ýòàìáóòîë [Ýòàìáóòîë]                             │ïðîòèâîòóáåðêóëåçíîå ñðåäñòâî [J04AK02] │òàáëåòêè 200, 400, 800 ìã     │Wave International (Èíäèÿ)    │007545,       

                                                                                                                                                      │27.05.96      

                                                                                                                                                                    

│Ýòèäèíèç [Èçîñîðáèä äèíèòðàò]                     │âàçîäèëàòèðóþùåå ñðåäñòâî [C01DA08]     │êàïñóëû 20, 40 ìã             │Ethypharm (Ôðàíöèÿ)           │003579,       

                                                                                                                                                      │13.12.93      

                                                                                                                                                                    

│Ýòèäîêñèí [Äîêñèöèêëèí]                           │àíòèáèîòèê, òåòðàöèêëèí                 │êàïñóëû 100 ìã                │Ethypharm (Ôðàíöèÿ)           │002783,       

                                                  │ïîëóñèíòåòè÷åñêèé [J01AA02]                                                                         │29.12.92      

                                                                                                                                                                    

│Ýòèîíàìèä [Ýòèîíàìèä]                             │ïðîòèâîòóáåðêóëåçíîå ñðåäñòâî [J04AD03] │äðàæå 250 ìã                  │Gedeon Richter (Âåíãðèÿ)      │2650,         

                                                                                                                                                      │09.12.80,     

                                                                                                                                                      │25.01.93      

                                                                                                                                                                    

│Ýòèôåíàê [Äèêëîôåíàê]                             │ÍÏÂÑ [M01AB05]                          │êàïñóëû ïðîëîíãèðîâàííîãî     │Ethypharm (Ôðàíöèÿ)           │005418,       

                                                                                          │âûñâîáîæäåíèÿ 100 ìã                                        │24.10.94      

                                                                                                                                                                    

│Ýòèôèëëèí [Òåîôèëëèí]                             │áðîíõîäèëàòèðóþùåå ñðåäñòâî [R03DA04]   │òàáëåòêè 100, 200, 300 ìã     │Ethypharm (Ôðàíöèÿ)           │003163,       

                                                                                                                                                      │19.07.93      

                                                                                                                                                                    

│Ýòîãåëü [Ýòîôåíàìàò]                              │ïðîòèâîâîñïàëèòåëüíîå ñðåäñòâî äëÿ      │ãåëü                          │Krka (Þãîñëàâèÿ)              │01212, 17.12.85│

                                                  │ìåñòíîãî ïðèìåíåíèÿ [M02AA06]                                                                                      

                                                                                                                                                                    

│Ýòîçèä [Ýòîïîçèä]                                 │öèòîñòàòè÷åñêîå ñðåäñòâî [L01CB01]      │ðàñòâîð äëÿ èíúåêöèé          │Cipla Ltd (Èíäèÿ)             │003001,       

                                                                                          │(ôëàêîíû) 100 ìã - 5 ìë                                     │26.05.93       

                                                                                                                                                                    

│Ýòîêñèñêëåðîë [Ïîëèäîêàíîë]                       │âåíîñêëåðîçèðóþùåå ñðåäñòâî [C05BB02]   │ðàñòâîð äëÿ èíúåêöèé (àìïóëû) │Kreussler Pharma (Ãåðìàíèÿ)   │002653,       

                                                                                          │2 ìë - 0.5%, 1%, 2%, 3%;                                    │08.10.92      

                                                                                          │ðàñòâîð äëÿ èíúåêöèé                                                      

                                                                                          │(ôëàêîíû) 30 ìë - 0.5%, 1%,                                               

                                                                                          │2%, 3%                                                                     

                                                                                                                                                                    

│Ýòîïîçèä [Ýòîïîçèä]                               │öèòîñòàòè÷åñêîå ñðåäñòâî [L01CB01]      │ðàñòâîð äëÿ èíúåêöèé          │Abyk (Èçðàèëü)                │002896,       

                                                                                          │(ôëàêîíû) 100 ìã - 5 ìë                                     │11.03.93      

                                                                                                                                                                    

│Ýòîïîçèä [Ýòîïîçèä]                               │öèòîñòàòè÷åñêîå ñðåäñòâî [L01CB01]      │ðàñòâîð äëÿ èíúåêöèé          │Delta West (Àâñòðàëèÿ)        │006775,       

                                                                                          │(ôëàêîíû) 20 ìã - 1 ìë                                      │01.11.95      

                                                                                                                                                                    

│Ýòîïîçèä [Ýòîïîçèä]                               │öèòîñòàòè÷åñêîå ñðåäñòâî [L01CB01]      │ðàñòâîð äëÿ èíúåêöèé          │Pierre Fabre Medicament       │003467,       

                                                                                          │(ôëàêîíû) 100 ìã - 5 ìë       │(Ôðàíöèÿ)                     │28.10.93      

                                                                                                                                                                    

│Ýòîôåí [Ýòîôåíàìàò]                               │ïðîòèâîâîñïàëèòåëüíîå ñðåäñòâî äëÿ      │ãåëü (òóáû) 5%                │Ecosol AG Pharmaceutical      │006091,       

                                                  │ìåñòíîãî ïðèìåíåíèÿ [M02AA06]                                         │Production (Øâåéöàðèÿ)        │23.05.95      

                                                                                                                                                                    

│Ýòðàí [Ýíôëóðàí]                                  │íàðêîòè÷åñêîå èíãàëÿöèîííîå ñðåäñòâî    │æèäêîñòü äëÿ èíãàëÿöèîíîé     │Abbott Laboratories (Èòàëèÿ)  │005387,       

                                                  │[N01AB04]                               │àíåñòåçèè (ôëàêîíû) 125, 250                                │07.10.94      

                                                                                          │ìë                                                                        

                                                                                                                                                                    

│Ýóáåòàë àíòèáèîòèê {ðîëèòåòðàöèêëèí 5 ìã,         │ãëþêîêîðòèêîñòåðîèä+ïðîòèâîìèêðîáíîå    │êàïëè ãëàçíûå; ìàçü ãëàçíàÿ   │S.I.F.I. Spa (Èòàëèÿ)         │01926, 19.07.90│

│êîïèñòèí 180000 ÅÄ, õëîðàìôåíèêîë 4 ìã,           │ñðåäñòâî [S01CA05]                                                                                                

│áåòàìåòàçîí äèïðîïèîíàò 1 ìã}                                                                                                                                       

                                                                                                                                                                    

│Ýóãëþêîí [Ãëèáåíêëàìèä]                           │ñàõàðîñíèæàþùåå ñðåäñòâî äëÿ            │òàáëåòêè 5 ìã                 │Boehringer Mannheim GmbH      │002139,       

                                                  │ïåðîðàëüíîãî ïðèåìà [A10BB01]                                         │(Àâñòðèÿ)                     │27.05.91      

                                                                                                                                                                    

│Ýóãëþêîí [Ãëèáåíêëàìèä]                           │ñàõàðîñíèæàþùåå ñðåäñòâî äëÿ            │òàáëåòêè 5 ìã                 │Boehringer Mannheim Ltd       │002413,       

                                                  │ïåðîðàëüíîãî ïðèåìà [A10BB01]                                         │(Èíäèÿ)                       │30.01.92      

                                                                                                                                                                    

│Ýóãëþêîí [Ãëèáåíêëàìèä]                           │ñàõàðîñíèæàþùåå ñðåäñòâî äëÿ            │òàáëåòêè 5 ìã                 │Pliva (Þãîñëàâèÿ)             │2365,         

                                                  │ïåðîðàëüíîãî ïðèåìà [A10BB01]                                                                       │05.11.85,     

                                                                                                                                                      │28.03.74      

                                                                                                                                                                    

│Ýóíîêòèí [Íèòðàçåïàì]                             │òðàíêâèëèçàòîð [N05CD02]                │òàáëåòêè 10 ìã                │Gedeon Richter (Âåíãðèÿ)      │2043,         

                                                                                                                                                      │01.07.70,     

                                                                                                                                                      │30.10.87      

                                                                                                                                                                    

│Ýóòèðîêñ [Ëåâîòèðîêñèí]                           │òèðåîèäíîå ñðåäñòâî [H03AA01]           │òàáëåòêè 100 ìêã              │E.Merck (ÔÐÃ)                 │002453,       

                                                                                                                                                      │24.04.92      

                                                                                                                                                                    

│Ýóôèëëèí [Òåîôèëëèí]                              │áðîíõîäèëàòèðóþùåå ñðåäñòâî [R03DA04]   │òàáëåòêè ïîêðûòûå îáîëî÷êîé   │Byk Gulden GmbH (ÔÐÃ)         │002810,       

                                                                                          │ðåòàðä ìèòå Í 125 ìã;                                       │18.01.93      

                                                                                          │òàáëåòêè ïîêðûòûå îáîëî÷êîé                                               

                                                                                          │ðåòàðä Í 250 ìã; ðàñòâîð äëÿ                                              

                                                                                          │âíóòðèâåííîãî ââåäåíèÿ                                                    

                                                                                          │(àìïóëû) 240 ìã - 10 ìë                                                   

                                                                                                                                                                    

│Ýóôèëîíã [Òåîôèëëèí]                              │áðîíõîäèëàòèðóþùåå ñðåäñòâî [R03DA04]   │êàïñóëû 375 ìã; êàïñóëû ìèòå  │Byk Gulden GmbH (ÔÐÃ)         │002314,       

                                                                                          │250 ìã                                                      │09.01.92      

                                                                                                                                                                    

│Ýôåðîêñ [Ëåâîòèðîêñèí]                            │òèðåîèäíîå ñðåäñòâî [H03AA01]           │òàáëåòêè ïîêðûòûå îáîëî÷êîé   │Wyeth Group (ÔÐÃ)             │002849,        

                                                                                          │25, 50, 100, 150 ìêã                                        │16.02.93      

                                                                                                                                                                    

│Ýôëîðàí [Ìåòðîíèäàçîë]                            │ïðîòèâîìèêðîáíîå ñðåäñòâî [J01XD01]     │òàáëåòêè 400 ìã; ðàñòâîð äëÿ  │Krka (Þãîñëàâèÿ)              │01435, 27.04.88│

                                                                                          │èíôóçèé (ôëàêîíû) 100 ìë                                                  

                                                                                                                                                                    

│Ýôîêñ [Èçîñîðáèä ìîíîíèòðàò]                      │âàçîäèëàòèðóþùåå ñðåäñòâî [C01DA14]     │òàáëåòêè 20 ìã                │Schwarz Pharma AG (Ãåðìàíèÿ)  │002771,       

                                                                                                                                                      │19.05.94,     

                                                                                                                                                      │21.12.92      

                                                                                                                                                                     

│Ýôîêñ [Èçîñîðáèä ìîíîíèòðàò]                      │âàçîäèëàòèðóþùåå ñðåäñòâî [C01DA14]     │òàáëåòêè 20 ìã                │Schwarz Pharma Poland GmbH    │007567,       

                                                                                                                        │(Ïîëüøà)                      │04.06.96      

                                                                                                                                                                    

│Ýôîêñ ëîíã [Èçîñîðáèä ìîíîíèòðàò]                 │âàçîäèëàòèðóþùåå ñðåäñòâî [C01DA14]     │êàïñóëû ðåòàðä 50 ìã          │Schwarz Pharma AG (Ãåðìàíèÿ)  │002696,       

                                                                                                                                                      │18.11.92,     

                                                                                                                                                      │19.05.94      

                                                                                                                                                                    

│Ýôîêñ ëîíã [Èçîñîðáèä ìîíîíèòðàò]                 │âàçîäèëàòèðóþùåå ñðåäñòâî [C01DA14]     │òàáëåòêè ðåòàðä 50 ìã         │Schwarz Pharma AG (Ãåðìàíèÿ)  │006054,       

                                                                                                                                                      │17.05.95      

                                                                                                                                                                    

│Ýôôåêò {ôåíèëïðîïàíàìèí 50 ìã, õëîðôåíàìèí 8 ìã - │ñðåäñòâî äëÿ óñòðàíåíèÿ ñèìïòîìîâ       │êàïñóëû                       │Rusan Pharma (Èíäèÿ)          │006445,       

│êàïñóëà; ôåíèëïðîïàíàìèí 2 ìã, õëîðôåíàìèí 0.4 ìã │ïðîñòóäû [R05X]                                                                                     │29.08.95      

│- 1 ìë}                                                                                                                                                             

                                                                                                                                                                    

│Ýôôåðàëãàí [Ïàðàöåòàìîë]                          │àíàëüãåòè÷åñêîå íåíàðêîòè÷åñêîå         │ðàñòâîð îðàëüíûé äëÿ äåòåé    │Laboratoires Upsa (Ôðàíöèÿ)   │002479,       

                                                  │ñðåäñòâî [N02BE01]                      │(ôëàêîíû) 3 ã/100 ìë                                        │26.05.92      

                                                                                                                                                                    

│Ýôôåðàëãàí [Ïàðàöåòàìîë]                          │àíàëüãåòè÷åñêîå íåíàðêîòè÷åñêîå         │òàáëåòêè øèïó÷èå ðàñòâîðèìûå  │Laboratoires Upsa (Ôðàíöèÿ)   │003944,       

                                                  │ñðåäñòâî [N02BE01]                      │500 ìã                                                      │25.05.94      

                                                                                                                                                                    

│Ýôôåðàëãàí [Ïàðàöåòàìîë]                          │àíàëüãåòè÷åñêîå íåíàðêîòè÷åñêîå         │ïîðîøîê äëÿ ïðèãîòîâëåíèÿ     │Laboratoires Upsa (Ôðàíöèÿ)   │007146,       

                                                  │ñðåäñòâî [N02BE01]                      │îðàëüíîãî ðàñòâîðà äëÿ äåòåé                                │15.03.96      

                                                                                          │(ñàøå) 80, 150 ìã                                                         

                                                                                                                                                                    

│Ýôôåðàëãàí ñ âèòàìèíîì C {ïàðàöåòàìîë 0.33 ã,     │àíàëüãåòè÷åñêîå íåíàðêîòè÷åñêîå         │òàáëåòêè øèïó÷èå              │Laboratoires Upsa (Ôðàíöèÿ)   │002480,       

│àñêîðáèíîâàÿ êèñëîòà 0.2 ã}                       │ñðåäñòâî [N02BE51]                                                                                  │26.05.92      

                                                                                                                                                                    

│Ýôôëþìèäåêñ ëèêâèôèëì [Ôòîðìåòîëîí]               │ãëþêîêîðòèêîñòåðîèä äëÿ ìåñòíîãî        │êàïëè ãëàçíûå 0.1%            │Krka (Ñëîâåíèÿ)               │005053,       

                                                  │ïðèìåíåíèÿ [S01BA07]                                                                                │29.06.94      

                                                                                                                                                                    

│Þìåêñ [Ñåëåãèëèí]                                 │ïðîòèâîïàðêèíñîíè÷åñêîå ñðåäñòâî        │òàáëåòêè 5 ìã                 │Chinoin (Âåíãðèÿ)             │007206,       

                                                  │[N04BD01]                                                                                           │04.06.96      

                                                                                                                                                                    

│Þíèäîêñ [Äîêñèöèêëèí]                             │àíòèáèîòèê, òåòðàöèêëèí                 │êàïñóëû 100 ìã                │United Pharmaceutical         │002949,       

                                                  │ïîëóñèíòåòè÷åñêèé [J01AA02]                                           │Manufactoring Co Ltd          │31.03.93      

                                                                                                                        │(Èîðäàíèÿ)                                  

                                                                                                                                                                    

│Þíèäîêñ ñîëþòàá [Äîêñèöèêëèí]                     │àíòèáèîòèê, òåòðàöèêëèí                 │òàáëåòêè 100 ìã               │Yamanouchi Europe B.V.        │006566,       

                                                  │ïîëóñèíòåòè÷åñêèé [J01AA02]                                           │(Íèäåðëàíäû)                  │28.09.95      

                                                                                                                                                                    

│Þíèêàì [Ïèðîêñèêàì]                               │ÍÏÂÑ [M02AA07]                          │êàïñóëû 20 ìã                 │United Pharmaceutical         │002950,       

                                                                                                                        │Manufactoring Co Ltd          │31.03.93      

                                                                                                                        │(Èîðäàíèÿ)                                  

                                                                                                                                                                    

│Þíèêïåô [Ïåôëîêñàöèí]                             │ïðîòèâîìèêðîáíîå ñðåäñòâî, ôòîðõèíîëîí  │òàáëåòêè ïîêðûòûå îáîëî÷êîé   │Unique Pharmaceutical         │006132,       

                                                  │[J01MA03]                               │400 ìã; ðàñòâîð äëÿ           │Laboratories (Èíäèÿ)          │01.06.95      

                                                                                          │âíóòðèâåííîãî ââåäåíèÿ                                                    

                                                                                          │(ôëàêîíû) 4 ìã/ìë                                                         

                                                                                                                                                                     

│Þíèýíçàéì {äèàñòàçà 20 ìã, ïàïàèí 30 ìã,          │ïèùåâàðèòåëüíîå ôåðìåíòíîå ñðåäñòâî     │òàáëåòêè                      │Unichem Laboratories Ltd      │005498,       

│ñèìåòèêîí 50 ìã, íèêîòèíàìèä 25 ìã, óãîëü         │[A09AA02]                                                             │(Èíäèÿ)                       │15.11.94      

│àêòèâèðîâàííûé 75 ìã}                                                                                                                                                

                                                                                                                                                                    

│Þðàêñ [Êðîòàìèòîí]                                │ïðîòèâîïàðàçèòàðíîå ñðåäñòâî [P03AX]    │êðåì (òóáû) 10% - 60 ã;       │Bristol-Myers Squibb (ÑØÀ)    │007651,       

                                                                                          │ëîñüîí (ôëàêîíû ïëàñòèêîâûå)                                │19.07.96      

                                                                                          │10% - 60 ìë                                                               

                                                                                                                                                                    

│Þðèíåêñ [Áóìåòàíèä]                               │äèóðåòè÷åñêîå ñðåäñòâî [C03CA02]        │òàáëåòêè 1 ìã; ðàñòâîð äëÿ    │Inex Hemofarm (ÑÔÐÞ)          │01095, 09.07.84│

                                                                                          │èíúåêöèé (àìïóëû) 0.5 ìã - 2                                              

                                                                                          │ìë                                                                        

                                                                                                                                                                    

│Þòèáèä [Íîðôëîêñàöèí]                             │ïðîòèâîìèêðîáíîå ñðåäñòâî, ôòîðõèíîëîí  │òàáëåòêè 400, 800 ìã          │Lupin Laboratories Ltd (Èíäèÿ)│003729,       

                                                  │[J01MA06]                                                                                           │25.02.94      

└──────────────────────────────────────────────────┴────────────────────────────────────────┴──────────────────────────────┴──────────────────────────────┴───────────────┘

 

 

 

 

Ðàçäåë 3. ËÅÊÀÐÑÒÂÅÍÍÛÅ ÑÐÅÄÑÒÂÀ ÐÀÑÒÈÒÅËÜÍÎÃÎ ÏÐÎÈÑÕÎÆÄÅÍÈß.

 

┌──────────────────────────────┬──────────────────────────────┬──────────────────────────────┬───────────────┐

│Òîðãîâîå íàçâàíèå [Ôàðì.äåéñò]│       Ôîðìà âûïóñêà                  Ôèðìà (Ñòðàíà)        │ Íîìåð, Äàòà  

├──────────────────────────────┼──────────────────────────────┼──────────────────────────────┼───────────────┤

│Àãèîëàêñ  [ñëàáèòåëüíîå]      │ãðàíóëû                       │Madaus AG (Ãåðìàíèÿ)          │00741,        

                                                                                          │10.03.80,     

                                                                                          │12.04.95      

                                                                                                        

│Àãèîëàêñ  [ñëàáèòåëüíîå]      │ãðàíóëû                       │Madaus Cerapharm SA (Èñïàíèÿ) │002389,       

                                                                                          │29.01.92      

                                                                                                        

│Àäåíîñòîï  [ñíèæàþùåå         │ðàñòâîð  îðàëüíûé  (ôëàêîíû)  │Biofarm SA, Medchim (Ðóìûíèÿ) │007454,       

│ïðîëèôåðàöèþ  êëåòîê                                                                      │18.04.96      

│ïðîñòàòû]                                                                                               

                                                                                                        

│Àëòàëåêñ  [àíòèìèêðîáíîå,     │êàïëè  îðàëüíûå  (ôëàêîíû)    │Lek D.D.Ljubljana (Ñëîâåíèÿ)  │005041,       

│ïîâûøàþùåå  àïïåòèò,                                                                      │24.06.94      

│ñåäàòèâíîå]                                                                                             

                                                                                                        

│Àìîë  [àíàëüãåòè÷åñêîå,       │ðàñòâîð  ýôèðíûõ  ìàñåë       │Roland (Ãåðìàíèÿ)             │003912,       

│ìåñòíîðàçäðàæàþùåå]           │ñïèðòîâîé  70% (ôëàêîíû)                                    │16.05.94      

                                                                                                        

│Àíãè  Ñåïò  äîêòîðà  Òàéññà   │ïàñòèëêè                      │Naturwaren, Dr.P.Theiss       │007604,       

│[àíòèìèêðîáíîå,                                             │(Ãåðìàíèÿ)                    │24.06.96      

│ëå÷åáíî-ïðîôèëàêòè÷åñêîå                                                                                

│ñðåäñòâî,                                                                                               

│ìåñòíîàíåñòåçèðóþùåå]                                                                                   

                                                                                                        

│Àóðèòà  Òûêâåííîå  ñåìÿ       │êîìïëåêò                      │Richard Bittner GmbH (Àâñòðèÿ)│007691,       

│[àíàëüãåòè÷åñêîå,                                                                         │25.07.96      

│íîîòðîïíîå,  ñíèæàþùåå                                                                                  

│ïðîëèôåðàöèþ  êëåòîê                                                                                    

│ïðîñòàòû]                                                                                               

                                                                                                        

│Àóðèòà-êóðñ  äëÿ  ðåãåíåðàöèè │êîìïëåêò                      │Richard Bittner GmbH (Àâñòðèÿ)│007690,       

│êîæè  è óêðåïëåíèÿ  âîëîñ  è                                                              │25.07.96      

│íîãòåé  [äåðìàòîïðîòåêòèâíîå] │                                                                          

                                                                                                        

│Àóðèòà-êóðñ  îáùåóêðåïëÿþùèé  │êîìïëåêò                      │Richard Bittner GmbH (Àâñòðèÿ)│007686,       

│[äåçèíòîêñèêàöèîííîå,                                                                     │25.07.96      

│îáùåòîíèçèðóþùåå]                                                                                       

                                                                                                        

│Àóðèòà-êóðñ  ïðè              │êîìïëåêò                      │Richard Bittner GmbH (Àâñòðèÿ)│007685,       

│çàáîëåâàíèÿõ  ïå÷åíè  è                                                                   │25.07.96      

│æåë÷íîãî  ïóçûðÿ                                                                                        

│[ãåïàòîïðîòåêòîðíîå,                                                                                    

│æåë÷åãîííîå]                                                                                            

                                                                                                        

│Àóðèòà-êóðñ  ïðè  íåðâíûõ     │êîìïëåêò                      │Richard Bittner GmbH (Àâñòðèÿ)│007689,       

│ðàññòðîéñòâàõ  [ñåäàòèâíîå]                                                               │25.07.96      

                                                                                                        

│Àóðèòà-êóðñ  ïðè              │êîìïëåêò                      │Richard Bittner GmbH (Àâñòðèÿ)│007687,       

│ðàññòðîéñòâàõ  êèøå÷íèêà                                                                  │25.07.96       

                                                                                                        

│Àóðèòà-êóðñ  ïðè  ñêëîííîñòè  │êîìïëåêò                      │Richard Bittner GmbH (Àâñòðèÿ)│007692,       

│ê  çàïîðàì  [ñëàáèòåëüíîå]                                                                │25.07.96      

                                                                                                        

│Àóðèòà-êóðñ  Òîíèçèðóþùèé     │êîìïëåêò                      │Richard Bittner GmbH (Àâñòðèÿ)│007688,       

│[îáùåòîíèçèðóþùåå]                                                                        │25.07.96      

                                                                                                        

│Áàëüçàì  Çäîðîâüå             │ìàçü                          │Biopharmtech (ÑÐÂ)            │007107,       

│[àíàëüãåòè÷åñêîå,                                                                         │27.02.96       

│ìåñòíîðàçäðàæàþùåå]                                                                                     

                                                                                                        

│Áàëüçàì  Çîëîòàÿ  çâåçäà      │ìàçü                          │Biopharmtech (ÑÐÂ)            │007106,       

│[àíàëüãåòè÷åñêîå,                                                                         │27.02.96      

│ìåñòíîðàçäðàæàþùåå]                                                                                     

                                                                                                        

│Áàëüçàì  çîëîòîé  äðàêîí      │áàëüçàì  îðàëüíûé  (ôëàêîíû)  │Biopharmtech (ÑÐÂ)            │005888,       

│[àäàïòîãåííîå,                                                                            │03.04.95      

│àíòèàíãèíàëüíîå,                                                                                        

│àíòèáàêòåðèàëüíîå,                                                                                      

│ãåìîïîýòè÷åñêîå,                                                                                        

│ãèïåðòåíçèâíîå,                                                                                         

│ãèïîãëèêåìè÷åñêîå,                                                                                      

│äèóðåòè÷åñêîå,                                                                                          

│æàðîïîíèæàþùåå,                                                                                         

│ñòèìóëèðóþùåå  ÖÍÑ,                                                                                     

│óñêîðÿþùåå  ìîòîðèêó  ÆÊÒ,                                                                              

│óòåðîòîíèçèðóþùåå]                                                                                      

                                                                                                        

│Áàëüçàì Ìàóðåðà îðèãèíàëüíûé  │íàñòîéêà (ôëàêîíû) 50, 250,   │Ñåáàñòèàí Øòðî ÃìáÕ (Àâñòðèÿ) │007421,       

                              │500 ìë                                                      │08.04.96      

                                                                                                        

│Áåáèíîñ  [âåòðîãîííîå]        │êàïëè  îðàëüíûå  äëÿ  äåòåé   │Dentinox (Ãåðìàíèÿ)           │005545,       

                                                                                          │06.12.94      

                                                                                                        

│Áåêóíèñ  [ñëàáèòåëüíîå]       │äðàæå                         │Rocha Arzneimittel GmbH       │006032,       

                                                            │(Ãåðìàíèÿ)                    │05.05.95      

                                                                                                        

│Áåêóíèñ  ëåãêèé               │ãðàíóëû                       │Rocha Arzneimittel GmbH       │006030,       

│[àíîðåêñèãåííîå,                                            │(Ãåðìàíèÿ)                    │05.05.95      

│ñëàáèòåëüíîå]                                                                                           

                                                                                                        

│Áèëîáèë  [àíãèîïðîòåêòîðíîå,  │êàïñóëû  40 ìã                │Krka (Ñëîâåíèÿ)               │007464,       

│àíòèãèïîêñè÷åñêîå,                                                                        │23.04.96      

│àíòèêîàãóëÿíòíîå,                                                                                       

│íîîòðîïíîå,  ðåãåíåðèðóþùåå,                                                                            

│ñíèæàþùåå  ïðîíèöàåìîñòü                                                                                

│êàïèëëÿðîâ,  óëó÷øàþùåå                                                                                 

│ìèêðîöèðêóëÿöèþ,                                                                                        

│öåðåáðîâàçîäèëàòèðóþùåå]                                                                                

                                                                                                        

│Áèòòíåð  òðàâÿíîé  ýëèêñèð    │ýëèêñèð  îðàëüíûé  (ôëàêîíû)  │Richard Bittner GmbH (Àâñòðèÿ)│006179,       

│[àäàïòîãåííîå]                                                                            │14.06.95      

                                                                                                        

│Áðîìãåêñèí  8 [îòõàðêèâàþùåå] │êàïëè  20 ìë                  │Meuselbach Pharma GmbH (ÔÐÃ)  │002250,       

                                                                                          │14.10.91       

                                                                                                        

│Áðîíõèêóì  [îòõàðêèâàþùåå]    │êàïëè  îðàëüíûå  (ôëàêîíû);   │Rhone-Poulenc Rorer (Ãåðìàíèÿ)│005174,       

                              │ýëèêñèð  îðàëüíûé  (ôëàêîíû)                                │26.07.94      

                                                                                                        

│Áðîíõèêóì                     │÷àé  ðàñòèòåëüíûé             │Nattermann GmbH (ÔÐÃ)         │002351,       

│[àíòèáàêòåðèàëüíîå,                                                                       │16.01.92      

│îòõàðêèâàþùåå,                                                                                          

│ïðîòèâîâîñïàëèòåëüíîå]                                                                                  

                                                                                                         

│Áðîíõèêóì  áàëüçàì  ñ         │ãåëü  (ôëàêîíû)  55 ã         │Rhone-Poulenc Rorer (Ãåðìàíèÿ)│003563,       

│ýâêàëèïòîâûì  ìàñëîì                                                                      │08.12.93      

│[àíòèáàêòåðèàëüíîå,                                                                                     

│îòõàðêèâàþùåå,                                                                                          

│ïðîòèâîâîñïàëèòåëüíîå]                                                                                  

                                                                                                        

│Áðîíõèêóì  èíãàëÿò            │ýìóëüñèÿ  (ôëàêîíû)  50 ìë    │Rhone-Poulenc Rorer (Ãåðìàíèÿ)│003564,       

│[àíòèáàêòåðèàëüíîå,                                                                       │08.12.93      

│îòõàðêèâàþùåå,                                                                                          

│ïðîòèâîâîñïàëèòåëüíîå]                                                                                  

                                                                                                        

│Áðîíõèêóì  ìåäèöèíñêèå  âàííû │ðàñòâîð  (ôëàêîíû)  15 ìã/100 │Rhone-Poulenc Rorer (Ãåðìàíèÿ)│003670,       

│ñ  òèìüÿíîì                   │ìë                                                          │03.02.94      

│[àíòèáàêòåðèàëüíîå,                                                                                     

│îòõàðêèâàþùåå,                                                                                          

│ïðîòèâîâîñïàëèòåëüíîå]                                                                                  

                                                                                                        

│Áðîíõèêóì  ïàñòèëêè  îò       │ïàñòèëêè  100 ìã              │Rhone-Poulenc Rorer (Ãåðìàíèÿ)│005118,       

│êàøëÿ  [îòõàðêèâàþùåå]                                                                    │11.07.94      

                                                                                                        

│Áðîíõèêóì  ñèðîï  îò  êàøëÿ   │ñèðîï  (ôëàêîíû)              │Rhone-Poulenc Rorer (Ãåðìàíèÿ)│005519,       

│[îòõàðêèâàþùåå]                                                                           │22.11.94      

                                                                                                         

│Áðîíõîëèòèí                   │ñèðîï                         │Bulgarska Rosa (Áîëãàðèÿ)     │002359,       

│[áðîíõîëèòè÷åñêîå,                                                                        │23.01.92      

│ìåñòíîàíåñòåçèðóþùåå,                                                                                   

│ïðîòèâîêàøëåâîå]                                                                                        

                                                                                                        

│Áðîíõîëèòèí                   │ñèðîï                         │Pharmachim (ÍÐÁ)              │2381,         

│[áðîíõîëèòè÷åñêîå,                                                                        │25.07.74,     

│ìåñòíîàíåñòåçèðóþùåå,                                                                     │29.11.89      

│ïðîòèâîêàøëåâîå]                                                                                         

                                                                                                        

│Âàëîêîðäèí  [ñåäàòèâíîå,      │êàïëè  äëÿ  ïðèåìà  âíóòðü    │Krewel Meuselbach GmbH        │006670,       

│ñïàçìîëèòè÷åñêîå]             │(ôëàêîíû)                     │(Ãåðìàíèÿ)                    │26.03.96      

                                                                                                        

│Âåíåí  [àíàëüãåòè÷åñêîå,      │äðàæå;  ìàçü  (òóáû)          │CT-Arzneimittel Chemishe      │005771,       

│àíòèàãðåãàíòíîå,                                            │Tempelchof GmbH (Ãåðìàíèÿ)    │22.02.95      

│âåíîòîíèçèðóþùåå,  ñíèæàþùåå                                                                            

│ïðîíèöàåìîñòü  âåí,                                                                                     

│óëó÷øàþùåå  ìèêðîöèðêóëÿöèþ]                                                                            

                                                                                                        

│Âåíåí  [àíàëüãåòè÷åñêîå,      │ðàñòâîð  äëÿ  íàðóæíîãî       │CT-Arzneimittel Chemishe      │006196,       

│àíòèàãðåãàíòíîå,              │ïðèìåíåíèÿ  (ôëàêîíû)         │Tempelchof GmbH (Ãåðìàíèÿ)    │16.06.95      

│âåíîòîíèçèðóþùåå,  ñíèæàþùåå                                                                            

│ïðîíèöàåìîñòü  âåí,                                                                                     

│óëó÷øàþùåå  ìèêðîöèðêóëÿöèþ]                                                                            

                                                                                                        

│Âåíåí  ãåëü  äîêòîðà  Òàéññà  │ãåëü  (òóáû)  100 ã           │Naturwaren, Dr.P.Theiss       │007446,       

│[àíàëüãåòè÷åñêîå,                                           │(Ãåðìàíèÿ)                    │17.04.96      

│àíòèàãðåãàíòíîå,                                                                                        

│âåíîòîíèçèðóþùåå,  ñíèæàþùåå                                                                            

│ïðîíèöàåìîñòü  âåí,                                                                                     

│óëó÷øàþùåå  ìèêðîöèðêóëÿöèþ]                                                                            

                                                                                                         

│Âåíèòàí  [àíàëüãåòè÷åñêîå,    │êðåì  (òóáû)                  │Lek D.D.Ljubljana (Ñëîâåíèÿ)  │005039,       

│àíòèàãðåãàíòíîå,                                                                          │24.06.94      

│âåíîòîíèçèðóþùåå,  ñíèæàþùåå                                                                            

│ïðîíèöàåìîñòü  âåí,                                                                                     

│óëó÷øàþùåå  ìèêðîöèðêóëÿöèþ]                                                                            

                                                                                                        

│Âèòàëüï  ëèìîííûå  ñ          │ïàñòèëêè                      │Domaco - Dr.Aufdemaur SA      │005479,       

│ýêñòðàêòàìè                                                 │(Øâåéöàðèÿ)                   │11.11.94      

│[àíòèñåïòè÷åñêîå,                                                                                       

│ïðîòèâîêàøëåâîå]                                                                                        

                                                                                                        

│Âèòàëüï  ìåäîâûå  ñ           │ïàñòèëêè                      │Domaco - Dr.Aufdemaur SA      │005478,       

│ýêñòðàêòàìè                                                 │(Øâåéöàðèÿ)                   │11.11.94      

│[àíòèñåïòè÷åñêîå,                                                                                       

│ïðîòèâîêàøëåâîå]                                                                                        

                                                                                                        

│Âýéòàé  [ïèùåâàðèòåëüíîå,     │êàïñóëû  500 ìã;  ãðàíóëû     │Nanfang Pharmaceutical        │007034,       

│ðåãåíåðèðóþùåå,  ñíèæàþùåå    │îðàëüíûå  (ïàêåòèêè           │Factory (Êèòàé)               │31.01.96      

│êèñëîòîïðîäóêöèþ]             │îäíîðàçîâûå)  20 ã                                                        

                                                                                                        

│Ãåäåëèêñ  [îòõàðêèâàþùåå]     │êàïëè  (ôëàêîíû)  50 ìë       │Krewel Meuselbach GmbH        │007232,       

                                                            │(Ãåðìàíèÿ)                    │26.06.96      

                                                                                                         

│Ãåäåëèêñ  ñèðîï  îò  êàøëÿ    │ñèðîï  (ôëàêîíû)  100 ìë      │Krewel Meuselbach GmbH        │007233,       

│[îòõàðêèâàþùåå]                                             │(Ãåðìàíèÿ)                    │26.06.96      

                                                                                                        

│Ãåëîìèðòîë  ôîðòå             │êàïñóëû  300 ìã               │G.Pohl-Boscamp GmbH & Co      │007650,       

│[àíòèìèêðîáíîå,                                             │(Ãåðìàíèÿ)                    │17.07.96      

│ìóêîëèòè÷åñêîå,                                                                                         

│îòõàðêèâàþùåå]                                                                                          

                                                                                                        

│Ãåïàáåíå                      │êàïñóëû                       │Ludwig Merckle GmbH (Àâñòðèÿ) │006087,       

│[ãåïàòîïðîòåêòîðíîå,                                                                      │23.05.95      

│æåë÷åãîííîå,                                                                                            

│õîëåêèíåòè÷åñêîå]                                                                                       

                                                                                                        

│Ãåïàëèâ  [ãåïàòîïðîòåêòîðíîå, │òàáëåòêè                      │Torrent Exports Ltd (Èíäèÿ)   │002218,       

│æåë÷åãîííîå]                                                                              │20.08.91      

                                                                                                        

│Ãåïàòîôàëüê  ïëàíòà           │êàïñóëû                       │Dr.Falk Pharma GmbH (Ãåðìàíèÿ)│005219,       

│[ãåïàòîïðîòåêòîðíîå,                                                                      │10.08.94      

│æåë÷åãîííîå]                                                                                            

                                                                                                        

│Ãèíêèî  [àíãèîïðîòåêòîðíîå,   │òàáëåòêè  ïîêðûòûå  îáîëî÷êîé │Lichtwer Pharma (Ãåðìàíèÿ)    │007607,       

│àíòèãèïîêñè÷åñêîå,            │50 ìã                                                       │24.06.96      

│àíòèêîàãóëÿíòíîå,                                                                                       

│íîîòðîïíîå,  ðåãåíåðèðóþùåå,                                                                            

│ñíèæàþùåå  ïðîíèöàåìîñòü                                                                                

│êàïèëëÿðîâ,  óëó÷øàþùåå                                                                                 

│ìèêðîöèðêóëÿöèþ,                                                                                        

│öåðåáðîâàçîäèëàòèðóþùåå]                                                                                

                                                                                                        

│Ãèíêîð  ïðîêòî                │ñâå÷è                         │Beaufour-Ipsen International  │006405,       

│[àíãèîïðîòåêòîðíîå,                                         │(Ôðàíöèÿ)                     │15.08.95      

│àíòèãåìîððîèäàëüíîå,                                                                                     

│âåíîòîíèçèðóþùåå,                                                                                       

│ìåñòíîàíåñòåçèðóþùåå]                                                                                   

                                                                                                        

│Ãèíêîð  ôîðò                  │êàïñóëû                       │Beaufour-Ipsen (Ôðàíöèÿ)      │005279,       

│[àíãèîïðîòåêòîðíîå,                                                                       │30.08.94      

│âåíîòîíèçèðóþùåå]                                                                                       

                                                                                                        

│Ãëàêñåííà  [ñëàáèòåëüíîå]     │òàáëåòêè                      │Glaxo Laboratories Ltd (Èíäèÿ)│00575, 24.05.78│

                                                                                                         

│Äåíòèíîêñ                     │ðàñòâîð  (ôëàêîíû);  ãåëü     │Dentinox (Ãåðìàíèÿ)           │005250,       

│[ìåñòíîàíåñòåçèðóþùåå         │(òóáû)                                                      │19.08.94      

│(ïðîðåçûâàíèå  çóáîâ)]                                                                                  

                                                                                                        

│Äåïóðàôëóêñ  [ñëàáèòåëüíîå]   │ïîðîøîê  /÷àé  ðàñòèòåëüíûé   │Rhone-Poulenc Rorer (Ãåðìàíèÿ)│006607,       

                              │áûñòðîðàñòâîðèìûé                                           │20.12.95      

                              │ëåêàðñòâåííûé/  (ôëàêîíû)                                                 

                                                                                                        

│Äèåòïëàñò  ãîìåîïàòè÷åñêèé    │ïëàñòûðü                      │Four Venturis Enterprises     │005974,       

│ïëàñòûðü  äëÿ  ïîõóäàíèÿ                                    │(ÑØÀ)                         │19.04.95      

│[àíîðåêñèãåííîå]                                                                                        

                                                                                                        

│Äîêòîð  Ìîì                   │ñèðîï  ðàñòèòåëüíûé  (ôëàêîíû)│Unique Pharmaceutical         │003640,       

│[áðîíõîëèòè÷åñêîå,                                          │Laboratories (Èíäèÿ)          │25.01.94      

│îòõàðêèâàþùåå,                                                                                          

│ïðîòèâîâîñïàëèòåëüíîå,                                                                                  

│ïðîòèâîêàøëåâîå]                                                                                        

                                                                                                        

│Äîêòîð  Ìîì                   │ìàçü                          │Unique Pharmaceutical         │003915,       

│[àíàëüãåòè÷åñêîå,                                           │Laboratories (Èíäèÿ)          │17.05.94      

│ìåñòíîðàçäðàæàþùåå,                                                                                     

│ïðîòèâîâîñïàëèòåëüíîå,                                                                                  

│ïðîòèâîêàøëåâîå]                                                                                         

                                                                                                        

│Äîêòîð  Òàéñ-ëåäåíöû  ñ       │ïàñòèëêè                      │Naturwaren Ohg (Ãåðìàíèÿ)     │005491,       

│ýêñòðàêòîì  øàëôåÿ  è                                                                     │14.11.94      

│âèòàìèíîì  Ñ                                                                                            

│[àíòèñåïòè÷åñêîå,                                                                                       

│âèòàìèííîå,  âÿæóùåå,                                                                                   

│ëå÷åáíî-ïðîôèëàêòè÷åñêîå                                                                                

│ñðåäñòâî,                                                                                               

│ïðîòèâîâîñïàëèòåëüíîå                                                                                   

│ìåñòíîå]                                                                                                

                                                                                                        

│Äîêòîð  Òàéññ-ëåäåíöû  ñ      │ïàñòèëêè                      │Naturwaren, Dr.P.Theiss       │005557,       

│ýêñòðàêòîì  ýõèíàöåè                                        │(Ãåðìàíèÿ)                    │08.12.94      

│[àíòèñåïòè÷åñêîå,                                                                                       

│ëå÷åáíî-ïðîôèëàêòè÷åñêîå                                                                                

│ñðåäñòâî]                                                                                               

                                                                                                       

│Æåíü-øåíü  [àäàïòîãåííîå,     │êàïñóëû  1 ã                  │Krka (Ñëîâåíèÿ)               │006614,       

│îáùåòîíèçèðóþùåå]                                                                         │22.12.95      

                                                                                                        

│Æåíü-øåíü  [àäàïòîãåííîå,     │êàïñóëû  500 ìã               │Sunray Export-Import Company  │006525,       

│îáùåòîíèçèðóþùåå]                                           │(ÑØÀ)                         │20.09.95      

                                                                                                         

│Æåíüøåíü  ñ  âèòàìèíàìè  è    │êàïñóëû                       │Lyka Labs Ltd (Èíäèÿ)         │002276,       

│ìèíåðàëüíûìè  âåùåñòâàìè                                                                  │12.11.91      

│[àäàïòîãåííîå,                                                                                          

│îáùåòîíèçèðóþùåå]                                                                                       

                                                                                                        

│Æåíüøåíü-ìàòî÷íîå  ìîëî÷êî    │ðàñòâîð  îðàëüíûé  (ôëàêîíû)  │Harbin Medicine Co Ltd (ÊÍÐ)  │003714,       

│[àäàïòîãåííîå,                │10 ìë                                                       │21.02.94      

│áèîñòèìóëèðóþùåå,                                                                                       

│ìåòàáîëè÷åñêîå]                                                                                          

                                                                                                        

│Èëüÿ  Ðîãîâ  ôîðòå            │äðàæå                         │Rhone-Poulenc Rorer (Ãåðìàíèÿ)│003991,       

│[àäàïòîãåííîå,                                                                            │09.06.94      

│ãèïîëèïèäåìè÷åñêîå,                                                                                     

│ãèïîõîëåñòåðèíåìè÷åñêîå,                                                                                

│îáùåòîíèçèðóþùåå]                                                                                       

                                                                                                        

│Èììóíàë  [èììóíîñòèìóëèðóþùåå]│êàïëè  îðàëüíûå               │Lek D.D. (Ñëîâåíèÿ)           │006284,       

                                                                                          │13.07.95      

                                                                                                        

│Êàëåíäóëà  ãëàçíîé  êîìïëåêñ  │ãåëü                          │Naturwaren, Dr.P.Theiss       │007605,       

│äîêòîðà  Òàéññà                                             │(Ãåðìàíèÿ)                    │24.06.96      

│[ëå÷åáíî-ïðîôèëàêòè÷åñêîå                                                                               

│ñðåäñòâî  ïî  óõîäó  çà êîæåé │                                                                          

│âåê]                                                                                                    

                                                                                                        

│Êàëèôèã  [ñëàáèòåëüíîå]       │ñèðîï                         │Sterling Health               │003644,       

                                                            │(Âåëèêîáðèòàíèÿ)              │27.01.94      

                                                                                                        

│Êàìèëëîäåðì                   │ìàçü                          │Serum-Werk Bernburg AG        │006365,       

│[àíòèñåïòè÷åñêîå,                                           │(Ãåðìàíèÿ)                    │08.08.95      

│ïðîòèâîâîñïàëèòåëüíîå                                                                                   

│ìåñòíîå]                                                                                                 

                                                                                                        

│Êàìèñàí                       │ìàçü                          │Eipico (ÀÐÅ)                  │003708,       

│[ïðîòèâîâîñïàëèòåëüíîå]                                                                   │18.02.94      

                                                                                                        

│Êàíåôðîí  [àíòèáàêòåðèàëüíîå] │äðàæå;  êàïëè  îðàëüíûå       │Bionorica GmbH (Ãåðìàíèÿ)     │005326,       

                                                                                          │15.09.94      

                                                                                                        

│Êàðäèïëàíò                    │êàïñóëû  ôîðòå                │Dr.Willmar Schwabe GmbH       │006215,       

│[àíòèàðèòìè÷åñêîå,                                          │(Ãåðìàíèÿ)                    │23.06.95       

│êàðäèîòîíè÷åñêîå]                                                                                       

                                                                                                        

│Êâàé  [àíòèàãðåãàíòíîå,       │äðàæå  100 ìã                 │Lichtwer Pharma GmbH          │006835,       

│àíòèàòåðîñêëåðîòè÷åñêîå,                                    │(Ãåðìàíèÿ)                    │15.11.95      

│âàçîäèëàòèðóþùåå,                                                                                       

│ãèïîòåíçèâíîå,                                                                                          

│ôèáðèíîëèòè÷åñêîå]                                                                                      

                                                                                                        

│Êèì  áàëüçàì  íàðóæíûé        │áàëüçàì  äëÿ  íàðóæíîãî       │Sanofi Pharma (Âüåòíàì)       │005883,       

│[àíàëüãåòè÷åñêîå,             │ïðèìåíåíèÿ  (ôëàêîíû)                                       │31.03.95      

│ìåñòíîðàçäðàæàþùåå]                                                                                     

                                                                                                        

│ÊÊ (êîøà÷èé  êîãîòü)          │êàïñóëû  230 ìã               │Chimica Interamerica SA (Ïåðó)│003993,       

│[èììóíîñòèìóëèðóþùåå,                                                                     │10.06.94      

│ïðîòèâîÿçâåííîå,                                                                                        

│ðåãåíåðèðóþùåå,                                                                                         

│ñïàçìîëèòè÷åñêîå]                                                                                       

                                                                                                        

│Êëèìàäèíîí                    │òàáëåòêè  ïîêðûòûå            │Bionorica GmbH (Ãåðìàíèÿ)     │005459,       

│[àíòèàòåðîñêëåðîòè÷åñêîå,     │îáîëî÷êîé;  ðàñòâîð  îðàëüíûé │                              │04.11.94      

│àíòèêëèìàêòåðè÷åñêîå,         │(ôëàêîíû)                                                                 

│ãèïîëèïèäåìè÷åñêîå,                                                                                     

│ãèïîòåíçèâíîå,                                                                                           

│äèóðåòè÷åñêîå,  ñåäàòèâíîå,                                                                             

│ñïàçìîëèòè÷åñêîå,                                                                                       

│ýñòðîãåííîå]                                                                                            

                                                                                                        

│Êëîñòåðôðàó  Ìåëèñàíà         │êîíöåíòðàò  äëÿ  íàðóæíîãî    │MKM Klosterfrau Vertriebs     │006532,       

│[ïðîòèâîâîñïàëèòåëüíîå,       │ïðèìåíåíèÿ;  êîíöåíòðàò  äëÿ  │GmbH (Ãåðìàíèÿ)               │21.09.95      

│ðåãåíåðèðóþùåå,  ñåäàòèâíîå,  │âíóòðåííåãî  ïðèìåíåíèÿ                                                   

│ñïàçìîëèòè÷åñêîå]                                                                                       

                                                                                                        

│Êîðâàëäèí  [ñåäàòèâíîå,       │êàïëè  îðàëüíûå  (ôëàêîí      │(Óêðàèíà)                     │95/178/8      

│ñïàçìîëèòè÷åñêîå]             │êàïåëüíèöà)  - 15, 25 ìë                                                  

                                                                                                        

│Ëàéòàí  [ñåäàòèâíîå,          │êàïñóëû                       │Dr.Willmar Schwabe GmbH & Co  │006865,       

│ñïàçìîëèòè÷åñêîå]                                           │(Ãåðìàíèÿ)                    │30.11.95      

                                                                                                        

│Ëàêðè÷íèê  [àíòèñåïòè÷åñêîå]  │ïàñòèëêè                      │Kurtsan Ilaclary AS (Òóðöèÿ)  │006705,       

                                                                                         │11.10.95      

                                                                                                        

│Ëàíàòîçèä  Ö                  │äðàæå  0.25 ìã                │Biofarm-Romferchim (Ðóìûíèÿ)  │2591,         

│[êàðäèîòîíè÷åñêîå,  ñåðäå÷íûé │                                                            │12.09.94,     

│ãëèêîçèä]                                                                                 │17.01.79      

                                                                                                        

│Ëåñïåíåôðèë                   │ðàñòâîð  îðàëüíûé  (ôëàêîíû)  │Laboratoires Darsi/ucb SA     │003358,        

│[ãèïîàçîòåìè÷åñêîå]           │120 ìë                        │(Ôðàíöèÿ)                     │22.09.93      

                                                                                                        

│Ëåóçåÿ  [ñòèìóëèðóþùåå  ÖÍÑ]  │ýêñòðàêò  æèäêèé  îðàëüíûé    │Slovakofarma SA (Ñëîâàêèÿ)    │007035,       

                              │(ôëàêîíû)                                                   │31.01.96      

                                                                                                        

│Ëèâ-52 [ãåïàòîïðîòåêòîðíîå,   │òàáëåòêè;  êàïëè;  ñèðîï      │Himalaya Drug Company Ltd     │00631, 03.10.78│

│æåë÷åãîííîå]                                                │(Èíäèÿ)                                     

                                                                                                        

│Ëèâîìèí  [ãåïàòîïðîòåêòîðíîå, │òàáëåòêè                      │Charak Pharmaceutical (Èíäèÿ) │01168, 21.05.85│

│äèóðåòè÷åñêîå,  æåë÷åãîííîå,                                                                            

│ïðîòèâîâîñïàëèòåëüíîå]                                                                                  

                                                                                                        

│Ëèïîññîë  [àíòèáàêòåðèàëüíîå, │ìàçü  (òóáû)  1%              │Dong Kook Pharmaceutical Co   │006229,       

│ïðîòèâîâîñïàëèòåëüíîå,                                      │Ltd (Êîðåÿ  Þæíàÿ)            │27.06.95      

│ðåãåíåðèðóþùåå]                                                                                         

                                                                                                        

│Ëîìàãåðïàí  [ïðîòèâîâèðóñíîå, │êðåì                          │Eudac AG (Øâåéöàðèÿ)          │002273,       

│ïðîòèâîãåðïåòè÷åñêîå]                                                                     │28.10.91      

                                                                                                        

│Ì.Äæ.Ìàãèê  áàëüçàì           │ìàçü                          │M.J.Pharmaceuticals Ltd       │003372,       

│[àíàëüãåòè÷åñêîå,                                           │(Èíäèÿ)                       │05.10.93      

│ìåñòíîðàçäðàæàþùåå]                                                                                     

                                                                                                         

│Ìàðàñëàâèí  [àíòèñåïòè÷åñêîå, │æèäêîñòü                      │Pharmachim (Áîëãàðèÿ)         │2139,         

│îòâàð  ôèòîïðåïàðàòîâ,                                                                    │22.10.70,     

│ïðîòèâîâîñïàëèòåëüíîå                                                                     │28.04.84      

│ìåñòíîå]                                                                                                

                                                                                                        

│Ìàðãàëè  [ãåïàòîïðîòåêòîðíîå, │êàïñóëû  0.25 ã               │Margali (Ãðóçèÿ)              │007480,       

│æåë÷åãîííîå]                                                                              │30.04.96      

                                                                                                        

│Ìàñòîäèíîí                    │êàïëè  îðàëüíûå               │Bionorica GmbH (Ãåðìàíèÿ)     │005327,       

│[äîôàìèí-ñòèìóëèðóþùåå,                                                                   │15.09.94      

│ïðîëàêòèíà  èíãèáèòîð                                                                                   

│ñåêðåöèè,  ñðåäñòâî  äëÿ                                                                                

│ëå÷åíèÿ  ìàñòîïàòèè,                                                                                    

│ñðåäñòâî  ëå÷åíèÿ                                                                                       

│ïðåäìåíñòðóàëüíîãî  ñèíäðîìà] │                                                                          

                                                                                                         

│Ìåìîïëàíò                     │òàáëåòêè  ïîêðûòûå  îáîëî÷êîé │Dr.Willmar Schwabe GmbH & Co  │007587,       

│[àíãèîïðîòåêòîðíîå,           │40 ìã                         │(Ãåðìàíèÿ)                    │17.06.96      

│àíòèãèïîêñè÷åñêîå,                                                                                      

│àíòèêîàãóëÿíòíîå,                                                                                       

│íîîòðîïíîå,  ðåãåíåðèðóþùåå,                                                                            

│ñíèæàþùåå  ïðîíèöàåìîñòü                                                                                

│êàïèëëÿðîâ,  óëó÷øàþùåå                                                                                 

│ìèêðîöèðêóëÿöèþ,                                                                                        

│öåðåáðîâàçîäèëàòèðóþùåå]                                                                                

                                                                                                        

│Ìåíòîêëàð  [àíòèêîíãåñòèâíîå] │êàïëè  äëÿ  èíãàëÿöèé         │Lek D.D. (Ñëîâåíèÿ)           │007483,       

                              │(ôëàêîíû)  50 ìë                                          │05.05.96      

                              │êîìïëåêòå  ñ  èíãàëÿòîðîì/                                                

                                                                                                        

│Ìåíòîêëàð  [àíòèêîíãåñòèâíîå] │èíãàëÿòîð  êàðìàííûé;  ãåëü   │Lek D.D.Ljubljana (Ñëîâåíèÿ)  │005040,       

                              │äëÿ  èíãàëÿöèé;  ãåëü  äëÿ                                  │24.06.94      

                              │íàðóæíîãî  ïðèìåíåíèÿ;  êàïëè │                                            

                              │äëÿ  èíãàëÿöèé  (ôëàêîíû)                                                 

                                                                                                        

│Ìèíòîí  [àíòèìèêðîáíîå,       │ïàñòèëêè                      │Leaf (Ôèíëÿíäèÿ)              │006035,       

│ëå÷åáíî-ïðîôèëàêòè÷åñêîå                                                                  │06.05.95      

│ñðåäñòâî,  îñâåæàþùåå                                                                                   

│ïîëîñòü  ðòà]                                                                                           

                                                                                                        

│Ìèíòîí  øóãàôðè               │ïàñòèëêè                      │Leaf (Ôèíëÿíäèÿ)              │006217,       

│[àíòèìèêðîáíîå,                                                                          │23.06.95      

│ëå÷åáíî-ïðîôèëàêòè÷åñêîå                                                                                

│ñðåäñòâî,  îñâåæàþùåå                                                                                   

│ïîëîñòü  ðòà]                                                                                           

                                                                                                         

│Ìèðòèëåíå  ôîðòå              │êàïñóëû                       │S.I.F.I. Spa (Èòàëèÿ)         │01923, 19.07.90│

│[ìåòàáîëè÷åñêîå,  óëó÷øàþùåå                                                                            

│êðîâîñíàáæåíèå  ñåò÷àòêè]                                                                               

                                                                                                        

│Ìèðòîïëåêñ  [ïðîòèâîâèðóñíîå, │ìàçü  (òóáû)  5 ã             │Darou Paksh Pharmaceutical    │006827,       

│ïðîòèâîãåðïåòè÷åñêîå]                                       │Company (Èðàí)                │13.11.95      

                                                                                                        

│Ìîðèñòåðîë  [àíòèàãðåãàíòíîå, │êàïñóëû  200 ìã               │Morishita Pharmaceutical Co,  │01242, 15.02.86│

│ãèïîëèïèäåìè÷åñêîå,                                         │Ltd (ßïîíèÿ)                                

│ãèïîõîëåñòåðèíåìè÷åñêîå,                                                                                

│ñíèæàþùåå  àäñîðáöèþ                                                                                    

│õîëåñòåðèíà,  óâåëè÷èâàþùåå                                                                             

│âûâåäåíèå  õîëåñòåðèíà]                                                                                 

                                                                                                        

│Ìóñèíóì  [ñëàáèòåëüíîå]       │òàáëåòêè                      │Laboratoires Innothera        │007077,       

                                                            │(Ôðàíöèÿ)                     │13.02.96      

                                                                                                        

│Íàêñîë  [àíòèñåïòè÷åñêîå,     │àýðîçîëü                      │Human (Âåíãðèÿ)               │2859, 02.02.87 │

│äóáÿùåå,                                                                                                

│ïðîòèâîâîñïàëèòåëüíîå                                                                                   

│ìåñòíîå,  ïðîòèâîîæîãîâîå,                                                                              

│ðåãåíåðèðóþùåå]                                                                                         

                                                                                                        

│Íàñòîéêà  æåíüøåíÿ            │íàñòîéêà  (ôëàêîíû)           │Chensu Factory (ÊÍÄÐ)         │005853,       

│[àäàïòîãåííîå,                                                                            │13.03.95      

│îáùåòîíèçèðóþùåå]                                                                                       

                                                                                                        

│Íàòóðîëàêñ  [ñëàáèòåëüíîå]    │ïîðîøîê                       │Infar (india) Ltd (Èíäèÿ)     │02007, 05.11.90│

                                                                                                        

│Íåî-Àíãèí  Í                  │òàáëåòêè  áåç ñàõàðà;         │Dipharma-Knufinke             │005739,       

│[àíòèñåïòè÷åñêîå,             │òàáëåòêè                      │Arzneimittelwerk (Ãåðìàíèÿ)   │13.02.95      

│ïðîòèâîâîñïàëèòåëüíîå                                                                                   

│ìåñòíîå]                                                                                                

                                                                                                        

│Íåðâîôëóêñ  [ñåäàòèâíîå]      │ïîðîøîê  /÷àé  ðàñòèòåëüíûé   │Rhone-Poulenc Rorer (Ãåðìàíèÿ)│006606,       

                              │áûñòðîðàñòâîðèìûé                                           │20.12.95      

                              │ëåêàðñòâåííûé/  (ôëàêîíû)                                                 

                                                                                                        

│Íîâà  ôèãóðà                  │êàïñóëû                       │Naturwaren Ohg (Ãåðìàíèÿ)     │005485,       

│[àíîðåêñèãåííîå,                                                                          │14.11.94      

│ëå÷åáíî-ïðîôèëàêòè÷åñêîå                                                                                

│ñðåäñòâî,  ìåòàáîëè÷åñêîå]                                                                             

                                                                                                        

│Íîâà  ôèãóðà  êàïëè           │êàïëè                         │Naturwaren Ohg (Ãåðìàíèÿ)     │005492,       

│[àíîðåêñèãåííîå,                                                                          │14.11.94      

│ëå÷åáíî-ïðîôèëàêòè÷åñêîå                                                                                 

│ñðåäñòâî,  ìåòàáîëè÷åñêîå]                                                                              

                                                                                                        

│Íîâî-Ïàññèò  [ñåäàòèâíîå]     │ñèðîï  (ôëàêîíû)  100 ìë      │Spofa (×ÑÔÐ)                  │002772,       

                                                                                          │21.12.92      

                                                                                                        

│Íîñîâîé  èíãàëÿòîð  ÀÏ-×ÕÈ    │èíãàëÿòîð  êàðìàííûé          │Vitalos (Ñëîâàêèÿ)            │006011,       

│[àíòèêîíãåñòèâíîå,                                                                        │03.05.95      

│àíòèñåïòè÷åñêîå]                                                                                        

                                                                                                         

│Îêàìåíòîë  [àíòèìèêðîáíîå,    │ïàñòèëêè                      │Kurtsan Ilaclary AS (Òóðöèÿ)  │006706,       

│îòõàðêèâàþùåå,                                                                            │11.10.95      

│ïðîòèâîêàøëåâîå]                                                                                        

                                                                                                        

│Îðèãèíàëüíûé  áîëüøîé         │íàñòîéêà                      │Richard Bittner GmbH (Àâñòðèÿ)│006348,       

│áàëüçàì  Áèòòíåðà                                                                         │04.08.95      

│[àíàëüãåòè÷åñêîå,                                                                                       

│àíòèáàêòåðèàëüíîå,                                                                                      

│ãèïîõîëåñòåðèíåìè÷åñêîå,                                                                                

│äåçèíòîêñèêàöèîííîå,                                                                                    

│íîðìàëèçóþùåå  ôóíêöèè                                                                                  

│îðãàíîâ  ïèùåâàðåíèÿ,                                                                                   

│îáùåòîíèçèðóþùåå]                                                                                       

                                                                                                        

│Ïåêòóñèí  [îòõàðêèâàþùåå,     │òàáëåòêè                      │Natur Product (Ôðàíöèÿ)       │007419,       

│ïðîòèâîêàøëåâîå]                                                                          │05.04.96      

                                                                                                        

│Ïåïîíåí  [àíàëüãåòè÷åñêîå,    │êàïñóëû  300 ìã               │Biogal SA (Âåíãðèÿ)           │006470,       

│íîîòðîïíîå,  ñíèæàþùåå                                                                    │04.09.95      

│ïðîëèôåðàöèþ  êëåòîê                                                                                    

│ïðîñòàòû]                                                                                               

                                                                                                        

│Ïåðèäîë  [àíàëüãåòè÷åñêîå,    │òàáëåòêè  ïîêðûòûå  îáîëî÷êîé │Dong Kook Pharmaceutical Co   │007151,        

│àíòèáàêòåðèàëüíîå,                                          │Ltd (Êîðåÿ  Þæíàÿ)            │19.03.96      

│ïðîòèâîâîñïàëèòåëüíîå,                                                                                  

│ðåãåíåðèðóþùåå]                                                                                         

                                                                                                        

│Ïåðìèêñîí  [àíòèàíäðîãåííîå]  │òàáëåòêè  80 ìã               │Pierre Fabre Medicament       │006067,       

                                                            │(Ôðàíöèÿ)                     │19.05.95      

                                                                                                        

│Ïåðñåí  ôîðòå  [ñåäàòèâíîå,   │êàïñóëû                       │Lek D.D. (Ñëîâåíèÿ)           │006483,       

│ñïàçìîëèòè÷åñêîå]                                                                         │11.09.95       

                                                                                                        

│Ïèëîçóðèë  [äèóðåòè÷åñêîå]    │ðàñòâîð  îðàëüíûé  (ôëàêîíû)  │Pierre Fabre Medicament       │002920,       

                              │250 ìë                        │(Ôðàíöèÿ)                     │29.03.93      

                                                                                                        

│Ïèíîñîë  [àíòèêîíãåñòèâíîå,   │êàïëè  íàçàëüíûå  (ôëàêîíû)   │Slovakofarma SA (Ñëîâàêèÿ)    │003599,       

│àíòèñåïòè÷åñêîå,              │10 ìë                                                       │17.12.93      

│ïðîòèâîâèðóñíîå,  ñìÿã÷àþùåå] │                                                                          

                                                                                                        

│Ïèðàëâåêñ                     │ãåëü  (òóáû);  ðàñòâîð  äëÿ   │Norgine Pharma (Ôðàíöèÿ)      │006112,       

│[ïðîòèâîâîñïàëèòåëüíîå        │íàðóæíîãî  ïðèìåíåíèÿ                                       │26.05.95      

│ìåñòíîå]                      │(ôëàêîíû)                                                                 

                                                                                                        

│Ïëàíòåêñ  [âåòðîãîííîå,       │÷àé  ðàñòâîðèìûé  äëÿ  äåòåé  │Lek D.D. (Ñëîâåíèÿ)           │006330,       

│ñïàçìîëèòè÷åñêîå]                                                                         │27.07.95      

                                                                                                        

│Ïðîñòàãóò  [ñíèæàþùåå         │êàïñóëû  ìîíî;  êàïñóëû       │Dr.Willmar Schwabe GmbH       │003481,       

│ïðîëèôåðàöèþ  êëåòîê          │ôîðòå;  êàïëè                 │(Ãåðìàíèÿ)                    │02.11.93      

│ïðîñòàòû]                                                                                               

                                                                                                        

│Ïðîñòàñåðåí  [ñíèæàþùåå       │êàïñóëû  160 ìã               │Therabel Pharma SA (Áåëüãèÿ)  │006019,       

│ïðîëèôåðàöèþ  êëåòîê                                                                      │04.05.95      

│ïðîñòàòû]                                                                                               

                                                                                                        

│Ïðîñòåññ  [ñíèæàþùåå          │êàïñóëû  160 ìã               │Tad Pharmazeutisches Werk     │006276,       

│ïðîëèôåðàöèþ  êëåòîê                                        │GmbH (Ãåðìàíèÿ)               │12.07.95      

│ïðîñòàòû]                                                                                              

                                                                                                        

│Ïðîñòåññ  Óíî  [ñíèæàþùåå     │êàïñóëû  320 ìã               │Tad Pharmazeutisches Werk     │006275,       

│ïðîëèôåðàöèþ  êëåòîê                                        │GmbH (Ãåðìàíèÿ)               │12.07.95      

│ïðîñòàòû]                                                                                                

                                                                                                        

│Ïñîáåðàíîâàÿ  ìàçü            │ìàçü  (òóáû)  0.25% - 30 ã    │(Óçáåêèñòàí)                  │93/84/4       

│[ôîòîñåíñèáèëèçèðóþùåå]                                                                                 

                                                                                                        

│Ïóëüìåêñ  [áðîíõîëèòè÷åñêîå,  │ìàçü  (òóáû)                  │Zyma SA (Øâåéöàðèÿ)           │005881,       

│îòõàðêèâàþùåå,                                                                            │31.03.95      

│ïðîòèâîâîñïàëèòåëüíîå,                                                                                  

│ïðîòèâîêàøëåâîå,  óñòðàíÿþùåå │                                                                          

│ñèìïòîìû  ïðîñòóäû]                                                                                     

                                                                                                        

│Ïóëüìåêñ  áýáè                │ìàçü  (òóáû)                  │Zyma SA (Øâåéöàðèÿ)           │005882,       

│[áðîíõîëèòè÷åñêîå,                                                                        │31.03.95      

│îòõàðêèâàþùåå,                                                                                          

│ïðîòèâîâîñïàëèòåëüíîå,                                                                                  

│ïðîòèâîêàøëåâîå,  óñòðàíÿþùåå │                                                                          

│ñèìïòîìû  ïðîñòóäû]                                                                                     

                                                                                                        

│Ïóëüìîòèí  [áðîíõîëèòè÷åñêîå, │ñèðîï  (ôëàêîíû)              │Serum-Werk Bernburg AG        │006364,       

│îòõàðêèâàþùåå,                                              │(Ãåðìàíèÿ)                    │08.08.95      

│ïðîòèâîâîñïàëèòåëüíîå,                                                                                  

│ïðîòèâîêàøëåâîå]                                                                                        

                                                                                                        

│Ïóëüìîòèí  Í                  │ìàçü  (òóáû)                  │Serum-Werk Bernburg AG        │006363,       

│[áðîíõîëèòè÷åñêîå,                                          │(Ãåðìàíèÿ)                    │08.08.95      

│îòõàðêèâàþùåå,                                                                                          

│ïðîòèâîâîñïàëèòåëüíîå,                                                                                  

│ïðîòèâîêàøëåâîå]                                                                                        

                                                                                                        

│Ïóðñåííèä  [ñëàáèòåëüíîå]     │òàáëåòêè  â îáîëî÷êå  èç      │Sandoz (Òóðöèÿ)               │002099,       

                              │ñàõàðà  12 ìã                                               │04.04.91      

                                                                                                        

│Ðåâàéòë  Ãèíêî                │òàáëåòêè  ïîêðûòûå  îáîëî÷êîé │Ranbaxy Laboratories Ltd      │007584,       

│[àíãèîïðîòåêòîðíîå,           │40 ìã                         │(Èíäèÿ)                       │14.06.96      

│àíòèãèïîêñè÷åñêîå,                                                                                      

│àíòèêîàãóëÿíòíîå,                                                                                       

│íîîòðîïíîå,  ðåãåíåðèðóþùåå,                                                                            

│ñíèæàþùåå  ïðîíèöàåìîñòü                                                                                

│êàïèëëÿðîâ,  óëó÷øàþùåå                                                                                 

│ìèêðîöèðêóëÿöèþ,                                                                                        

│öåðåáðîâàçîäèëàòèðóþùåå]                                                                                

                                                                                                        

│Ðåâàéòë  ×åñíî÷íûå  æåì÷óæèíû │êàïñóëû                       │Ranbaxy Laboratories Ltd      │007493,       

│[àäàïòîãåííîå,                                              │(Èíäèÿ)                       │12.05.96      

│ãèïîëèïèäåìè÷åñêîå,                                                                                     

│ãèïîõîëåñòåðèíåìè÷åñêîå,                                                                                

│îáùåòîíèçèðóþùåå]                                                                                        

                                                                                                        

│Ðåãóëàêñ  [ñëàáèòåëüíîå]      │êóáèêè  îðàëüíûå              │Krewel Meuselbach GmbH        │007236,       

                                                            │(Ãåðìàíèÿ)                    │26.06.96      

                                                                                                        

│Ðîìàçóëàí  [àíòèñåïòè÷åñêîå,  │ðàñòâîð  (ôëàêîíû)            │Biofarm-Romferchim (Ðóìûíèÿ)  │2299,         

│äåçîäîðèðóþùåå,                                                                           │12.06.84,     

│ïðîòèâîâîñïàëèòåëüíîå                                                                     │17.10.72,     

│ìåñòíîå]                                                                                  │20.01.95      

                                                                                                         

│Ñàìîë                         │íàñòîéêà                      │Medipharma (Ãåðìàíèÿ)         │005559,       

│[ëå÷åáíî-ïðîôèëàêòè÷åñêîå                                                                 │08.12.94      

│ñðåäñòâî,  ñåäàòèâíîå,                                                                                  

│ñïàçìîëèòè÷åñêîå,                                                                                       

│óñòðàíÿþùåå  ñèìïòîìû                                                                                   

│ïðîñòóäû]                                                                                               

                                                                                                        

│Ñàíîñàí  [ñåäàòèâíîå,         │òàáëåòêè  ïîêðûòûå  îáîëî÷êîé │Lek D.D. (Ñëîâåíèÿ)           │006425,       

│ñíîòâîðíîå]                                                                               │18.08.95      

                                                                                                        

│Ñåíàäå  [ñëàáèòåëüíîå]        │òàáëåòêè  13.5 ìã             │Cipla Ltd (Èíäèÿ)             │007268,       

                                                                                          │30.07.96      

                                                                                                        

│Ñåííà  [ñëàáèòåëüíîå]         │òàáëåòêè  7.5 ìã              │Remedica Ltd - Minnex (Êèïð)  │006798,       

                                                                                          │09.11.95      

                                                                                                        

│Ñåííîçèä-Òåâà  [ñëàáèòåëüíîå] │òàáëåòêè  12 ìã               │Teva Pharmaceutical           │006738,       

                                                            │Industries Ltd (Èçðàèëü)      │23.10.95      

                                                                                                        

│Ñåïòîëåòå  [àíòèñåïòè÷åñêîå,  │äðàæå                         │Krka (Ñëîâåíèÿ)               │002484,       

│ïðîòèâîâîñïàëèòåëüíîå                                                                     │27.05.92      

│ìåñòíîå]                                                                                                

                                                                                                         

│Ñåðïåíñ  [àíòèàíäðîãåííîå]    │êàïñóëû  160 ìã               │Lisapharma (Èòàëèÿ)           │005546,       

                                                                                          │06.12.94      

                                                                                                        

│Ñèäàëåïà  [àíàëüãåòè÷åñêîå,   │áàëüçàì  äëÿ  íàðóæíîãî       │Hettigoda Industries Ltd (Øðè │005938,       

│ïðîòèâîâîñïàëèòåëüíîå]        │ïðèìåíåíèÿ  (ôëàêîíû)         │Ëàíêà)                        │07.04.95      

                                                                                                        

│Ñèíóïðåò  [àíòèìèêðîáíîå,     │äðàæå;  êàïëè  îðàëüíûå       │Bionorica GmbH (Ãåðìàíèÿ)     │005106,       

│ìóêîëèòè÷åñêîå,               │(ôëàêîíû)                                                   │08.07.94      

│îòõàðêèâàþùåå,                                                                                           

│ïðîòèâîâîñïàëèòåëüíîå]                                                                                  

                                                                                                        

│Ñèíóñàí  [àíòèêîíãåñòèâíîå,   │ìàñëî  äëÿ  íàðóæíîãî         │Fidipharm Ltd (Õîðâàòèÿ)      │006871,       

│àíòèñåïòè÷åñêîå,              │ïðèìåíåíèÿ  (ôëàêîíû)                                       │01.12.95      

│âàçîêîíñòðèêòîðíîå,                                                                                     

│ïðîòèâîâîñïàëèòåëüíîå]                                                                                  

                                                                                                        

│Ñèðîï  ñ  ýêñòðàêòîì          │ñèðîï                         │Naturwaren, Dr.P.Theiss       │005465,       

│ïîäîðîæíèêà  îò  êàøëÿ                                      │(Ãåðìàíèÿ)                    │09.11.94      

│[ëå÷åáíî-ïðîôèëàêòè÷åñêîå                                                                               

│ñðåäñòâî,  îòõàðêèâàþùåå]                                                                               

                                                                                                        

│Ñïàçìîöèñòåíàë                │êàïëè  (ôëàêîíû)              │Galena Opava (×åõèÿ)          │006588,       

│[àíòèñåïòè÷åñêîå,                                                                         │25.10.95      

│çàêèñëÿþùåå  ìî÷ó,                                                                                      

│ñåäàòèâíîå,  ñïàçìîëèòè÷åñêîå]│                                                                          

                                                                                                        

│Ñïåìàí  [ïîâûøàþùåå           │òàáëåòêè;  òàáëåòêè  ôîðòå    │Himalaya Drug Company Ltd     │003060,       

│ïîòåíöèþ,  ïðåäóïðåæäàþùåå                                  │(Èíäèÿ)                       │15.06.93      

│ïðåæäåâðåìåííóþ  ýÿêóëÿöèþ,                                                                             

│ñòèìóëèðóþùåå  ñïåðìàòîãåíåç, │                                                                          

│óìåíüøàþùåå  ðàçìåðû                                                                                    

│ïðîñòàòû]                                                                                                

                                                                                                        

│Ñòîìåä  [äèóðåòè÷åñêîå,       │òàáëåòêè  ïîêðûòûå  îáîëî÷êîé │Multani Pharmaceuticals       │006881,       

│ñïàçìîëèòè÷åñêîå]                                           │(Èíäèÿ)                       │08.12.95      

                                                                                                        

│Òàäåíàí                       │êàïñóëû  50 ìã                │Laboratoires Debat,           │007105,       

│[ïðîòèâîâîñïàëèòåëüíîå]                                     │Laboratoires Furnie Sca       │26.02.96      

                                                            │(Ôðàíöèÿ)                                   

                                                                                                        

│Òàíàêàí  [àíãèîïðîòåêòîðíîå,  │òàáëåòêè  40 ìã;  ðàñòâîð     │Beaufour-Ipsen International  │003877,       

│àíòèãèïîêñè÷åñêîå,            │îðàëüíûé  (ôëàêîíû)  40 ìã/ìë │(Ôðàíöèÿ)                     │26.04.94      

│àíòèêîàãóëÿíòíîå,                                                                                       

│íîîòðîïíîå,  ðåãåíåðèðóþùåå,                                                                            

│ñíèæàþùåå  ïðîíèöàåìîñòü                                                                                

│êàïèëëÿðîâ,  óëó÷øàþùåå                                                                                 

│ìèêðîöèðêóëÿöèþ,                                                                                        

│öåðåáðîâàçîäèëàòèðóþùåå]                                                                                

                                                                                                       

│Òåíòåêñ  [ïîâûøàþùåå          │òàáëåòêè  ôîðòå               │Himalaya Drug Company Ltd     │002162,       

│ïîòåíöèþ]                                                   │(Èíäèÿ)                       │19.06.91      

                                                                                                        

│Òåðïîí  [àíòèìèêðîáíîå,       │ñèðîï  200 ìë;  ñâå÷è  50 ìã  │Laboratoires Rosa-Phytopharma │01322, 17.02.87│

│æàðîïîíèæàþùåå,                                             │(Ôðàíöèÿ)                                   

│ìóêîëèòè÷åñêîå,                                                                                          

│îòõàðêèâàþùåå,                                                                                          

│ïðîòèâîêàøëåâîå]                                                                                        

                                                                                                        

│Òèñàñåí  [ñëàáèòåëüíîå]       │äðàæå                         │Alkaloida (ÂÍÐ)               │2570,         

                                                                                          │01.08.78,     

                                                                                          │17.05.89      

                                                                                                        

│Òîíçèëãîí                     │äðàæå;  ðàñòâîð  îðàëüíûé     │Bionorica GmbH (Ãåðìàíèÿ)     │005360,       

│[àíòèáàêòåðèàëüíîå,           │(ôëàêîíû)                                                   │23.09.94      

│èììóíîñòèìóëèðóþùåå,                                                                                    

│ïðîòèâîâèðóñíîå,                                                                                        

│ïðîòèâîâîñïàëèòåëüíîå]                                                                                  

                                                                                                        

│Òðàâà  Ïîë-Ïàëà               │òðàâà  èçìåëü÷åííàÿ           │Jafferjee Brothers (Øðè       │007611,       

│[àíòèñåïòè÷åñêîå,             │(ïàêåòèêè)  100 ã             │Ëàíêà)                        │28.06.96      

│äèóðåòè÷åñêîå]                                                                                          

                                                                                                        

│Òðàâà  Ýõèíàöåè  â êàïëÿõ     │íàñòîéêà                      │Naturwaren, Dr.P.Theiss       │005466,       

│[àíòèñåïòè÷åñêîå,                                           │(Ãåðìàíèÿ)                    │09.11.94      

│ëå÷åáíî-ïðîôèëàêòè÷åñêîå                                                                                

│ñðåäñòâî]                                                                                               

                                                                                                        

│Òðèàíîë                       │êàïñóëû  25 ìã                │Lek (Þãîñëàâèÿ)               │01379, 29.10.87│

│[ïðîòèâîâîñïàëèòåëüíîå]                                                                                 

                                                                                                        

│Òóðèíîéðèí  [àíòèñåïòè÷åñêîå, │êàïñóëû                       │Jenapharm GmbH (Ãåðìàíèÿ)     │006760,       

│âÿæóùåå,                                                                                  │31.10.95      

│ïðîòèâîâîñïàëèòåëüíîå                                                                                   

│ìåñòíîå]                                                                                                

                                                                                                        

│Òóðèïëåêñ                     │êàïñóëû                       │Jenapharm GmbH (Ãåðìàíèÿ)     │006913,       

│[ãåïàòîïðîòåêòîðíîå,                                                                      │19.12.95       

│æåë÷åãîííîå]                                                                                            

                                                                                                        

│Òóññàìàã  [îòõàðêèâàþùåå,     │ñèðîï  áåç ñàõàðà             │CT-Arzneimittel Chemishe      │003443,       

│ïðîòèâîêàøëåâîå]                                            │Tempelchof GmbH (Ãåðìàíèÿ)    │22.10.93      

                                                                                                        

│Òóññàìàã  [îòõàðêèâàþùåå,     │ñèðîï                         │CT-Arzneimittel Chemishe      │003966,       

│ïðîòèâîêàøëåâîå]                                            │Tempelchof GmbH (Ãåðìàíèÿ)    │01.06.94      

                                                                                                        

│Òóññàìàã  [îòõàðêèâàþùåå,     │êàïëè  îðàëüíûå  (ôëàêîíû)    │CT-Arzneimittel Chemishe      │005779,        

│ïðîòèâîêàøëåâîå]              </